data_2m9o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m9o _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.6 mt -135.47 121.69 14.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 117.174 0.487 . . . . 0.0 110.465 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.498 ' CB ' HD13 ' A' ' 25' ' ' ILE . 86.1 Cg_endo -78.33 47.54 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.949 2.433 . . . . 0.0 112.376 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.97 37.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.157 0.503 . . . . 0.0 112.336 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -89.58 -33.28 16.76 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.03 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.17 29.31 50.96 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.215 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.48 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 53.0 mt-10 -135.32 154.59 51.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.275 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.1 p -103.12 143.46 32.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.428 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.44 40.69 3.15 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.251 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.647 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -73.27 -27.37 61.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.798 ' H ' HD22 ' A' ' 11' ' ' LEU . 2.6 pt? -81.87 -19.82 40.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.611 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 90.96 44.44 4.46 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.159 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.0 m -156.89 152.91 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -145.98 127.51 15.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -91.08 -19.4 23.18 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.003 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.565 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.45 155.62 40.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.509 0.671 . . . . 0.0 112.15 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -81.89 133.8 35.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.359 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 67.58 9.72 56.16 Favored Glycine 0 C--N 1.329 0.177 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.776 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 84.2 m -88.4 134.32 33.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.2 p -111.08 142.53 43.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.34 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.44 117.5 5.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.072 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 m -136.2 72.27 1.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.647 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.3 t90 -35.7 129.1 0.59 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 124.32 1.013 . . . . 0.0 112.256 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.1 Cg_endo -97.47 28.97 15.61 Favored 'Cis proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.26 -1.558 . . . . 0.0 114.163 1.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -132.87 -166.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 112.184 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.1 m -124.35 136.63 54.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.0 ttpp -126.16 123.25 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 111.446 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.634 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 12.2 ptm180 -104.59 133.73 48.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 112.73 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.672 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -130.68 126.13 21.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.791 ' HB3' HD13 ' A' ' 25' ' ' ILE . 7.8 Cg_exo -73.54 48.4 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.582 2.854 . . . . 0.0 112.805 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.02 38.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.498 0.666 . . . . 0.0 111.857 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.545 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 26.9 m -105.13 -33.47 8.26 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.368 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.17 55.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.986 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.511 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-10 -134.4 145.88 49.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.954 0.407 . . . . 0.0 110.922 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.8 p -97.89 145.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -127.46 38.84 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.214 -0.994 . . . . 0.0 112.085 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.586 HG23 HD23 ' A' ' 11' ' ' LEU . 13.5 t -64.88 -24.28 67.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.063 0.459 . . . . 0.0 109.837 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.586 HD23 HG23 ' A' ' 10' ' ' THR . 2.6 mm? -80.47 -16.03 55.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.171 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.03 46.33 4.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.84 154.56 32.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -146.63 130.51 17.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.511 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 4.8 m-85 -96.66 -24.67 15.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.364 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -70.97 152.76 43.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.607 0.718 . . . . 0.0 112.376 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.19 136.53 38.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.574 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.39 10.41 42.27 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 93.2 m -91.56 132.28 36.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.235 0.54 . . . . 0.0 110.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -108.42 140.84 41.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -73.25 119.4 17.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.553 0.692 . . . . 0.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -137.14 84.02 2.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.583 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 11.8 t90 -31.56 124.12 0.35 Allowed Pre-proline 0 C--O 1.231 0.127 0 O-C-N 124.736 1.272 . . . . 0.0 112.759 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 90.6 Cg_endo -104.44 30.27 8.19 Favored 'Cis proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.377 -1.51 . . . . 0.0 114.397 1.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.791 HD13 ' HB3' ' A' ' 3' ' ' PRO . 9.0 pt -136.45 161.01 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 68.9 m -96.97 131.87 43.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.014 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.672 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 11.9 pttp -132.72 135.88 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.095 0.474 . . . . 0.0 111.667 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' HB ' ' A' ' 16' ' ' THR . 12.6 ptp180 -103.79 134.81 46.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--N 1.323 -0.551 0 O-C-N 123.678 0.611 . . . . 0.0 110.778 -179.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.169 -0.239 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.407 ' HA ' HD21 ' A' ' 2' ' ' LEU . 91.3 mt -123.18 121.32 27.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.215 0.507 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.7 Cg_endo -73.1 48.43 1.45 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.98 2.454 . . . . 0.0 112.913 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.29 38.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.374 0.607 . . . . 0.0 111.715 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 22.2 m -95.3 -32.76 12.83 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.328 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.04 44.01 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.814 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 16.3 mt-10 -88.86 140.15 29.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.445 0.641 . . . . 0.0 111.658 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -97.69 148.04 23.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.197 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -144.58 128.09 17.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.687 0.756 . . . . 0.0 111.236 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.776 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -120.99 -32.63 3.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.137 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.45 -43.12 19.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.072 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.585 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 126.89 47.3 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.156 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -128.34 139.43 52.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.834 -0.183 . . . . 0.0 111.479 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -147.52 125.95 12.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 6.7 m-85 -95.93 -20.5 18.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.264 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.541 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -67.94 155.53 39.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.42 0.629 . . . . 0.0 111.762 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.9 132.17 35.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.453 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 64.93 17.69 63.46 Favored Glycine 0 C--N 1.329 0.165 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.484 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 82.2 m -97.48 135.34 39.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.094 0.473 . . . . 0.0 111.129 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 p -116.64 138.0 51.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.064 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 48.9 t -65.22 122.39 16.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.275 0.56 . . . . 0.0 110.884 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m -136.09 81.12 1.86 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.776 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 6.3 t90 -29.18 120.21 0.28 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.618 1.199 . . . . 0.0 112.814 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 92.9 Cg_endo -104.88 37.09 4.6 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.912 -1.287 . . . . 0.0 114.624 1.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 25' ' ' ILE . 5.2 tt -150.61 150.18 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.2 m -80.75 136.48 36.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.587 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 23.4 pttm -125.05 130.63 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 0.0 111.223 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.721 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 13.8 ptm180 -104.31 128.08 52.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 109.876 -178.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 113.817 0.287 . . . . 0.0 113.817 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -120.62 126.05 26.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.405 0.603 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.65 ' HB3' HD11 ' A' ' 25' ' ' ILE . 59.3 Cg_endo -71.76 49.95 1.3 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.276 2.651 . . . . 0.0 113.344 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -104.67 39.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.0 111.835 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -96.66 -34.7 11.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 26.68 56.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -131.88 155.38 47.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.026 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.0 p -108.21 141.71 39.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.122 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 6.1 t -115.27 38.91 3.07 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.371 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.675 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.0 t -72.55 -33.61 66.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 10' ' ' THR . 92.8 mt -82.92 -16.19 48.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.322 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.505 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 86.43 38.26 8.41 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.693 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -143.66 135.37 26.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.103 0.161 . . . . 0.0 111.32 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -154.63 130.59 10.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.5 10.28 31.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.818 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.514 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -79.72 155.4 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.696 0.76 . . . . 0.0 112.091 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.22 130.7 40.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.555 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.13 27.48 46.12 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.7 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 81.3 m -99.36 134.76 41.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.935 0.397 . . . . 0.0 110.643 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.4 p -111.52 139.66 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.484 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 24.8 t -60.3 117.92 5.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 0.0 110.602 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m -137.39 75.31 1.52 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.675 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 27.7 t90 -35.78 128.68 0.61 Allowed Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 124.156 0.91 . . . . 0.0 112.321 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.8 Cg_endo -97.4 27.99 16.96 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.291 -1.546 . . . . 0.0 114.244 1.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 3' ' ' PRO . 7.3 pt -133.11 -159.57 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.211 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 13.6 m -142.48 140.52 31.91 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -121.84 132.9 54.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.449 0.642 . . . . 0.0 112.131 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.701 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 22.6 ttm180 -102.56 125.31 49.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.445 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.767 -178.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.8 mt -133.82 120.61 15.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.873 ' HB3' HD11 ' A' ' 25' ' ' ILE . 2.8 Cg_exo -76.49 48.98 2.52 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.496 2.798 . . . . 0.0 112.284 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.463 HG21 HH11 ' A' ' 28' ' ' ARG . 8.1 m -103.59 31.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.321 0.581 . . . . 0.0 111.983 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 32.3 m -89.54 -34.82 16.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.78 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.14 30.5 50.61 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.573 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 16' ' ' THR . 79.9 mt-10 -136.27 148.83 48.2 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.7 p -96.64 143.8 27.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -123.93 33.23 5.36 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.5 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.617 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.6 t -63.27 -26.42 68.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 110.095 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.88 -6.47 58.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.656 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.74 43.47 10.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.151 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -154.54 156.06 35.95 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.0 m -145.23 129.93 18.08 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.08 -24.26 17.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.984 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.561 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -70.38 154.41 41.92 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.736 0.779 . . . . 0.0 112.491 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -76.32 131.84 39.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.265 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 17.28 59.21 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.419 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 87.7 m -93.08 136.11 33.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.933 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -112.38 142.6 44.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.054 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.03 121.99 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 111.122 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.1 m -135.4 74.96 1.54 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.617 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.7 t90 -28.92 124.4 0.26 Allowed Pre-proline 0 C--O 1.232 0.148 0 O-C-N 124.858 1.349 . . . . 0.0 113.142 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.2 Cg_endo -103.22 32.22 8.1 Favored 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.393 -1.503 . . . . 0.0 114.221 0.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.873 HD11 ' HB3' ' A' ' 3' ' ' PRO . 8.0 pt -133.8 160.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 72.9 m -91.14 134.82 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.036 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 15.9 ttpt -131.65 123.1 27.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.781 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 9.6 ptp85 -107.68 135.77 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.583 0.23 . . . . 0.0 110.574 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.133 179.705 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 CA-C-O 120.29 -0.172 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.498 ' HA ' HD11 ' A' ' 2' ' ' LEU . 2.7 mm? -133.48 132.48 21.93 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.979 0.389 . . . . 0.0 110.118 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.5 Cg_endo -73.54 49.34 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.782 2.321 . . . . 0.0 112.196 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.61 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.203 0.525 . . . . 0.0 112.328 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.623 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 37.0 m -89.31 -29.39 19.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.74 30.93 57.18 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.143 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -138.18 153.06 49.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 p -98.35 143.27 29.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.566 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.2 p -116.83 32.48 6.13 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.154 -1.019 . . . . 0.0 112.14 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.535 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -65.04 -29.49 70.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -3.97 55.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.942 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 75.43 46.27 15.8 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.425 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.0 m -157.29 154.26 28.77 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.636 -0.332 . . . . 0.0 110.631 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -151.33 126.01 9.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -80.1 -32.98 39.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 2.2 p -58.76 153.69 16.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.707 0.765 . . . . 0.0 112.872 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -79.62 131.17 35.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.43 24.51 75.05 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.931 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.003 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 7.7 t -93.33 147.07 23.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.4 p -128.95 141.98 51.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.05 126.21 28.95 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.639 0.733 . . . . 0.0 111.4 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 m -135.54 66.82 1.5 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.535 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.9 t90 -26.97 124.36 0.22 Allowed Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.483 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.2 Cg_endo -101.17 27.3 14.18 Favored 'Cis proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.2 -1.583 . . . . 0.0 113.898 0.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.495 HD11 HG23 ' A' ' 25' ' ' ILE . 6.0 pt -121.04 154.05 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.003 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 67.0 m -88.45 137.25 32.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.687 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 18.5 ttpt -133.45 115.4 14.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.561 0.22 . . . . 0.0 111.57 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -108.28 140.68 41.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA2' ' HE2' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.57 0 CA-C-O 120.237 -0.202 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 2' ' ' LEU . 3.4 mm? -119.16 125.29 27.7 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.144 0.472 . . . . 0.0 110.559 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.735 ' HB3' HD13 ' A' ' 25' ' ' ILE . 73.1 Cg_endo -75.99 49.91 2.66 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.264 2.643 . . . . 0.0 112.69 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.45 31.35 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.538 0.685 . . . . 0.0 111.48 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 16.5 m -98.18 -33.94 10.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.517 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.01 56.58 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.802 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.505 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-10 -134.0 146.49 50.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.58 145.19 26.51 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.697 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 10.3 p -127.22 37.96 4.16 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.052 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.653 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.2 t -63.03 -30.33 71.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.038 0.447 . . . . 0.0 110.029 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.06 -1.24 47.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.937 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.7 48.63 10.02 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.484 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -151.21 151.8 32.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.685 -0.303 . . . . 0.0 110.463 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.0 m -148.79 132.34 16.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.505 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 8.5 m-85 -102.25 -20.75 14.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.272 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.1 p -72.71 152.19 41.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.642 0.734 . . . . 0.0 112.328 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -75.56 134.47 40.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.663 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.27 4.34 29.33 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.32 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 87.8 m -85.05 135.88 33.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.228 0.537 . . . . 0.0 111.483 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 p -113.05 144.18 43.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.2 t -75.29 121.24 21.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.465 0.65 . . . . 0.0 111.423 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.1 m -135.67 83.16 2.0 Allowed 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.653 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 18.0 t90 -31.71 124.46 0.35 Allowed Pre-proline 0 C--N 1.332 -0.167 0 O-C-N 124.644 1.215 . . . . 0.0 112.81 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -104.73 32.28 6.91 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.528 -1.446 . . . . 0.0 114.304 0.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.735 HD13 ' HB3' ' A' ' 3' ' ' PRO . 9.2 pt -135.19 158.67 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -95.0 130.34 41.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HE2' ' HA2' ' A' ' 1' ' ' GLY . 18.5 ptmt -135.89 133.44 37.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.6 ptp85 -103.04 133.66 47.78 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.268 -178.72 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.28 -0.178 . . . . 0.0 113.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.0 138.73 28.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.787 0.327 . . . . 0.0 110.499 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.34 52.67 2.84 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.846 2.364 . . . . 0.0 111.94 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.54 49.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.606 0.717 . . . . 0.0 112.211 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.604 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.0 m -119.43 -33.9 3.96 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.165 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.48 30.33 56.74 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.787 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.06 151.27 49.66 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 25.1 p -98.2 143.82 28.3 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -121.95 34.83 5.05 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.813 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.601 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.9 t -62.66 -30.42 71.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 110.135 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.404 ' N ' HG23 ' A' ' 10' ' ' THR . 92.3 mt -81.72 -2.75 51.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.972 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 76.33 46.78 11.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 1.8 m -152.91 154.42 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.752 -0.263 . . . . 0.0 110.436 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -151.38 125.39 9.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.86 -22.86 27.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.557 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.619 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -70.93 156.84 39.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.674 0.749 . . . . 0.0 112.252 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.63 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 15.6 mp0 -89.97 131.62 35.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.599 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.56 16.43 80.1 Favored Glycine 0 N--CA 1.454 -0.148 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.25 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.4 m -100.61 135.35 42.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.8 p -115.74 142.32 46.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.419 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.75 121.52 16.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.609 0.718 . . . . 0.0 111.195 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -134.44 74.68 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.601 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.2 t90 -29.44 124.18 0.27 Allowed Pre-proline 0 C--O 1.231 0.118 0 O-C-N 124.829 1.331 . . . . 0.0 113.01 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.2 Cg_endo -103.42 31.57 8.31 Favored 'Cis proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.408 -1.496 . . . . 0.0 114.214 0.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 11.4 pt -132.89 158.47 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 74.7 m -86.53 132.21 33.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 14.7 ttmt -121.58 118.08 28.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 0.0 111.984 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.763 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 27.0 ttp180 -104.68 133.6 49.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.585 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 124.051 0.94 . . . . 0.0 112.644 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 113.334 0.093 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.5 mt -125.01 124.47 25.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.955 0.377 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.756 ' HB3' HD13 ' A' ' 25' ' ' ILE . 73.9 Cg_endo -75.53 49.24 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.044 2.496 . . . . 0.0 113.101 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.525 HG21 ' HD3' ' A' ' 28' ' ' ARG . 4.0 m -103.36 54.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.976 0.893 . . . . 0.0 111.659 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HB3' HG21 ' A' ' 16' ' ' THR . 58.0 m -128.64 -32.16 2.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.438 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.77 32.88 39.43 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.597 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 10.8 pt-20 -139.2 143.85 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.528 0.68 . . . . 0.0 112.367 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.3 p -92.13 146.37 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.191 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 12.6 p -125.7 37.19 4.41 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.304 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.552 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.7 t -62.62 -27.6 69.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.097 0.475 . . . . 0.0 110.047 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.46 -9.07 59.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.893 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.405 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 81.66 47.91 6.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.519 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 1.8 m -155.51 154.52 31.92 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.695 -0.297 . . . . 0.0 110.36 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -145.99 130.28 17.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -88.04 -30.38 19.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.692 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 5' ' ' CYS . 73.5 p -72.86 150.97 42.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.439 0.638 . . . . 0.0 111.816 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -82.59 133.94 35.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.92 50.34 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.127 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.446 ' HB2' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -74.46 146.68 42.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.096 0.474 . . . . 0.0 110.954 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -127.0 142.02 51.65 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.87 121.28 14.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.709 . . . . 0.0 111.473 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -135.73 69.89 1.43 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.552 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 10.4 t90 -24.69 128.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 125.055 1.472 . . . . 0.0 113.323 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 72.2 Cg_endo -98.19 23.35 22.81 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.997 -1.668 . . . . 0.0 114.237 0.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.756 HD13 ' HB3' ' A' ' 3' ' ' PRO . 7.5 pt -134.97 158.75 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 121.81 -0.556 . . . . 0.0 112.306 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 73.2 m -85.24 138.12 32.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.583 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -133.48 130.15 38.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.525 ' HD3' HG21 ' A' ' 4' ' ' VAL . 14.0 ptm180 -102.79 121.15 41.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.077 -177.582 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.454 0 CA-C-O 120.439 -0.089 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.9 mt -131.83 127.71 21.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.292 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 5.7 Cg_exo -74.66 49.35 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.311 2.674 . . . . 0.0 112.526 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 m -103.88 43.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.344 0.592 . . . . 0.0 112.286 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.0 m -99.43 -35.32 9.94 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.764 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.07 28.67 40.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.92 151.4 49.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 110.853 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -97.61 143.16 28.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.459 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 9.0 p -120.26 34.87 5.05 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.823 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -65.12 -24.86 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.067 0.461 . . . . 0.0 109.962 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.58 -15.28 57.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.03 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.53 43.63 6.09 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.981 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -154.78 156.94 37.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -149.56 126.63 11.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.83 -22.19 25.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.696 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.654 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.67 159.11 35.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.673 0.749 . . . . 0.0 112.55 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -80.73 131.77 35.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.179 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.05 18.79 65.14 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.115 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 72.3 m -92.91 134.02 35.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.067 0.46 . . . . 0.0 110.651 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 p -114.57 144.14 43.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.8 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -70.75 122.95 20.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.677 0.751 . . . . 0.0 111.254 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -135.17 71.0 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.571 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 17.3 t90 -27.39 123.57 0.24 Allowed Pre-proline 0 N--CA 1.462 0.172 0 O-C-N 125.002 1.439 . . . . 0.0 113.287 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 96.9 Cg_endo -103.16 31.23 8.71 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.348 -1.521 . . . . 0.0 114.016 0.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.81 158.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.4 m -89.96 135.42 33.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.287 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 12.8 ttmt -124.79 117.72 24.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.664 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.757 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.9 ptm180 -108.22 133.3 52.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.432 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 CA-C-O 120.355 -0.136 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.1 mt -131.31 125.21 20.75 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.854 0.359 . . . . 0.0 110.157 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.824 ' HB3' HD11 ' A' ' 25' ' ' ILE . 2.8 Cg_exo -75.86 47.92 2.08 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.192 2.594 . . . . 0.0 112.382 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 m -104.85 45.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 35.5 m -97.96 -33.43 11.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.798 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.01 30.8 45.53 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.026 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.71 153.66 50.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.043 0.449 . . . . 0.0 110.529 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 40.9 p -101.37 143.0 31.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 t -122.19 41.88 3.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.779 HG22 HD23 ' A' ' 11' ' ' LEU . 14.7 t -73.04 -26.02 61.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.779 HD23 HG22 ' A' ' 10' ' ' THR . 2.4 mm? -81.38 -18.8 44.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.401 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.9 34.93 7.42 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.437 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.0 p -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.573 0.349 . . . . 0.0 110.608 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.2 m -131.19 123.95 29.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.99 -25.63 27.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.767 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.612 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -68.21 153.93 42.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.589 0.709 . . . . 0.0 111.994 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -86.38 138.35 31.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.526 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 66.87 16.04 65.56 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.612 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 86.4 m -100.59 134.98 42.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -109.77 144.29 38.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.75 118.4 8.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.546 0.689 . . . . 0.0 110.414 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -136.21 73.17 1.45 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.72 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 26.9 t90 -34.44 127.3 0.49 Allowed Pre-proline 0 N--CA 1.465 0.29 0 O-C-N 124.367 1.042 . . . . 0.0 112.236 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -98.92 30.48 12.63 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 -1.471 . . . . 0.0 114.169 0.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.824 HD11 ' HB3' ' A' ' 3' ' ' PRO . 8.6 pt -133.71 -164.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.965 0.412 . . . . 0.0 111.801 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.6 m -125.62 138.23 53.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 ttmp? -119.07 120.06 36.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.586 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.9 ptp180 -105.91 129.01 54.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.472 0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.821 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.472 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.64 123.41 32.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.067 0.434 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.708 ' HB3' HD13 ' A' ' 25' ' ' ILE . 72.3 Cg_endo -76.76 52.57 3.76 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.213 2.608 . . . . 0.0 112.724 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.41 22.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 111.555 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 4.0 m -89.63 -33.82 16.53 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.5 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.16 25.97 56.29 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.206 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -125.76 144.08 50.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.129 0.49 . . . . 0.0 111.108 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.4 p -101.62 144.52 30.24 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.0 p -148.07 128.66 14.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.821 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.0 t -116.06 -34.03 4.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.961 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.4 -53.14 6.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.251 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.56 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 140.75 47.88 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 p -122.73 133.15 54.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -147.74 124.3 11.07 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -86.0 -25.22 26.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.664 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -69.65 154.45 41.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.439 0.637 . . . . 0.0 112.568 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -85.18 133.68 34.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.504 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.39 -12.45 26.49 Favored Glycine 0 C--O 1.23 -0.108 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.261 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 69.4 m -75.84 139.14 41.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.964 0.412 . . . . 0.0 111.142 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.9 p -122.42 142.43 50.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.812 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.56 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 42.6 t -71.72 121.79 19.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.362 0.601 . . . . 0.0 110.613 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.564 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 49.8 m -135.44 83.49 2.02 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.821 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 7.5 t90 -27.65 121.33 0.25 Allowed Pre-proline 0 C--N 1.331 -0.217 0 O-C-N 125.077 1.485 . . . . 0.0 113.091 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 86.5 Cg_endo -106.05 33.94 5.27 Favored 'Cis proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.863 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.708 HD13 ' HB3' ' A' ' 3' ' ' PRO . 8.7 pt -139.23 153.59 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -89.09 132.0 34.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 18.5 ptpt -136.12 133.58 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.578 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -103.85 131.68 50.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 113.814 0.285 . . . . 0.0 113.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -127.5 123.79 23.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.32 0.56 . . . . 0.0 110.399 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.717 ' HB2' HD11 ' A' ' 25' ' ' ILE . 72.2 Cg_endo -76.41 47.47 2.09 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.871 2.38 . . . . 0.0 112.668 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.412 HG22 ' HD2' ' A' ' 28' ' ' ARG . 7.7 m -104.8 48.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.536 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 47.9 m -101.12 -33.16 10.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.71 150.51 22.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 111.355 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.41 143.07 28.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.288 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.19 41.05 1.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.721 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.76 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.8 t -76.87 -34.93 57.77 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 11' ' ' LEU . 94.1 mt -82.0 -15.48 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.623 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 37.54 9.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.382 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -137.53 145.39 42.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.223 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.75 133.88 9.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -110.78 -10.79 14.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.609 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.574 ' HB ' HH21 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -71.84 154.95 40.93 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.687 0.756 . . . . 0.0 112.289 -178.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -68.3 129.85 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.246 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.45 28.25 50.29 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.591 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 85.3 m -96.77 135.57 38.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -113.49 140.03 48.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.18 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.14 115.29 10.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.466 0.65 . . . . 0.0 111.41 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -135.88 84.25 2.07 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.76 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.9 t90 -33.82 125.22 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.689 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 85.3 Cg_endo -104.45 33.04 6.73 Favored 'Cis proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.592 -1.42 . . . . 0.0 114.16 0.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 3' ' ' PRO . 11.9 tt -144.11 159.74 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 84.3 m -79.03 136.15 37.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.131 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 13.0 ttpp -127.56 116.11 19.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.054 0.454 . . . . 0.0 111.221 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.574 HH21 ' HB ' ' A' ' 16' ' ' THR . 8.5 ptp180 -104.7 128.36 52.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.26 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.148 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 2' ' ' LEU . 4.1 mm? -114.63 122.19 34.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.434 0.617 . . . . 0.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 5.3 Cg_exo -77.62 50.01 3.09 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.693 2.929 . . . . 0.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 m -103.72 28.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.344 0.592 . . . . 0.0 111.608 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.464 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.9 m -89.49 -33.59 16.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.3 30.25 57.17 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.032 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.27 155.13 48.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.938 0.399 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 23.2 p -107.46 144.26 34.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.882 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 8.9 t -119.83 38.66 3.86 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.033 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.662 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.9 t -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.811 ' H ' HD22 ' A' ' 11' ' ' LEU . 2.6 pt? -81.89 -18.71 42.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.54 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 91.14 44.63 4.35 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.145 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.419 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.0 m -157.17 152.65 26.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -142.42 130.29 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.85 -22.18 18.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.352 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.572 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -70.53 156.12 39.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.606 0.717 . . . . 0.0 112.096 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -85.39 133.25 34.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.48 -7.04 27.33 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.561 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.572 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 89.1 m -78.66 133.54 37.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -108.85 148.04 31.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.512 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.24 116.97 11.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.317 0.58 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -137.1 80.94 1.84 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.662 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 24.0 t90 -37.22 129.54 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 O-C-N 124.251 0.969 . . . . 0.0 112.079 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.7 Cg_endo -98.96 29.0 14.57 Favored 'Cis proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.389 -1.505 . . . . 0.0 114.225 1.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.4 pt -133.93 -167.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 112.301 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.7 m -128.86 138.79 52.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -135.17 133.44 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.194 0.521 . . . . 0.0 111.66 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.636 ' HD3' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -102.56 130.42 49.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.636 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 4.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.282 -0.177 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 3.2 mm? -121.83 113.97 31.37 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 117.252 0.526 . . . . 0.0 110.371 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 5.8 Cg_exo -79.85 43.31 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.49 2.793 . . . . 0.0 112.158 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.75 42.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.235 0.54 . . . . 0.0 112.413 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.717 ' HA ' HH12 ' A' ' 28' ' ' ARG . 16.8 m -89.61 -32.79 16.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.67 24.87 52.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.732 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.77 150.84 52.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -98.35 141.78 30.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.755 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 m -114.58 40.79 2.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.743 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.687 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.7 t -74.32 -34.84 63.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 11' ' ' LEU . 2.5 tm? -81.92 -37.15 27.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.033 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 45.4 1.01 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.602 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -139.74 143.42 36.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.821 -0.19 . . . . 0.0 111.097 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -154.2 122.83 6.21 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.35 -20.03 24.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.142 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.678 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -67.84 156.83 36.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.969 -179.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -84.28 134.89 34.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.16 -6.45 14.36 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.808 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.888 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 58.2 m -73.27 139.2 45.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 111.36 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 p -125.0 139.81 53.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.07 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.27 121.88 13.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.541 0.686 . . . . 0.0 111.509 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 m -135.03 73.67 1.49 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.687 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -33.69 127.02 0.44 Allowed Pre-proline 0 N--CA 1.463 0.213 0 O-C-N 124.414 1.071 . . . . 0.0 112.708 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -97.48 19.72 28.7 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.223 -1.574 . . . . 0.0 113.886 0.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 5.9 pt -116.99 -163.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 111.958 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.888 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 8.5 t -132.34 139.99 48.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.2 ttpm? -135.69 127.81 29.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.717 HH12 ' HA ' ' A' ' 5' ' ' CYS . 23.4 ptt-85 -115.31 130.26 56.85 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.655 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 113.461 0.145 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 97.4 mt -137.06 121.24 12.24 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 110.456 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HB3' HD13 ' A' ' 25' ' ' ILE . 3.2 Cg_exo -76.93 54.32 4.51 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.46 2.774 . . . . 0.0 112.08 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.89 52.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.733 0.777 . . . . 0.0 112.269 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.43 ' HB3' HG22 ' A' ' 16' ' ' THR . 70.0 m -125.82 -30.3 3.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.426 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.03 -11.22 49.6 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.766 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.33 145.89 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.462 0.649 . . . . 0.0 111.765 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.9 p -95.83 145.65 25.18 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.626 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -124.09 36.2 4.67 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.943 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.658 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.0 t -62.26 -28.68 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.056 0.455 . . . . 0.0 110.037 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.35 -2.31 48.73 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.437 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 76.48 45.43 14.02 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.092 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.3 m -157.24 155.96 31.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.6 m -143.74 127.7 17.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -84.76 -33.63 23.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.294 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 5' ' ' CYS . 1.3 p -64.58 151.12 45.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.635 0.731 . . . . 0.0 111.953 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -82.68 137.13 34.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.382 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.94 -14.59 13.2 Favored Glycine 0 N--CA 1.454 -0.137 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.384 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -74.88 141.23 44.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -118.04 141.61 48.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.278 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.4 t -66.22 121.5 15.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.604 0.716 . . . . 0.0 111.19 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 m -136.43 73.94 1.48 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.658 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -29.28 125.68 0.26 Allowed Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 124.811 1.319 . . . . 0.0 113.074 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.7 Cg_endo -101.41 26.0 15.09 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.212 -1.578 . . . . 0.0 114.358 1.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.5 pt -131.83 160.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.459 0.647 . . . . 0.0 112.587 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -88.63 133.89 34.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.172 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 14.4 ttpp -132.06 123.84 28.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.949 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -104.48 132.0 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.857 179.479 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 CA-C-O 120.397 -0.113 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.5 mt -135.55 126.11 16.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.518 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.599 ' HB3' HD13 ' A' ' 25' ' ' ILE . 2.8 Cg_exo -75.85 53.35 3.67 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.347 2.698 . . . . 0.0 111.992 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.36 43.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 112.463 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.66 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 59.0 m -112.2 -30.16 7.31 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.149 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.64 49.79 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.189 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -131.72 148.88 52.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 111.382 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 39.2 p -96.63 143.3 27.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.6 p -123.17 37.15 4.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.169 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.628 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.2 t -63.71 -28.45 69.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.17 0.51 . . . . 0.0 109.997 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.06 -18.16 47.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.205 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.44 46.91 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.316 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.58 154.3 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.806 -0.232 . . . . 0.0 110.442 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -150.15 126.74 10.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -78.46 -35.79 46.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 4.3 p -61.5 149.99 37.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.781 0.8 . . . . 0.0 112.193 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -84.58 134.67 34.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.12 -5.33 77.1 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.14 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -80.47 145.06 32.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.0 p -124.76 143.78 50.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.47 125.3 26.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.727 0.775 . . . . 0.0 111.833 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.2 m -135.58 70.73 1.43 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.628 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -28.43 125.14 0.24 Allowed Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 124.881 1.363 . . . . 0.0 113.105 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -101.55 28.57 12.4 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.285 -1.548 . . . . 0.0 114.072 0.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 3' ' ' PRO . 5.2 pt -129.59 156.83 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 96.9 m -84.98 137.92 32.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 16.1 ttmt -135.09 121.18 19.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.441 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.66 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -108.8 133.55 52.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 123.543 0.527 . . . . 0.0 111.278 179.486 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.862 -0.095 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -128.44 123.51 22.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.323 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.594 ' HB3' HD13 ' A' ' 25' ' ' ILE . 6.8 Cg_exo -74.16 50.13 2.15 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.459 2.773 . . . . 0.0 112.468 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.1 m -103.87 26.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.192 0.52 . . . . 0.0 111.924 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.9 m -91.69 -34.06 14.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.77 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.2 -8.1 61.91 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.796 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.736 ' HG3' ' HG1' ' A' ' 16' ' ' THR . 28.4 mm-40 -87.82 145.3 26.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 111.426 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.4 p -98.49 147.39 24.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -132.81 38.69 3.38 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.753 HG21 HD23 ' A' ' 11' ' ' LEU . 10.6 t -64.95 -26.96 68.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD23 HG21 ' A' ' 10' ' ' THR . 2.5 mm? -80.75 -13.87 58.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.78 34.4 8.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.608 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -139.58 146.5 39.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.727 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.3 m -130.31 121.17 25.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.479 0.657 . . . . 0.0 109.853 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.49 -30.83 57.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.686 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.736 ' HG1' ' HG3' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -78.69 157.75 28.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.222 0.534 . . . . 0.0 112.046 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 18.2 mp0 -90.71 137.24 32.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.092 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.62 1.37 65.96 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.028 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 94.5 m -89.3 134.06 34.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.468 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.8 p -109.21 140.49 42.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.98 122.67 17.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.693 0.759 . . . . 0.0 111.027 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 71.09 1.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.646 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.2 t90 -26.56 121.45 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 124.777 1.298 . . . . 0.0 113.105 -176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -103.59 30.99 8.5 Favored 'Cis proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.455 -1.477 . . . . 0.0 114.284 0.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 3' ' ' PRO . 7.8 pt -131.94 161.51 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.466 0.575 . . . . 0.0 112.49 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 86.1 m -101.2 134.36 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.843 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -123.48 129.9 51.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.195 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.685 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 57.5 ttp180 -104.27 132.54 50.41 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.321 -0.663 0 O-C-N 123.863 0.727 . . . . 0.0 110.57 -179.253 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.074 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.21 122.72 16.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 110.423 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.8 Cg_endo -76.83 52.37 3.71 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.048 2.498 . . . . 0.0 111.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -103.36 24.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.238 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 61.0 m -89.63 -30.55 18.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 33.83 64.65 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.615 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -131.92 147.97 52.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.01 0.434 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -93.16 142.79 26.91 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.1 p -124.84 33.5 5.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.94 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.573 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.4 t -64.34 -25.22 67.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.082 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.8 mm? -80.66 -11.51 59.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.29 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.27 42.71 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.879 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.43 153.82 32.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.545 0.212 . . . . 0.0 111.12 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -144.44 129.57 18.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.49 -34.16 28.09 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -58.78 153.36 17.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.873 0.844 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -80.08 127.04 31.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.927 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.77 74.7 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.842 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 1.7 t -96.26 148.41 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.6 p -123.45 142.35 51.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.3 t -69.92 125.37 26.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.688 0.756 . . . . 0.0 111.732 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.8 m -135.49 69.07 1.44 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.573 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -26.6 124.46 0.22 Allowed Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 125.034 1.459 . . . . 0.0 113.414 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.5 Cg_endo -101.21 26.75 14.67 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.344 -1.523 . . . . 0.0 114.016 0.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 25' ' ' ILE . 5.1 pt -126.04 157.14 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 112.901 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.842 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 85.3 m -87.21 140.08 29.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.162 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 15.1 ttmt -135.43 117.52 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.928 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -106.58 133.59 51.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.7 0.286 . . . . 0.0 110.853 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.543 -179.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -121.51 120.97 28.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 117.007 0.404 . . . . 0.0 110.616 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.9 Cg_endo -75.4 47.29 1.8 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.311 2.674 . . . . 0.0 113.293 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.475 HG22 HH11 ' A' ' 28' ' ' ARG . 6.0 m -105.83 34.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 112.093 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.432 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 31.3 m -89.41 -34.95 16.3 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.447 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.26 29.32 41.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.557 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -136.9 157.52 46.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.884 0.373 . . . . 0.0 110.061 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.6 p -109.05 140.62 42.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.572 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.4 t -107.56 33.45 4.04 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.061 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 13.1 t -71.55 -27.97 63.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.08 -16.28 50.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.331 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.09 41.83 6.13 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.23 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -170.02 160.07 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 111.01 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 m -161.2 134.98 6.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.806 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -97.44 10.18 40.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.697 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -82.9 158.46 22.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.541 0.686 . . . . 0.0 111.834 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.67 130.8 36.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.329 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 59.2 19.16 44.97 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.644 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.697 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 81.8 m -89.65 134.35 34.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.09 0.471 . . . . 0.0 111.104 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.3 p -108.25 141.61 39.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.5 t -62.71 118.86 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 110.463 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -136.66 68.7 1.42 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.592 ' CD1' ' HA ' ' A' ' 10' ' ' THR . 31.8 t90 -34.6 128.94 0.48 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 124.319 1.012 . . . . 0.0 112.207 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 61.6 Cg_endo -95.03 25.23 23.01 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.063 -1.64 . . . . 0.0 114.216 1.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.52 HG22 HD11 ' A' ' 25' ' ' ILE . 7.2 pt -128.67 -159.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 121.929 -0.482 . . . . 0.0 111.477 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 27.1 m -144.98 140.83 28.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.323 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -127.37 133.63 50.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.1 ptp85 -103.61 128.74 50.85 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 -177.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.6 mt -135.47 121.69 14.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 117.174 0.487 . . . . 0.0 110.465 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.498 ' CB ' HD13 ' A' ' 25' ' ' ILE . 86.1 Cg_endo -78.33 47.54 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.949 2.433 . . . . 0.0 112.376 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.97 37.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.157 0.503 . . . . 0.0 112.336 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -89.58 -33.28 16.76 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.03 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.17 29.31 50.96 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.215 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.48 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 53.0 mt-10 -135.32 154.59 51.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.275 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.1 p -103.12 143.46 32.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.428 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.44 40.69 3.15 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.251 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.647 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -73.27 -27.37 61.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.798 ' H ' HD22 ' A' ' 11' ' ' LEU . 2.6 pt? -81.87 -19.82 40.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.611 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 90.96 44.44 4.46 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.159 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.0 m -156.89 152.91 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -145.98 127.51 15.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -91.08 -19.4 23.18 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.003 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.565 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.45 155.62 40.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.509 0.671 . . . . 0.0 112.15 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -81.89 133.8 35.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.359 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 67.58 9.72 56.16 Favored Glycine 0 C--N 1.329 0.177 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.776 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 84.2 m -88.4 134.32 33.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.2 p -111.08 142.53 43.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.34 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.44 117.5 5.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.072 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 m -136.2 72.27 1.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.647 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.3 t90 -35.7 129.1 0.59 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 124.32 1.013 . . . . 0.0 112.256 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.1 Cg_endo -97.47 28.97 15.61 Favored 'Cis proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.26 -1.558 . . . . 0.0 114.163 1.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -132.87 -166.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 112.184 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.1 m -124.35 136.63 54.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.0 ttpp -126.16 123.25 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 111.446 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.634 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 12.2 ptm180 -104.59 133.73 48.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 112.73 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.672 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -130.68 126.13 21.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.791 ' HB3' HD13 ' A' ' 25' ' ' ILE . 7.8 Cg_exo -73.54 48.4 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.582 2.854 . . . . 0.0 112.805 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.02 38.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.498 0.666 . . . . 0.0 111.857 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 26.9 m -105.13 -33.47 8.26 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.368 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.17 55.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.986 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.511 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-10 -134.4 145.88 49.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.954 0.407 . . . . 0.0 110.922 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.8 p -97.89 145.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -127.46 38.84 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.214 -0.994 . . . . 0.0 112.085 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.586 HG23 HD23 ' A' ' 11' ' ' LEU . 13.5 t -64.88 -24.28 67.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.063 0.459 . . . . 0.0 109.837 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.586 HD23 HG23 ' A' ' 10' ' ' THR . 2.6 mm? -80.47 -16.03 55.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.171 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.03 46.33 4.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.84 154.56 32.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -146.63 130.51 17.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.511 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 4.8 m-85 -96.66 -24.67 15.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.364 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.545 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -70.97 152.76 43.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.607 0.718 . . . . 0.0 112.376 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.19 136.53 38.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.574 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.39 10.41 42.27 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 93.2 m -91.56 132.28 36.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.235 0.54 . . . . 0.0 110.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -108.42 140.84 41.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -73.25 119.4 17.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.553 0.692 . . . . 0.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -137.14 84.02 2.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.583 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 11.8 t90 -31.56 124.12 0.35 Allowed Pre-proline 0 C--O 1.231 0.127 0 O-C-N 124.736 1.272 . . . . 0.0 112.759 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 90.6 Cg_endo -104.44 30.27 8.19 Favored 'Cis proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.377 -1.51 . . . . 0.0 114.397 1.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.791 HD13 ' HB3' ' A' ' 3' ' ' PRO . 9.0 pt -136.45 161.01 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 68.9 m -96.97 131.87 43.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.014 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.672 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 11.9 pttp -132.72 135.88 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.095 0.474 . . . . 0.0 111.667 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' HB ' ' A' ' 16' ' ' THR . 12.6 ptp180 -103.79 134.81 46.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--N 1.323 -0.551 0 O-C-N 123.678 0.611 . . . . 0.0 110.778 -179.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.169 -0.239 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.407 ' HA ' HD21 ' A' ' 2' ' ' LEU . 91.3 mt -123.18 121.32 27.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.215 0.507 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.7 Cg_endo -73.1 48.43 1.45 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.98 2.454 . . . . 0.0 112.913 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.29 38.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.374 0.607 . . . . 0.0 111.715 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 22.2 m -95.3 -32.76 12.83 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.328 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.04 44.01 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.814 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 16.3 mt-10 -88.86 140.15 29.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.445 0.641 . . . . 0.0 111.658 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -97.69 148.04 23.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.197 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -144.58 128.09 17.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.687 0.756 . . . . 0.0 111.236 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.776 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -120.99 -32.63 3.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.137 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.45 -43.12 19.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.072 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.585 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 126.89 47.3 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.156 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -128.34 139.43 52.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.834 -0.183 . . . . 0.0 111.479 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -147.52 125.95 12.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 6.7 m-85 -95.93 -20.5 18.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.264 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.541 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -67.94 155.53 39.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.42 0.629 . . . . 0.0 111.762 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.9 132.17 35.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.453 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 64.93 17.69 63.46 Favored Glycine 0 C--N 1.329 0.165 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.484 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 82.2 m -97.48 135.34 39.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.094 0.473 . . . . 0.0 111.129 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 p -116.64 138.0 51.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.064 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 48.9 t -65.22 122.39 16.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.275 0.56 . . . . 0.0 110.884 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m -136.09 81.12 1.86 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.776 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 6.3 t90 -29.18 120.21 0.28 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.618 1.199 . . . . 0.0 112.814 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 92.9 Cg_endo -104.88 37.09 4.6 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.912 -1.287 . . . . 0.0 114.624 1.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 25' ' ' ILE . 5.2 tt -150.61 150.18 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.2 m -80.75 136.48 36.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.587 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 23.4 pttm -125.05 130.63 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 0.0 111.223 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.721 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 13.8 ptm180 -104.31 128.08 52.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 109.876 -178.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 113.817 0.287 . . . . 0.0 113.817 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -120.62 126.05 26.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.405 0.603 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.65 ' HB3' HD11 ' A' ' 25' ' ' ILE . 59.3 Cg_endo -71.76 49.95 1.3 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.276 2.651 . . . . 0.0 113.344 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -104.67 39.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.0 111.835 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -96.66 -34.7 11.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 26.68 56.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -131.88 155.38 47.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.026 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.0 p -108.21 141.71 39.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.122 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 6.1 t -115.27 38.91 3.07 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.371 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.675 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.0 t -72.55 -33.61 66.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 10' ' ' THR . 92.8 mt -82.92 -16.19 48.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.322 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.505 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 86.43 38.26 8.41 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.693 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -143.66 135.37 26.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.103 0.161 . . . . 0.0 111.32 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -154.63 130.59 10.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.5 10.28 31.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.818 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.514 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -79.72 155.4 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.696 0.76 . . . . 0.0 112.091 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.22 130.7 40.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.555 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.13 27.48 46.12 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.7 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 81.3 m -99.36 134.76 41.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.935 0.397 . . . . 0.0 110.643 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.4 p -111.52 139.66 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.484 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 24.8 t -60.3 117.92 5.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 0.0 110.602 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m -137.39 75.31 1.52 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.675 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 27.7 t90 -35.78 128.68 0.61 Allowed Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 124.156 0.91 . . . . 0.0 112.321 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.8 Cg_endo -97.4 27.99 16.96 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.291 -1.546 . . . . 0.0 114.244 1.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 3' ' ' PRO . 7.3 pt -133.11 -159.57 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.211 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 13.6 m -142.48 140.52 31.91 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -121.84 132.9 54.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.449 0.642 . . . . 0.0 112.131 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.701 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 22.6 ttm180 -102.56 125.31 49.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.445 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.767 -178.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.8 mt -133.82 120.61 15.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.873 ' HB3' HD11 ' A' ' 25' ' ' ILE . 2.8 Cg_exo -76.49 48.98 2.52 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.496 2.798 . . . . 0.0 112.284 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 HG21 HH11 ' A' ' 28' ' ' ARG . 8.1 m -103.59 31.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.321 0.581 . . . . 0.0 111.983 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 32.3 m -89.54 -34.82 16.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.78 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.14 30.5 50.61 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.573 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 16' ' ' THR . 79.9 mt-10 -136.27 148.83 48.2 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.7 p -96.64 143.8 27.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -123.93 33.23 5.36 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.5 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.617 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.6 t -63.27 -26.42 68.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 110.095 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.88 -6.47 58.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.656 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.74 43.47 10.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.151 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -154.54 156.06 35.95 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.0 m -145.23 129.93 18.08 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.08 -24.26 17.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.984 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.561 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -70.38 154.41 41.92 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.736 0.779 . . . . 0.0 112.491 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -76.32 131.84 39.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.265 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 17.28 59.21 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.419 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 87.7 m -93.08 136.11 33.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.933 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -112.38 142.6 44.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.054 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.03 121.99 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 111.122 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.1 m -135.4 74.96 1.54 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.617 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.7 t90 -28.92 124.4 0.26 Allowed Pre-proline 0 C--O 1.232 0.148 0 O-C-N 124.858 1.349 . . . . 0.0 113.142 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.2 Cg_endo -103.22 32.22 8.1 Favored 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.393 -1.503 . . . . 0.0 114.221 0.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.873 HD11 ' HB3' ' A' ' 3' ' ' PRO . 8.0 pt -133.8 160.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 72.9 m -91.14 134.82 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.036 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 15.9 ttpt -131.65 123.1 27.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.781 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 9.6 ptp85 -107.68 135.77 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.583 0.23 . . . . 0.0 110.574 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.133 179.705 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 CA-C-O 120.29 -0.172 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.498 ' HA ' HD11 ' A' ' 2' ' ' LEU . 2.7 mm? -133.48 132.48 21.93 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.979 0.389 . . . . 0.0 110.118 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.5 Cg_endo -73.54 49.34 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.782 2.321 . . . . 0.0 112.196 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.61 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.203 0.525 . . . . 0.0 112.328 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.623 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 37.0 m -89.31 -29.39 19.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.74 30.93 57.18 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.143 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -138.18 153.06 49.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 p -98.35 143.27 29.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.566 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.2 p -116.83 32.48 6.13 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.154 -1.019 . . . . 0.0 112.14 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.535 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -65.04 -29.49 70.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -3.97 55.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.942 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 75.43 46.27 15.8 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.425 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.0 m -157.29 154.26 28.77 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.636 -0.332 . . . . 0.0 110.631 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -151.33 126.01 9.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -80.1 -32.98 39.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 2.2 p -58.76 153.69 16.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.707 0.765 . . . . 0.0 112.872 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -79.62 131.17 35.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.43 24.51 75.05 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.931 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.003 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 7.7 t -93.33 147.07 23.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.4 p -128.95 141.98 51.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.05 126.21 28.95 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.639 0.733 . . . . 0.0 111.4 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 m -135.54 66.82 1.5 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.535 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.9 t90 -26.97 124.36 0.22 Allowed Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.483 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.2 Cg_endo -101.17 27.3 14.18 Favored 'Cis proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.2 -1.583 . . . . 0.0 113.898 0.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.495 HD11 HG23 ' A' ' 25' ' ' ILE . 6.0 pt -121.04 154.05 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.003 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 67.0 m -88.45 137.25 32.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.687 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 18.5 ttpt -133.45 115.4 14.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.561 0.22 . . . . 0.0 111.57 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -108.28 140.68 41.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA2' ' HE2' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.57 0 CA-C-O 120.237 -0.202 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 2' ' ' LEU . 3.4 mm? -119.16 125.29 27.7 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.144 0.472 . . . . 0.0 110.559 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.735 ' HB3' HD13 ' A' ' 25' ' ' ILE . 73.1 Cg_endo -75.99 49.91 2.66 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.264 2.643 . . . . 0.0 112.69 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.45 31.35 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.538 0.685 . . . . 0.0 111.48 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 16.5 m -98.18 -33.94 10.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.517 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.01 56.58 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.802 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-10 -134.0 146.49 50.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.58 145.19 26.51 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.697 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 10.3 p -127.22 37.96 4.16 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.052 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.653 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.2 t -63.03 -30.33 71.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.038 0.447 . . . . 0.0 110.029 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.06 -1.24 47.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.937 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.7 48.63 10.02 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.484 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -151.21 151.8 32.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.685 -0.303 . . . . 0.0 110.463 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.0 m -148.79 132.34 16.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.505 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 8.5 m-85 -102.25 -20.75 14.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.272 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.1 p -72.71 152.19 41.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.642 0.734 . . . . 0.0 112.328 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -75.56 134.47 40.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.663 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.27 4.34 29.33 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.32 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 87.8 m -85.05 135.88 33.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.228 0.537 . . . . 0.0 111.483 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 p -113.05 144.18 43.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.2 t -75.29 121.24 21.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.465 0.65 . . . . 0.0 111.423 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.1 m -135.67 83.16 2.0 Allowed 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.653 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 18.0 t90 -31.71 124.46 0.35 Allowed Pre-proline 0 C--N 1.332 -0.167 0 O-C-N 124.644 1.215 . . . . 0.0 112.81 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -104.73 32.28 6.91 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.528 -1.446 . . . . 0.0 114.304 0.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.735 HD13 ' HB3' ' A' ' 3' ' ' PRO . 9.2 pt -135.19 158.67 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -95.0 130.34 41.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HE2' ' HA2' ' A' ' 1' ' ' GLY . 18.5 ptmt -135.89 133.44 37.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.6 ptp85 -103.04 133.66 47.78 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.268 -178.72 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.28 -0.178 . . . . 0.0 113.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.0 138.73 28.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.787 0.327 . . . . 0.0 110.499 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.34 52.67 2.84 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.846 2.364 . . . . 0.0 111.94 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.54 49.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.606 0.717 . . . . 0.0 112.211 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.604 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.0 m -119.43 -33.9 3.96 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.165 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.48 30.33 56.74 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.787 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.06 151.27 49.66 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 25.1 p -98.2 143.82 28.3 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -121.95 34.83 5.05 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.813 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.601 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.9 t -62.66 -30.42 71.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 110.135 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' N ' HG23 ' A' ' 10' ' ' THR . 92.3 mt -81.72 -2.75 51.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.972 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 76.33 46.78 11.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 1.8 m -152.91 154.42 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.752 -0.263 . . . . 0.0 110.436 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -151.38 125.39 9.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.86 -22.86 27.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.557 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.619 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -70.93 156.84 39.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.674 0.749 . . . . 0.0 112.252 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.63 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 15.6 mp0 -89.97 131.62 35.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.599 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.56 16.43 80.1 Favored Glycine 0 N--CA 1.454 -0.148 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.25 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.4 m -100.61 135.35 42.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.8 p -115.74 142.32 46.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.419 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.75 121.52 16.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.609 0.718 . . . . 0.0 111.195 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -134.44 74.68 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.601 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.2 t90 -29.44 124.18 0.27 Allowed Pre-proline 0 C--O 1.231 0.118 0 O-C-N 124.829 1.331 . . . . 0.0 113.01 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.2 Cg_endo -103.42 31.57 8.31 Favored 'Cis proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.408 -1.496 . . . . 0.0 114.214 0.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 11.4 pt -132.89 158.47 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 74.7 m -86.53 132.21 33.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 14.7 ttmt -121.58 118.08 28.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 0.0 111.984 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.763 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 27.0 ttp180 -104.68 133.6 49.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.585 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 124.051 0.94 . . . . 0.0 112.644 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 113.334 0.093 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.5 mt -125.01 124.47 25.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.955 0.377 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.756 ' HB3' HD13 ' A' ' 25' ' ' ILE . 73.9 Cg_endo -75.53 49.24 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.044 2.496 . . . . 0.0 113.101 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.525 HG21 ' HD3' ' A' ' 28' ' ' ARG . 4.0 m -103.36 54.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.976 0.893 . . . . 0.0 111.659 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HB3' HG21 ' A' ' 16' ' ' THR . 58.0 m -128.64 -32.16 2.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.438 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.77 32.88 39.43 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.597 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 10.8 pt-20 -139.2 143.85 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.528 0.68 . . . . 0.0 112.367 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.3 p -92.13 146.37 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.191 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 12.6 p -125.7 37.19 4.41 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.304 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.552 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.7 t -62.62 -27.6 69.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.097 0.475 . . . . 0.0 110.047 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.46 -9.07 59.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.893 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 81.66 47.91 6.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.519 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 1.8 m -155.51 154.52 31.92 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.695 -0.297 . . . . 0.0 110.36 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -145.99 130.28 17.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -88.04 -30.38 19.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.692 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 5' ' ' CYS . 73.5 p -72.86 150.97 42.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.439 0.638 . . . . 0.0 111.816 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -82.59 133.94 35.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.92 50.34 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.127 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.446 ' HB2' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -74.46 146.68 42.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.096 0.474 . . . . 0.0 110.954 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -127.0 142.02 51.65 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.87 121.28 14.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.709 . . . . 0.0 111.473 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -135.73 69.89 1.43 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.552 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 10.4 t90 -24.69 128.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 125.055 1.472 . . . . 0.0 113.323 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 72.2 Cg_endo -98.19 23.35 22.81 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.997 -1.668 . . . . 0.0 114.237 0.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.756 HD13 ' HB3' ' A' ' 3' ' ' PRO . 7.5 pt -134.97 158.75 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 121.81 -0.556 . . . . 0.0 112.306 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 73.2 m -85.24 138.12 32.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.583 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -133.48 130.15 38.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.525 ' HD3' HG21 ' A' ' 4' ' ' VAL . 14.0 ptm180 -102.79 121.15 41.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.077 -177.582 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.454 0 CA-C-O 120.439 -0.089 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.9 mt -131.83 127.71 21.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.292 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 5.7 Cg_exo -74.66 49.35 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.311 2.674 . . . . 0.0 112.526 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 m -103.88 43.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.344 0.592 . . . . 0.0 112.286 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.0 m -99.43 -35.32 9.94 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.764 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.07 28.67 40.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.92 151.4 49.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 110.853 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -97.61 143.16 28.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.459 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 9.0 p -120.26 34.87 5.05 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.823 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -65.12 -24.86 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.067 0.461 . . . . 0.0 109.962 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.58 -15.28 57.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.03 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.53 43.63 6.09 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.981 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -154.78 156.94 37.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -149.56 126.63 11.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.83 -22.19 25.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.696 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.654 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.67 159.11 35.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.673 0.749 . . . . 0.0 112.55 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -80.73 131.77 35.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.179 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.05 18.79 65.14 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.115 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 72.3 m -92.91 134.02 35.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.067 0.46 . . . . 0.0 110.651 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 p -114.57 144.14 43.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.8 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -70.75 122.95 20.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.677 0.751 . . . . 0.0 111.254 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -135.17 71.0 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.571 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 17.3 t90 -27.39 123.57 0.24 Allowed Pre-proline 0 N--CA 1.462 0.172 0 O-C-N 125.002 1.439 . . . . 0.0 113.287 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 96.9 Cg_endo -103.16 31.23 8.71 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.348 -1.521 . . . . 0.0 114.016 0.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 pt -129.81 158.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.4 m -89.96 135.42 33.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.287 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 12.8 ttmt -124.79 117.72 24.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.664 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.757 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.9 ptm180 -108.22 133.3 52.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.432 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 CA-C-O 120.355 -0.136 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.1 mt -131.31 125.21 20.75 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.854 0.359 . . . . 0.0 110.157 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.824 ' HB3' HD11 ' A' ' 25' ' ' ILE . 2.8 Cg_exo -75.86 47.92 2.08 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.192 2.594 . . . . 0.0 112.382 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 m -104.85 45.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 35.5 m -97.96 -33.43 11.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.798 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.01 30.8 45.53 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.026 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.71 153.66 50.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.043 0.449 . . . . 0.0 110.529 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 40.9 p -101.37 143.0 31.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 t -122.19 41.88 3.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.779 HG22 HD23 ' A' ' 11' ' ' LEU . 14.7 t -73.04 -26.02 61.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.779 HD23 HG22 ' A' ' 10' ' ' THR . 2.4 mm? -81.38 -18.8 44.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.401 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.9 34.93 7.42 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.437 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.0 p -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.573 0.349 . . . . 0.0 110.608 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.2 m -131.19 123.95 29.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.99 -25.63 27.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.767 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.612 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -68.21 153.93 42.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.589 0.709 . . . . 0.0 111.994 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -86.38 138.35 31.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.526 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 66.87 16.04 65.56 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.612 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 86.4 m -100.59 134.98 42.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -109.77 144.29 38.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.75 118.4 8.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.546 0.689 . . . . 0.0 110.414 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -136.21 73.17 1.45 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.72 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 26.9 t90 -34.44 127.3 0.49 Allowed Pre-proline 0 N--CA 1.465 0.29 0 O-C-N 124.367 1.042 . . . . 0.0 112.236 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -98.92 30.48 12.63 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 -1.471 . . . . 0.0 114.169 0.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.824 HD11 ' HB3' ' A' ' 3' ' ' PRO . 8.6 pt -133.71 -164.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.965 0.412 . . . . 0.0 111.801 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.6 m -125.62 138.23 53.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 ttmp? -119.07 120.06 36.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.586 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.9 ptp180 -105.91 129.01 54.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.472 0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.821 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.472 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.64 123.41 32.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.067 0.434 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.708 ' HB3' HD13 ' A' ' 25' ' ' ILE . 72.3 Cg_endo -76.76 52.57 3.76 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.213 2.608 . . . . 0.0 112.724 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.41 22.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 111.555 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 4.0 m -89.63 -33.82 16.53 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.5 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.16 25.97 56.29 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.206 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -125.76 144.08 50.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.129 0.49 . . . . 0.0 111.108 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.4 p -101.62 144.52 30.24 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.0 p -148.07 128.66 14.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.821 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.0 t -116.06 -34.03 4.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.961 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.4 -53.14 6.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.251 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.56 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 140.75 47.88 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 p -122.73 133.15 54.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -147.74 124.3 11.07 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -86.0 -25.22 26.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.664 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -69.65 154.45 41.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.439 0.637 . . . . 0.0 112.568 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -85.18 133.68 34.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.504 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.39 -12.45 26.49 Favored Glycine 0 C--O 1.23 -0.108 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.261 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 69.4 m -75.84 139.14 41.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.964 0.412 . . . . 0.0 111.142 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.9 p -122.42 142.43 50.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.812 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.56 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 42.6 t -71.72 121.79 19.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.362 0.601 . . . . 0.0 110.613 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.564 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 49.8 m -135.44 83.49 2.02 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.821 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 7.5 t90 -27.65 121.33 0.25 Allowed Pre-proline 0 C--N 1.331 -0.217 0 O-C-N 125.077 1.485 . . . . 0.0 113.091 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 86.5 Cg_endo -106.05 33.94 5.27 Favored 'Cis proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.863 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.708 HD13 ' HB3' ' A' ' 3' ' ' PRO . 8.7 pt -139.23 153.59 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -89.09 132.0 34.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 18.5 ptpt -136.12 133.58 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.578 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -103.85 131.68 50.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 113.814 0.285 . . . . 0.0 113.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -127.5 123.79 23.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.32 0.56 . . . . 0.0 110.399 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.717 ' HB2' HD11 ' A' ' 25' ' ' ILE . 72.2 Cg_endo -76.41 47.47 2.09 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.871 2.38 . . . . 0.0 112.668 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.412 HG22 ' HD2' ' A' ' 28' ' ' ARG . 7.7 m -104.8 48.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.536 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 47.9 m -101.12 -33.16 10.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.71 150.51 22.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 111.355 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.41 143.07 28.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.288 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.19 41.05 1.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.721 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.76 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.8 t -76.87 -34.93 57.77 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 11' ' ' LEU . 94.1 mt -82.0 -15.48 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.623 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 37.54 9.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.382 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -137.53 145.39 42.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.223 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.75 133.88 9.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -110.78 -10.79 14.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.609 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.574 ' HB ' HH21 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -71.84 154.95 40.93 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.687 0.756 . . . . 0.0 112.289 -178.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -68.3 129.85 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.246 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.45 28.25 50.29 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.591 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 85.3 m -96.77 135.57 38.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -113.49 140.03 48.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.18 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.14 115.29 10.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.466 0.65 . . . . 0.0 111.41 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -135.88 84.25 2.07 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.76 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.9 t90 -33.82 125.22 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.689 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 85.3 Cg_endo -104.45 33.04 6.73 Favored 'Cis proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.592 -1.42 . . . . 0.0 114.16 0.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 3' ' ' PRO . 11.9 tt -144.11 159.74 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 84.3 m -79.03 136.15 37.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.131 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 13.0 ttpp -127.56 116.11 19.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.054 0.454 . . . . 0.0 111.221 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.574 HH21 ' HB ' ' A' ' 16' ' ' THR . 8.5 ptp180 -104.7 128.36 52.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.26 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.148 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 2' ' ' LEU . 4.1 mm? -114.63 122.19 34.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.434 0.617 . . . . 0.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 5.3 Cg_exo -77.62 50.01 3.09 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.693 2.929 . . . . 0.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 m -103.72 28.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.344 0.592 . . . . 0.0 111.608 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.464 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.9 m -89.49 -33.59 16.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.3 30.25 57.17 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.032 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.27 155.13 48.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.938 0.399 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 23.2 p -107.46 144.26 34.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.882 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 8.9 t -119.83 38.66 3.86 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.033 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.662 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.9 t -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.811 ' H ' HD22 ' A' ' 11' ' ' LEU . 2.6 pt? -81.89 -18.71 42.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.54 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 91.14 44.63 4.35 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.145 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.419 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.0 m -157.17 152.65 26.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -142.42 130.29 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.85 -22.18 18.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.352 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.572 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -70.53 156.12 39.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.606 0.717 . . . . 0.0 112.096 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -85.39 133.25 34.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.48 -7.04 27.33 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.561 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.572 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 89.1 m -78.66 133.54 37.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -108.85 148.04 31.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.512 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.24 116.97 11.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.317 0.58 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -137.1 80.94 1.84 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.662 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 24.0 t90 -37.22 129.54 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 O-C-N 124.251 0.969 . . . . 0.0 112.079 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.7 Cg_endo -98.96 29.0 14.57 Favored 'Cis proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.389 -1.505 . . . . 0.0 114.225 1.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.4 pt -133.93 -167.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 112.301 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.7 m -128.86 138.79 52.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -135.17 133.44 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.194 0.521 . . . . 0.0 111.66 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.636 ' HD3' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -102.56 130.42 49.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.636 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 4.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.282 -0.177 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 3.2 mm? -121.83 113.97 31.37 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 117.252 0.526 . . . . 0.0 110.371 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 5.8 Cg_exo -79.85 43.31 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.49 2.793 . . . . 0.0 112.158 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.75 42.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.235 0.54 . . . . 0.0 112.413 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.717 ' HA ' HH12 ' A' ' 28' ' ' ARG . 16.8 m -89.61 -32.79 16.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.67 24.87 52.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.732 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.77 150.84 52.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -98.35 141.78 30.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.755 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 m -114.58 40.79 2.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.743 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.687 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.7 t -74.32 -34.84 63.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 11' ' ' LEU . 2.5 tm? -81.92 -37.15 27.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.033 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 45.4 1.01 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.602 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -139.74 143.42 36.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.821 -0.19 . . . . 0.0 111.097 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -154.2 122.83 6.21 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.35 -20.03 24.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.142 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.678 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -67.84 156.83 36.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.969 -179.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -84.28 134.89 34.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.16 -6.45 14.36 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.808 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.888 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 58.2 m -73.27 139.2 45.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 111.36 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 p -125.0 139.81 53.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.07 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.27 121.88 13.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.541 0.686 . . . . 0.0 111.509 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 m -135.03 73.67 1.49 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.687 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -33.69 127.02 0.44 Allowed Pre-proline 0 N--CA 1.463 0.213 0 O-C-N 124.414 1.071 . . . . 0.0 112.708 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -97.48 19.72 28.7 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.223 -1.574 . . . . 0.0 113.886 0.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 5.9 pt -116.99 -163.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 111.958 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.888 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 8.5 t -132.34 139.99 48.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.2 ttpm? -135.69 127.81 29.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.717 HH12 ' HA ' ' A' ' 5' ' ' CYS . 23.4 ptt-85 -115.31 130.26 56.85 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.655 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 113.461 0.145 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 97.4 mt -137.06 121.24 12.24 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 110.456 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HB3' HD13 ' A' ' 25' ' ' ILE . 3.2 Cg_exo -76.93 54.32 4.51 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.46 2.774 . . . . 0.0 112.08 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.89 52.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.733 0.777 . . . . 0.0 112.269 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.43 ' HB3' HG22 ' A' ' 16' ' ' THR . 70.0 m -125.82 -30.3 3.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.426 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.03 -11.22 49.6 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.766 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.33 145.89 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.462 0.649 . . . . 0.0 111.765 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.9 p -95.83 145.65 25.18 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.626 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -124.09 36.2 4.67 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.943 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.658 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.0 t -62.26 -28.68 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.056 0.455 . . . . 0.0 110.037 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.35 -2.31 48.73 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.437 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 76.48 45.43 14.02 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.092 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 2.3 m -157.24 155.96 31.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.6 m -143.74 127.7 17.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -84.76 -33.63 23.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.294 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 5' ' ' CYS . 1.3 p -64.58 151.12 45.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.635 0.731 . . . . 0.0 111.953 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -82.68 137.13 34.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.382 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.94 -14.59 13.2 Favored Glycine 0 N--CA 1.454 -0.137 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.384 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -74.88 141.23 44.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -118.04 141.61 48.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.278 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.4 t -66.22 121.5 15.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.604 0.716 . . . . 0.0 111.19 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 m -136.43 73.94 1.48 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.658 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -29.28 125.68 0.26 Allowed Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 124.811 1.319 . . . . 0.0 113.074 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.7 Cg_endo -101.41 26.0 15.09 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.212 -1.578 . . . . 0.0 114.358 1.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.5 pt -131.83 160.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.459 0.647 . . . . 0.0 112.587 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -88.63 133.89 34.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.172 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 14.4 ttpp -132.06 123.84 28.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.949 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -104.48 132.0 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.857 179.479 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 CA-C-O 120.397 -0.113 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.5 mt -135.55 126.11 16.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.518 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.599 ' HB3' HD13 ' A' ' 25' ' ' ILE . 2.8 Cg_exo -75.85 53.35 3.67 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.347 2.698 . . . . 0.0 111.992 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.36 43.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 112.463 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.66 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 59.0 m -112.2 -30.16 7.31 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.149 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.64 49.79 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.189 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -131.72 148.88 52.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 111.382 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 39.2 p -96.63 143.3 27.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.6 p -123.17 37.15 4.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.169 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.628 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.2 t -63.71 -28.45 69.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.17 0.51 . . . . 0.0 109.997 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.06 -18.16 47.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.205 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.44 46.91 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.316 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.58 154.3 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.806 -0.232 . . . . 0.0 110.442 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -150.15 126.74 10.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -78.46 -35.79 46.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 4.3 p -61.5 149.99 37.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.781 0.8 . . . . 0.0 112.193 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -84.58 134.67 34.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.12 -5.33 77.1 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.14 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -80.47 145.06 32.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.0 p -124.76 143.78 50.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.47 125.3 26.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.727 0.775 . . . . 0.0 111.833 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.2 m -135.58 70.73 1.43 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.628 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -28.43 125.14 0.24 Allowed Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 124.881 1.363 . . . . 0.0 113.105 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -101.55 28.57 12.4 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.285 -1.548 . . . . 0.0 114.072 0.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 3' ' ' PRO . 5.2 pt -129.59 156.83 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 96.9 m -84.98 137.92 32.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 16.1 ttmt -135.09 121.18 19.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.441 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.66 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -108.8 133.55 52.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 123.543 0.527 . . . . 0.0 111.278 179.486 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.862 -0.095 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -128.44 123.51 22.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.323 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.594 ' HB3' HD13 ' A' ' 25' ' ' ILE . 6.8 Cg_exo -74.16 50.13 2.15 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.459 2.773 . . . . 0.0 112.468 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.1 m -103.87 26.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.192 0.52 . . . . 0.0 111.924 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.9 m -91.69 -34.06 14.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.77 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.2 -8.1 61.91 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.796 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.736 ' HG3' ' HG1' ' A' ' 16' ' ' THR . 28.4 mm-40 -87.82 145.3 26.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 111.426 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.4 p -98.49 147.39 24.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -132.81 38.69 3.38 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.753 HG21 HD23 ' A' ' 11' ' ' LEU . 10.6 t -64.95 -26.96 68.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD23 HG21 ' A' ' 10' ' ' THR . 2.5 mm? -80.75 -13.87 58.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.78 34.4 8.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.608 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -139.58 146.5 39.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.727 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.3 m -130.31 121.17 25.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.479 0.657 . . . . 0.0 109.853 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.49 -30.83 57.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.686 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.736 ' HG1' ' HG3' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -78.69 157.75 28.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.222 0.534 . . . . 0.0 112.046 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 18.2 mp0 -90.71 137.24 32.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.092 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.62 1.37 65.96 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.028 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 94.5 m -89.3 134.06 34.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.468 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.8 p -109.21 140.49 42.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.98 122.67 17.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.693 0.759 . . . . 0.0 111.027 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 71.09 1.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.646 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.2 t90 -26.56 121.45 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 124.777 1.298 . . . . 0.0 113.105 -176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -103.59 30.99 8.5 Favored 'Cis proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.455 -1.477 . . . . 0.0 114.284 0.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 3' ' ' PRO . 7.8 pt -131.94 161.51 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.466 0.575 . . . . 0.0 112.49 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 86.1 m -101.2 134.36 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.843 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -123.48 129.9 51.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.195 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.685 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 57.5 ttp180 -104.27 132.54 50.41 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.321 -0.663 0 O-C-N 123.863 0.727 . . . . 0.0 110.57 -179.253 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.074 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.21 122.72 16.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 110.423 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.8 Cg_endo -76.83 52.37 3.71 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.048 2.498 . . . . 0.0 111.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -103.36 24.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.238 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 61.0 m -89.63 -30.55 18.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 33.83 64.65 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.615 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -131.92 147.97 52.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.01 0.434 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -93.16 142.79 26.91 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.1 p -124.84 33.5 5.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.94 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.573 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.4 t -64.34 -25.22 67.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.082 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' HA ' HD11 ' A' ' 11' ' ' LEU . 2.8 mm? -80.66 -11.51 59.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.29 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.27 42.71 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.879 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.43 153.82 32.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.545 0.212 . . . . 0.0 111.12 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -144.44 129.57 18.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.49 -34.16 28.09 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -58.78 153.36 17.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.873 0.844 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -80.08 127.04 31.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.927 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.77 74.7 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.842 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 1.7 t -96.26 148.41 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.6 p -123.45 142.35 51.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.3 t -69.92 125.37 26.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.688 0.756 . . . . 0.0 111.732 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.8 m -135.49 69.07 1.44 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.573 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -26.6 124.46 0.22 Allowed Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 125.034 1.459 . . . . 0.0 113.414 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.5 Cg_endo -101.21 26.75 14.67 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.344 -1.523 . . . . 0.0 114.016 0.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 25' ' ' ILE . 5.1 pt -126.04 157.14 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 112.901 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.842 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 85.3 m -87.21 140.08 29.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.162 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 15.1 ttmt -135.43 117.52 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.928 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -106.58 133.59 51.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.7 0.286 . . . . 0.0 110.853 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.543 -179.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -121.51 120.97 28.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 117.007 0.404 . . . . 0.0 110.616 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.9 Cg_endo -75.4 47.29 1.8 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.311 2.674 . . . . 0.0 113.293 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.475 HG22 HH11 ' A' ' 28' ' ' ARG . 6.0 m -105.83 34.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 112.093 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.432 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 31.3 m -89.41 -34.95 16.3 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.447 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.26 29.32 41.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.557 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -136.9 157.52 46.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.884 0.373 . . . . 0.0 110.061 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.6 p -109.05 140.62 42.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.572 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.4 t -107.56 33.45 4.04 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.061 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 13.1 t -71.55 -27.97 63.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.08 -16.28 50.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.331 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.09 41.83 6.13 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.23 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -170.02 160.07 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 111.01 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 m -161.2 134.98 6.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.806 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -97.44 10.18 40.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.697 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -82.9 158.46 22.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.541 0.686 . . . . 0.0 111.834 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.67 130.8 36.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.329 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 59.2 19.16 44.97 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.644 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.697 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 81.8 m -89.65 134.35 34.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.09 0.471 . . . . 0.0 111.104 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.3 p -108.25 141.61 39.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.5 t -62.71 118.86 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 110.463 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -136.66 68.7 1.42 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.592 ' CD1' ' HA ' ' A' ' 10' ' ' THR . 31.8 t90 -34.6 128.94 0.48 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 124.319 1.012 . . . . 0.0 112.207 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 61.6 Cg_endo -95.03 25.23 23.01 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.063 -1.64 . . . . 0.0 114.216 1.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.52 HG22 HD11 ' A' ' 25' ' ' ILE . 7.2 pt -128.67 -159.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 121.929 -0.482 . . . . 0.0 111.477 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 27.1 m -144.98 140.83 28.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.323 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -127.37 133.63 50.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.1 ptp85 -103.61 128.74 50.85 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 -177.903 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.6 mt -135.47 121.69 14.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 117.174 0.487 . . . . 0.0 110.465 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 86.1 Cg_endo -78.33 47.54 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.949 2.433 . . . . 0.0 112.376 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.97 37.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.157 0.503 . . . . 0.0 112.336 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -89.58 -33.28 16.76 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.03 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.17 29.31 50.96 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.215 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 53.0 mt-10 -135.32 154.59 51.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.275 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.1 p -103.12 143.46 32.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.428 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.44 40.69 3.15 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.251 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -73.27 -27.37 61.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.87 -19.82 40.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.611 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.96 44.44 4.46 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.159 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -156.89 152.91 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -145.98 127.51 15.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -91.08 -19.4 23.18 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.003 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.576 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.45 155.62 40.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.509 0.671 . . . . 0.0 112.15 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -81.89 133.8 35.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.359 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 67.58 9.72 56.16 Favored Glycine 0 C--N 1.329 0.177 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.776 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 84.2 m -88.4 134.32 33.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.2 p -111.08 142.53 43.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.34 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.44 117.5 5.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.072 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 m -136.2 72.27 1.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.65 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.3 t90 -35.7 129.1 0.59 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 124.32 1.013 . . . . 0.0 112.256 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.1 Cg_endo -97.47 28.97 15.61 Favored 'Cis proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.26 -1.558 . . . . 0.0 114.163 1.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -132.87 -166.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 112.184 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.1 m -124.35 136.63 54.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.0 ttpp -126.16 123.25 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 111.446 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 12.2 ptm180 -104.59 133.73 48.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 112.73 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.682 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -130.68 126.13 21.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.675 ' HB3' HD12 ' A' ' 25' ' ' ILE . 7.8 Cg_exo -73.54 48.4 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.582 2.854 . . . . 0.0 112.805 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.02 38.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.498 0.666 . . . . 0.0 111.857 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 26.9 m -105.13 -33.47 8.26 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.368 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.17 55.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.986 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-10 -134.4 145.88 49.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.954 0.407 . . . . 0.0 110.922 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.8 p -97.89 145.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -127.46 38.84 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.214 -0.994 . . . . 0.0 112.085 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.602 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.5 t -64.88 -24.28 67.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.063 0.459 . . . . 0.0 109.837 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.47 -16.03 55.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.171 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.03 46.33 4.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.84 154.56 32.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -146.63 130.51 17.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.52 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 4.8 m-85 -96.66 -24.67 15.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.364 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' HH21 ' A' ' 28' ' ' ARG . 1.2 p -70.97 152.76 43.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.607 0.718 . . . . 0.0 112.376 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.19 136.53 38.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.574 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.39 10.41 42.27 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 93.2 m -91.56 132.28 36.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.235 0.54 . . . . 0.0 110.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -108.42 140.84 41.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -73.25 119.4 17.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.553 0.692 . . . . 0.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -137.14 84.02 2.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.602 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 11.8 t90 -31.56 124.12 0.35 Allowed Pre-proline 0 C--O 1.231 0.127 0 O-C-N 124.736 1.272 . . . . 0.0 112.759 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 90.6 Cg_endo -104.44 30.27 8.19 Favored 'Cis proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.377 -1.51 . . . . 0.0 114.397 1.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.0 pt -136.45 161.01 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 68.9 m -96.97 131.87 43.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.014 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.682 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 11.9 pttp -132.72 135.88 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.095 0.474 . . . . 0.0 111.667 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.552 HH21 ' HB ' ' A' ' 16' ' ' THR . 12.6 ptp180 -103.79 134.81 46.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--N 1.323 -0.551 0 O-C-N 123.678 0.611 . . . . 0.0 110.778 -179.579 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.169 -0.239 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -123.18 121.32 27.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.215 0.507 . . . . 0.0 110.344 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.7 Cg_endo -73.1 48.43 1.45 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.98 2.454 . . . . 0.0 112.913 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.29 38.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.374 0.607 . . . . 0.0 111.715 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 22.2 m -95.3 -32.76 12.83 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.328 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.04 44.01 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.814 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 16.3 mt-10 -88.86 140.15 29.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.445 0.641 . . . . 0.0 111.658 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -97.69 148.04 23.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.197 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -144.58 128.09 17.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.687 0.756 . . . . 0.0 111.236 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.796 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -120.99 -32.63 3.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.137 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.45 -43.12 19.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.072 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.589 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 126.89 47.3 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.156 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -128.34 139.43 52.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.834 -0.183 . . . . 0.0 111.479 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -147.52 125.95 12.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 6.7 m-85 -95.93 -20.5 18.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.264 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -67.94 155.53 39.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.42 0.629 . . . . 0.0 111.762 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -80.9 132.17 35.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.453 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 64.93 17.69 63.46 Favored Glycine 0 C--N 1.329 0.165 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.484 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 82.2 m -97.48 135.34 39.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.094 0.473 . . . . 0.0 111.129 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 p -116.64 138.0 51.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.064 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 48.9 t -65.22 122.39 16.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.275 0.56 . . . . 0.0 110.884 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m -136.09 81.12 1.86 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.796 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 6.3 t90 -29.18 120.21 0.28 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.618 1.199 . . . . 0.0 112.814 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 92.9 Cg_endo -104.88 37.09 4.6 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.912 -1.287 . . . . 0.0 114.624 1.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -150.61 150.18 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.2 m -80.75 136.48 36.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.587 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 23.4 pttm -125.05 130.63 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 0.0 111.223 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.73 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 13.8 ptm180 -104.31 128.08 52.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 109.876 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 113.817 0.287 . . . . 0.0 113.817 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -120.62 126.05 26.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.405 0.603 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.76 49.95 1.3 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.276 2.651 . . . . 0.0 113.344 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -104.67 39.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.0 111.835 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.455 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -96.66 -34.7 11.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 26.68 56.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -131.88 155.38 47.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.026 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.0 p -108.21 141.71 39.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.122 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 6.1 t -115.27 38.91 3.07 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.371 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.691 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.0 t -72.55 -33.61 66.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.92 -16.19 48.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.322 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.498 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 86.43 38.26 8.41 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.693 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -143.66 135.37 26.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.103 0.161 . . . . 0.0 111.32 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -154.63 130.59 10.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.5 10.28 31.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.818 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.525 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -79.72 155.4 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.696 0.76 . . . . 0.0 112.091 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.22 130.7 40.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.555 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.13 27.48 46.12 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.7 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 81.3 m -99.36 134.76 41.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.935 0.397 . . . . 0.0 110.643 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.4 p -111.52 139.66 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 24.8 t -60.3 117.92 5.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 0.0 110.602 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m -137.39 75.31 1.52 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.691 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 27.7 t90 -35.78 128.68 0.61 Allowed Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 124.156 0.91 . . . . 0.0 112.321 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.8 Cg_endo -97.4 27.99 16.96 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.291 -1.546 . . . . 0.0 114.244 1.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.3 pt -133.11 -159.57 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.211 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 13.6 m -142.48 140.52 31.91 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -121.84 132.9 54.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.449 0.642 . . . . 0.0 112.131 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 22.6 ttm180 -102.56 125.31 49.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.445 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.767 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.8 mt -133.82 120.61 15.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -76.49 48.98 2.52 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.496 2.798 . . . . 0.0 112.284 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG23 HH11 ' A' ' 28' ' ' ARG . 8.1 m -103.59 31.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.321 0.581 . . . . 0.0 111.983 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.537 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 32.3 m -89.54 -34.82 16.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.78 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.14 30.5 50.61 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.573 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' OE2' HG23 ' A' ' 16' ' ' THR . 79.9 mt-10 -136.27 148.83 48.2 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.7 p -96.64 143.8 27.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -123.93 33.23 5.36 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.5 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.636 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.6 t -63.27 -26.42 68.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 110.095 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.5 pt? -80.88 -6.47 58.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.656 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.74 43.47 10.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.151 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -154.54 156.06 35.95 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.0 m -145.23 129.93 18.08 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.08 -24.26 17.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.984 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -70.38 154.41 41.92 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.736 0.779 . . . . 0.0 112.491 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -76.32 131.84 39.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.265 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 17.28 59.21 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.419 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 87.7 m -93.08 136.11 33.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.933 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -112.38 142.6 44.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.054 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.03 121.99 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 111.122 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.1 m -135.4 74.96 1.54 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.636 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.7 t90 -28.92 124.4 0.26 Allowed Pre-proline 0 C--O 1.232 0.148 0 O-C-N 124.858 1.349 . . . . 0.0 113.142 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.2 Cg_endo -103.22 32.22 8.1 Favored 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.393 -1.503 . . . . 0.0 114.221 0.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.0 pt -133.8 160.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 72.9 m -91.14 134.82 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.036 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 15.9 ttpt -131.65 123.1 27.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.781 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 9.6 ptp85 -107.68 135.77 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.583 0.23 . . . . 0.0 110.574 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.133 179.705 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.411 ' C ' HD22 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.438 0 CA-C-O 120.29 -0.172 . . . . 0.0 113.061 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 1' ' ' GLY . 2.7 mm? -133.48 132.48 21.93 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.979 0.389 . . . . 0.0 110.118 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.5 Cg_endo -73.54 49.34 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.782 2.321 . . . . 0.0 112.196 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.61 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.203 0.525 . . . . 0.0 112.328 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 37.0 m -89.31 -29.39 19.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.74 30.93 57.18 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.143 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -138.18 153.06 49.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 p -98.35 143.27 29.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.2 p -116.83 32.48 6.13 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.154 -1.019 . . . . 0.0 112.14 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -65.04 -29.49 70.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -3.97 55.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.942 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.43 46.27 15.8 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.29 154.26 28.77 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.636 -0.332 . . . . 0.0 110.631 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -151.33 126.01 9.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -80.1 -32.98 39.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.609 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 2.2 p -58.76 153.69 16.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.707 0.765 . . . . 0.0 112.872 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -79.62 131.17 35.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.43 24.51 75.05 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.931 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.015 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 7.7 t -93.33 147.07 23.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.4 p -128.95 141.98 51.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.05 126.21 28.95 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.639 0.733 . . . . 0.0 111.4 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 m -135.54 66.82 1.5 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.554 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.9 t90 -26.97 124.36 0.22 Allowed Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.483 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.2 Cg_endo -101.17 27.3 14.18 Favored 'Cis proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.2 -1.583 . . . . 0.0 113.898 0.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.04 154.05 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.015 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 67.0 m -88.45 137.25 32.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.687 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 18.5 ttpt -133.45 115.4 14.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.561 0.22 . . . . 0.0 111.57 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -108.28 140.68 41.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.562 ' HA2' ' HE2' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.57 0 CA-C-O 120.237 -0.202 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.4 mm? -119.16 125.29 27.7 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.144 0.472 . . . . 0.0 110.559 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.1 Cg_endo -75.99 49.91 2.66 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.264 2.643 . . . . 0.0 112.69 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.488 HG23 HH11 ' A' ' 28' ' ' ARG . 6.6 m -103.45 31.35 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.538 0.685 . . . . 0.0 111.48 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 16.5 m -98.18 -33.94 10.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.517 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.01 56.58 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.802 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-10 -134.0 146.49 50.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.58 145.19 26.51 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 10.3 p -127.22 37.96 4.16 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.052 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.668 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.2 t -63.03 -30.33 71.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.038 0.447 . . . . 0.0 110.029 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.06 -1.24 47.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.937 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.7 48.63 10.02 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.484 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -151.21 151.8 32.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.685 -0.303 . . . . 0.0 110.463 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.0 m -148.79 132.34 16.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 8.5 m-85 -102.25 -20.75 14.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.272 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.588 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.1 p -72.71 152.19 41.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.642 0.734 . . . . 0.0 112.328 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -75.56 134.47 40.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.663 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.27 4.34 29.33 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.32 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 87.8 m -85.05 135.88 33.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.228 0.537 . . . . 0.0 111.483 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 p -113.05 144.18 43.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.2 t -75.29 121.24 21.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.465 0.65 . . . . 0.0 111.423 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.1 m -135.67 83.16 2.0 Allowed 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.668 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 18.0 t90 -31.71 124.46 0.35 Allowed Pre-proline 0 C--N 1.332 -0.167 0 O-C-N 124.644 1.215 . . . . 0.0 112.81 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -104.73 32.28 6.91 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.528 -1.446 . . . . 0.0 114.304 0.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.2 pt -135.19 158.67 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -95.0 130.34 41.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HE2' ' HA2' ' A' ' 1' ' ' GLY . 18.5 ptmt -135.89 133.44 37.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.488 HH11 HG23 ' A' ' 4' ' ' VAL . 10.6 ptp85 -103.04 133.66 47.78 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.268 -178.72 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.28 -0.178 . . . . 0.0 113.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.0 138.73 28.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.787 0.327 . . . . 0.0 110.499 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 64.4 Cg_endo -74.34 52.67 2.84 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.846 2.364 . . . . 0.0 111.94 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.54 49.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.606 0.717 . . . . 0.0 112.211 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.604 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.0 m -119.43 -33.9 3.96 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.165 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.48 30.33 56.74 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.787 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.06 151.27 49.66 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 25.1 p -98.2 143.82 28.3 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -121.95 34.83 5.05 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.813 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.619 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.9 t -62.66 -30.42 71.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 110.135 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.72 -2.75 51.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.972 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 46.78 11.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -152.91 154.42 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.752 -0.263 . . . . 0.0 110.436 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -151.38 125.39 9.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.86 -22.86 27.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.557 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.629 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -70.93 156.84 39.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.674 0.749 . . . . 0.0 112.252 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.646 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 15.6 mp0 -89.97 131.62 35.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.599 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.56 16.43 80.1 Favored Glycine 0 N--CA 1.454 -0.148 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.25 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.4 m -100.61 135.35 42.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.8 p -115.74 142.32 46.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.419 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.75 121.52 16.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.609 0.718 . . . . 0.0 111.195 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -134.44 74.68 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.619 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.2 t90 -29.44 124.18 0.27 Allowed Pre-proline 0 C--O 1.231 0.118 0 O-C-N 124.829 1.331 . . . . 0.0 113.01 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.2 Cg_endo -103.42 31.57 8.31 Favored 'Cis proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.408 -1.496 . . . . 0.0 114.214 0.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 11.4 pt -132.89 158.47 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 74.7 m -86.53 132.21 33.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 14.7 ttmt -121.58 118.08 28.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 0.0 111.984 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.778 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 27.0 ttp180 -104.68 133.6 49.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.585 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 124.051 0.94 . . . . 0.0 112.644 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 113.334 0.093 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.5 mt -125.01 124.47 25.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.955 0.377 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 49.24 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.044 2.496 . . . . 0.0 113.101 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG23 ' HD3' ' A' ' 28' ' ' ARG . 4.0 m -103.36 54.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.976 0.893 . . . . 0.0 111.659 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 28' ' ' ARG . 58.0 m -128.64 -32.16 2.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.438 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.77 32.88 39.43 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.597 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 10.8 pt-20 -139.2 143.85 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.528 0.68 . . . . 0.0 112.367 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.3 p -92.13 146.37 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.191 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 12.6 p -125.7 37.19 4.41 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.304 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.7 t -62.62 -27.6 69.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.097 0.475 . . . . 0.0 110.047 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.46 -9.07 59.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.893 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 47.91 6.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.519 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -155.51 154.52 31.92 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.695 -0.297 . . . . 0.0 110.36 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -145.99 130.28 17.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -88.04 -30.38 19.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.692 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' CYS . 73.5 p -72.86 150.97 42.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.439 0.638 . . . . 0.0 111.816 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -82.59 133.94 35.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.92 50.34 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.127 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HB2' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -74.46 146.68 42.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.096 0.474 . . . . 0.0 110.954 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -127.0 142.02 51.65 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.87 121.28 14.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.709 . . . . 0.0 111.473 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -135.73 69.89 1.43 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.571 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 10.4 t90 -24.69 128.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 125.055 1.472 . . . . 0.0 113.323 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 72.2 Cg_endo -98.19 23.35 22.81 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.997 -1.668 . . . . 0.0 114.237 0.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.5 pt -134.97 158.75 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 121.81 -0.556 . . . . 0.0 112.306 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 73.2 m -85.24 138.12 32.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.583 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -133.48 130.15 38.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.65 ' HD3' HG23 ' A' ' 4' ' ' VAL . 14.0 ptm180 -102.79 121.15 41.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.077 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.454 0 CA-C-O 120.439 -0.089 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.9 mt -131.83 127.71 21.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.292 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.7 Cg_exo -74.66 49.35 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.311 2.674 . . . . 0.0 112.526 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 m -103.88 43.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.344 0.592 . . . . 0.0 112.286 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.0 m -99.43 -35.32 9.94 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.764 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.07 28.67 40.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.92 151.4 49.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 110.853 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -97.61 143.16 28.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 9.0 p -120.26 34.87 5.05 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.823 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -65.12 -24.86 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.067 0.461 . . . . 0.0 109.962 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.58 -15.28 57.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.03 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.53 43.63 6.09 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.981 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -154.78 156.94 37.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -149.56 126.63 11.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.83 -22.19 25.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.696 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.662 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.67 159.11 35.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.673 0.749 . . . . 0.0 112.55 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -80.73 131.77 35.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.179 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 65.05 18.79 65.14 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.115 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 72.3 m -92.91 134.02 35.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.067 0.46 . . . . 0.0 110.651 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 p -114.57 144.14 43.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.8 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -70.75 122.95 20.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.677 0.751 . . . . 0.0 111.254 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -135.17 71.0 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.59 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 17.3 t90 -27.39 123.57 0.24 Allowed Pre-proline 0 N--CA 1.462 0.172 0 O-C-N 125.002 1.439 . . . . 0.0 113.287 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 96.9 Cg_endo -103.16 31.23 8.71 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.348 -1.521 . . . . 0.0 114.016 0.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.4 pt -129.81 158.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.4 m -89.96 135.42 33.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.287 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 12.8 ttmt -124.79 117.72 24.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.664 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.761 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.9 ptm180 -108.22 133.3 52.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.432 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 CA-C-O 120.355 -0.136 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.1 mt -131.31 125.21 20.75 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.854 0.359 . . . . 0.0 110.157 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.86 47.92 2.08 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.192 2.594 . . . . 0.0 112.382 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 28' ' ' ARG . 5.3 m -104.85 45.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 35.5 m -97.96 -33.43 11.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.798 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.01 30.8 45.53 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.026 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.71 153.66 50.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.043 0.449 . . . . 0.0 110.529 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 40.9 p -101.37 143.0 31.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 t -122.19 41.88 3.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.734 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.7 t -73.04 -26.02 61.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.38 -18.8 44.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.401 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.9 34.93 7.42 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.437 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.0 p -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.573 0.349 . . . . 0.0 110.608 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.2 m -131.19 123.95 29.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.99 -25.63 27.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.767 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.622 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -68.21 153.93 42.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.589 0.709 . . . . 0.0 111.994 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -86.38 138.35 31.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.526 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 66.87 16.04 65.56 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.622 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 86.4 m -100.59 134.98 42.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -109.77 144.29 38.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.75 118.4 8.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.546 0.689 . . . . 0.0 110.414 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -136.21 73.17 1.45 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.734 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 26.9 t90 -34.44 127.3 0.49 Allowed Pre-proline 0 N--CA 1.465 0.29 0 O-C-N 124.367 1.042 . . . . 0.0 112.236 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -98.92 30.48 12.63 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 -1.471 . . . . 0.0 114.169 0.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -133.71 -164.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.965 0.412 . . . . 0.0 111.801 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.6 m -125.62 138.23 53.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 ttmp? -119.07 120.06 36.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.9 ptp180 -105.91 129.01 54.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 . . . . . 0 N--CA 1.472 0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.821 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.472 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.64 123.41 32.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.067 0.434 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.3 Cg_endo -76.76 52.57 3.76 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.213 2.608 . . . . 0.0 112.724 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.41 22.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 111.555 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 4.0 m -89.63 -33.82 16.53 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.5 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.16 25.97 56.29 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.206 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -125.76 144.08 50.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.129 0.49 . . . . 0.0 111.108 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.4 p -101.62 144.52 30.24 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.0 p -148.07 128.66 14.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.831 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.0 t -116.06 -34.03 4.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.961 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.4 -53.14 6.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.251 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.562 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 140.75 47.88 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 p -122.73 133.15 54.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -147.74 124.3 11.07 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -86.0 -25.22 26.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.664 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -69.65 154.45 41.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.439 0.637 . . . . 0.0 112.568 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -85.18 133.68 34.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.504 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.39 -12.45 26.49 Favored Glycine 0 C--O 1.23 -0.108 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.261 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 69.4 m -75.84 139.14 41.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.964 0.412 . . . . 0.0 111.142 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.9 p -122.42 142.43 50.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.812 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 42.6 t -71.72 121.79 19.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.362 0.601 . . . . 0.0 110.613 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 49.8 m -135.44 83.49 2.02 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.831 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 7.5 t90 -27.65 121.33 0.25 Allowed Pre-proline 0 C--N 1.331 -0.217 0 O-C-N 125.077 1.485 . . . . 0.0 113.091 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 86.5 Cg_endo -106.05 33.94 5.27 Favored 'Cis proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.863 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.7 pt -139.23 153.59 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -89.09 132.0 34.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 18.5 ptpt -136.12 133.58 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -103.85 131.68 50.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.891 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 113.814 0.285 . . . . 0.0 113.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -127.5 123.79 23.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.32 0.56 . . . . 0.0 110.399 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.2 Cg_endo -76.41 47.47 2.09 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.871 2.38 . . . . 0.0 112.668 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.421 HG23 ' HD2' ' A' ' 28' ' ' ARG . 7.7 m -104.8 48.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 47.9 m -101.12 -33.16 10.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.71 150.51 22.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 111.355 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.1 p -97.41 143.07 28.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.288 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.19 41.05 1.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.721 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.771 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.8 t -76.87 -34.93 57.77 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -82.0 -15.48 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.623 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 37.54 9.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.382 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -137.53 145.39 42.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.223 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.75 133.88 9.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -110.78 -10.79 14.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.609 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.591 ' HB ' HH21 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -71.84 154.95 40.93 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.687 0.756 . . . . 0.0 112.289 -178.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -68.3 129.85 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.246 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.45 28.25 50.29 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.591 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 85.3 m -96.77 135.57 38.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -113.49 140.03 48.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.18 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.14 115.29 10.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.466 0.65 . . . . 0.0 111.41 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -135.88 84.25 2.07 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.771 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.9 t90 -33.82 125.22 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.689 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 85.3 Cg_endo -104.45 33.04 6.73 Favored 'Cis proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.592 -1.42 . . . . 0.0 114.16 0.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.445 ' CG1' ' N ' ' A' ' 26' ' ' CYS . 11.9 tt -144.11 159.74 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 84.3 m -79.03 136.15 37.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.131 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 13.0 ttpp -127.56 116.11 19.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.054 0.454 . . . . 0.0 111.221 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.591 HH21 ' HB ' ' A' ' 16' ' ' THR . 8.5 ptp180 -104.7 128.36 52.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.26 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.148 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 4.1 mm? -114.63 122.19 34.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.434 0.617 . . . . 0.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.3 Cg_exo -77.62 50.01 3.09 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.693 2.929 . . . . 0.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 m -103.72 28.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.344 0.592 . . . . 0.0 111.608 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.492 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 10.9 m -89.49 -33.59 16.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.3 30.25 57.17 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.032 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.27 155.13 48.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.938 0.399 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 23.2 p -107.46 144.26 34.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.882 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 8.9 t -119.83 38.66 3.86 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.033 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.684 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.9 t -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.89 -18.71 42.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.54 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 44.63 4.35 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.17 152.65 26.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -142.42 130.29 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.85 -22.18 18.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.352 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.585 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -70.53 156.12 39.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.606 0.717 . . . . 0.0 112.096 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -85.39 133.25 34.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.48 -7.04 27.33 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.561 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 89.1 m -78.66 133.54 37.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -108.85 148.04 31.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.512 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.24 116.97 11.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.317 0.58 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -137.1 80.94 1.84 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.684 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 24.0 t90 -37.22 129.54 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 O-C-N 124.251 0.969 . . . . 0.0 112.079 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.7 Cg_endo -98.96 29.0 14.57 Favored 'Cis proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.389 -1.505 . . . . 0.0 114.225 1.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.4 pt -133.93 -167.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 112.301 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.7 m -128.86 138.79 52.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -135.17 133.44 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.194 0.521 . . . . 0.0 111.66 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.648 ' HD3' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -102.56 130.42 49.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.648 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 4.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.282 -0.177 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.595 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.2 mm? -121.83 113.97 31.37 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 117.252 0.526 . . . . 0.0 110.371 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 5.8 Cg_exo -79.85 43.31 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.49 2.793 . . . . 0.0 112.158 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 2' ' ' LEU . 6.5 m -104.75 42.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.235 0.54 . . . . 0.0 112.413 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' HH12 ' A' ' 28' ' ' ARG . 16.8 m -89.61 -32.79 16.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.67 24.87 52.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.732 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.77 150.84 52.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -98.35 141.78 30.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.755 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 m -114.58 40.79 2.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.743 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.692 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.7 t -74.32 -34.84 63.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.92 -37.15 27.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.033 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 45.4 1.01 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.602 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -139.74 143.42 36.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.821 -0.19 . . . . 0.0 111.097 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -154.2 122.83 6.21 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.35 -20.03 24.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.142 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -67.84 156.83 36.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.969 -179.123 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -84.28 134.89 34.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.16 -6.45 14.36 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.808 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.903 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 58.2 m -73.27 139.2 45.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 111.36 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 p -125.0 139.81 53.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.07 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.27 121.88 13.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.541 0.686 . . . . 0.0 111.509 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 m -135.03 73.67 1.49 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.692 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -33.69 127.02 0.44 Allowed Pre-proline 0 N--CA 1.463 0.213 0 O-C-N 124.414 1.071 . . . . 0.0 112.708 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -97.48 19.72 28.7 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.223 -1.574 . . . . 0.0 113.886 0.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 5.9 pt -116.99 -163.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 111.958 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.903 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 8.5 t -132.34 139.99 48.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.2 ttpm? -135.69 127.81 29.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.73 HH12 ' HA ' ' A' ' 5' ' ' CYS . 23.4 ptt-85 -115.31 130.26 56.85 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.655 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 113.461 0.145 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 97.4 mt -137.06 121.24 12.24 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 110.456 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 3.2 Cg_exo -76.93 54.32 4.51 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.46 2.774 . . . . 0.0 112.08 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.89 52.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.733 0.777 . . . . 0.0 112.269 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB3' HG21 ' A' ' 16' ' ' THR . 70.0 m -125.82 -30.3 3.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.426 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.03 -11.22 49.6 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.766 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' OE2' HG23 ' A' ' 16' ' ' THR . 48.4 mt-10 -88.33 145.89 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.462 0.649 . . . . 0.0 111.765 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.9 p -95.83 145.65 25.18 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -124.09 36.2 4.67 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.943 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.675 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.0 t -62.26 -28.68 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.056 0.455 . . . . 0.0 110.037 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -81.35 -2.31 48.73 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.437 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.48 45.43 14.02 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.092 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -157.24 155.96 31.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.6 m -143.74 127.7 17.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -84.76 -33.63 23.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.294 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.475 HG23 ' OE2' ' A' ' 7' ' ' GLU . 1.3 p -64.58 151.12 45.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.635 0.731 . . . . 0.0 111.953 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -82.68 137.13 34.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.382 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.94 -14.59 13.2 Favored Glycine 0 N--CA 1.454 -0.137 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.384 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -74.88 141.23 44.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -118.04 141.61 48.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.278 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.4 t -66.22 121.5 15.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.604 0.716 . . . . 0.0 111.19 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 m -136.43 73.94 1.48 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.675 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -29.28 125.68 0.26 Allowed Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 124.811 1.319 . . . . 0.0 113.074 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.7 Cg_endo -101.41 26.0 15.09 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.212 -1.578 . . . . 0.0 114.358 1.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.5 pt -131.83 160.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.459 0.647 . . . . 0.0 112.587 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -88.63 133.89 34.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.172 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 14.4 ttpp -132.06 123.84 28.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.949 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -104.48 132.0 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.857 179.479 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 CA-C-O 120.397 -0.113 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.5 mt -135.55 126.11 16.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.518 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.85 53.35 3.67 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.347 2.698 . . . . 0.0 111.992 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.36 43.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 112.463 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.663 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 59.0 m -112.2 -30.16 7.31 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.149 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.64 49.79 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.189 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -131.72 148.88 52.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 111.382 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 39.2 p -96.63 143.3 27.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.6 p -123.17 37.15 4.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.169 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.644 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.2 t -63.71 -28.45 69.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.17 0.51 . . . . 0.0 109.997 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.06 -18.16 47.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.205 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.44 46.91 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.316 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.58 154.3 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.806 -0.232 . . . . 0.0 110.442 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -150.15 126.74 10.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -78.46 -35.79 46.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 4.3 p -61.5 149.99 37.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.781 0.8 . . . . 0.0 112.193 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.58 134.67 34.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.12 -5.33 77.1 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.14 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -80.47 145.06 32.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.0 p -124.76 143.78 50.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.47 125.3 26.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.727 0.775 . . . . 0.0 111.833 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.2 m -135.58 70.73 1.43 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -28.43 125.14 0.24 Allowed Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 124.881 1.363 . . . . 0.0 113.105 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -101.55 28.57 12.4 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.285 -1.548 . . . . 0.0 114.072 0.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 5.2 pt -129.59 156.83 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.735 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 96.9 m -84.98 137.92 32.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 16.1 ttmt -135.09 121.18 19.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.441 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -108.8 133.55 52.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 123.543 0.527 . . . . 0.0 111.278 179.486 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.862 -0.095 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -128.44 123.51 22.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.323 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HB3' HD12 ' A' ' 25' ' ' ILE . 6.8 Cg_exo -74.16 50.13 2.15 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.459 2.773 . . . . 0.0 112.468 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.1 m -103.87 26.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.192 0.52 . . . . 0.0 111.924 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.9 m -91.69 -34.06 14.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.77 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.2 -8.1 61.91 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.796 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -87.82 145.3 26.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 111.426 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.4 p -98.49 147.39 24.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -132.81 38.69 3.38 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.664 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.6 t -64.95 -26.96 68.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.454 HD22 HG23 ' A' ' 10' ' ' THR . 2.5 mm? -80.75 -13.87 58.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.78 34.4 8.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.608 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -139.58 146.5 39.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.727 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.3 m -130.31 121.17 25.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.479 0.657 . . . . 0.0 109.853 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.49 -30.83 57.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.686 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.634 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -78.69 157.75 28.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.222 0.534 . . . . 0.0 112.046 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 18.2 mp0 -90.71 137.24 32.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.092 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.62 1.37 65.96 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.028 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 94.5 m -89.3 134.06 34.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.468 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.8 p -109.21 140.49 42.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.98 122.67 17.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.693 0.759 . . . . 0.0 111.027 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 71.09 1.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.664 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.2 t90 -26.56 121.45 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 124.777 1.298 . . . . 0.0 113.105 -176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -103.59 30.99 8.5 Favored 'Cis proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.455 -1.477 . . . . 0.0 114.284 0.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.8 pt -131.94 161.51 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.466 0.575 . . . . 0.0 112.49 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 86.1 m -101.2 134.36 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.843 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -123.48 129.9 51.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.195 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.706 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 57.5 ttp180 -104.27 132.54 50.41 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.321 -0.663 0 O-C-N 123.863 0.727 . . . . 0.0 110.57 -179.253 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.074 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.21 122.72 16.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 110.423 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.8 Cg_endo -76.83 52.37 3.71 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.048 2.498 . . . . 0.0 111.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -103.36 24.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.238 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 61.0 m -89.63 -30.55 18.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 33.83 64.65 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.615 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -131.92 147.97 52.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.01 0.434 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -93.16 142.79 26.91 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.1 p -124.84 33.5 5.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.94 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.592 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.4 t -64.34 -25.22 67.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.082 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 HG23 ' A' ' 10' ' ' THR . 2.8 mm? -80.66 -11.51 59.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.29 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.27 42.71 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.879 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.43 153.82 32.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.545 0.212 . . . . 0.0 111.12 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -144.44 129.57 18.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.49 -34.16 28.09 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -58.78 153.36 17.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.873 0.844 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -80.08 127.04 31.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.927 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.77 74.7 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.863 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 1.7 t -96.26 148.41 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.6 p -123.45 142.35 51.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.3 t -69.92 125.37 26.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.688 0.756 . . . . 0.0 111.732 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.8 m -135.49 69.07 1.44 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.592 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -26.6 124.46 0.22 Allowed Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 125.034 1.459 . . . . 0.0 113.414 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.5 Cg_endo -101.21 26.75 14.67 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.344 -1.523 . . . . 0.0 114.016 0.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -126.04 157.14 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 112.901 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.863 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 85.3 m -87.21 140.08 29.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.162 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 15.1 ttmt -135.43 117.52 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.928 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -106.58 133.59 51.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.7 0.286 . . . . 0.0 110.853 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.543 -179.729 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -121.51 120.97 28.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 117.007 0.404 . . . . 0.0 110.616 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.4 47.29 1.8 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.311 2.674 . . . . 0.0 113.293 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.417 HG23 HH11 ' A' ' 28' ' ' ARG . 6.0 m -105.83 34.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 112.093 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 31.3 m -89.41 -34.95 16.3 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.447 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.26 29.32 41.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.557 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -136.9 157.52 46.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.884 0.373 . . . . 0.0 110.061 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.6 p -109.05 140.62 42.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.572 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.4 t -107.56 33.45 4.04 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.061 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.606 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 13.1 t -71.55 -27.97 63.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.08 -16.28 50.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.331 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.09 41.83 6.13 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.23 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -170.02 160.07 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 111.01 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 m -161.2 134.98 6.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.806 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -97.44 10.18 40.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.711 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -82.9 158.46 22.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.541 0.686 . . . . 0.0 111.834 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.67 130.8 36.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.329 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 59.2 19.16 44.97 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.644 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.711 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 81.8 m -89.65 134.35 34.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.09 0.471 . . . . 0.0 111.104 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.3 p -108.25 141.61 39.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.5 t -62.71 118.86 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 110.463 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -136.66 68.7 1.42 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 10' ' ' THR . 31.8 t90 -34.6 128.94 0.48 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 124.319 1.012 . . . . 0.0 112.207 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 61.6 Cg_endo -95.03 25.23 23.01 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.063 -1.64 . . . . 0.0 114.216 1.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.2 pt -128.67 -159.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 121.929 -0.482 . . . . 0.0 111.477 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 27.1 m -144.98 140.83 28.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.323 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -127.37 133.63 50.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.497 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.1 ptp85 -103.61 128.74 50.85 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 -177.903 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.6 mt -135.47 121.69 14.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 117.174 0.487 . . . . 0.0 110.465 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 86.1 Cg_endo -78.33 47.54 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.949 2.433 . . . . 0.0 112.376 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.97 37.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.157 0.503 . . . . 0.0 112.336 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -89.58 -33.28 16.76 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.03 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.17 29.31 50.96 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.215 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 53.0 mt-10 -135.32 154.59 51.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.275 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.1 p -103.12 143.46 32.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.428 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.44 40.69 3.15 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.251 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -73.27 -27.37 61.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.87 -19.82 40.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.611 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.96 44.44 4.46 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.159 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -156.89 152.91 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -145.98 127.51 15.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -91.08 -19.4 23.18 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.003 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.576 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.45 155.62 40.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.509 0.671 . . . . 0.0 112.15 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -81.89 133.8 35.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.359 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 67.58 9.72 56.16 Favored Glycine 0 C--N 1.329 0.177 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.776 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 84.2 m -88.4 134.32 33.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.2 p -111.08 142.53 43.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.34 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.44 117.5 5.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.072 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 m -136.2 72.27 1.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.65 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.3 t90 -35.7 129.1 0.59 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 124.32 1.013 . . . . 0.0 112.256 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.1 Cg_endo -97.47 28.97 15.61 Favored 'Cis proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.26 -1.558 . . . . 0.0 114.163 1.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -132.87 -166.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 112.184 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.1 m -124.35 136.63 54.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.0 ttpp -126.16 123.25 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 111.446 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 12.2 ptm180 -104.59 133.73 48.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 112.73 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.682 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -130.68 126.13 21.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.675 ' HB3' HD12 ' A' ' 25' ' ' ILE . 7.8 Cg_exo -73.54 48.4 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.582 2.854 . . . . 0.0 112.805 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.02 38.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.498 0.666 . . . . 0.0 111.857 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 26.9 m -105.13 -33.47 8.26 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.368 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.17 55.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.986 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-10 -134.4 145.88 49.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.954 0.407 . . . . 0.0 110.922 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.8 p -97.89 145.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -127.46 38.84 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.214 -0.994 . . . . 0.0 112.085 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.602 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.5 t -64.88 -24.28 67.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.063 0.459 . . . . 0.0 109.837 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.47 -16.03 55.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.171 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.03 46.33 4.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.84 154.56 32.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -146.63 130.51 17.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 4.8 m-85 -96.66 -24.67 15.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.364 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' HH21 ' A' ' 28' ' ' ARG . 1.2 p -70.97 152.76 43.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.607 0.718 . . . . 0.0 112.376 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.19 136.53 38.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.574 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.39 10.41 42.27 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 93.2 m -91.56 132.28 36.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.235 0.54 . . . . 0.0 110.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -108.42 140.84 41.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -73.25 119.4 17.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.553 0.692 . . . . 0.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -137.14 84.02 2.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.602 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 11.8 t90 -31.56 124.12 0.35 Allowed Pre-proline 0 C--O 1.231 0.127 0 O-C-N 124.736 1.272 . . . . 0.0 112.759 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 90.6 Cg_endo -104.44 30.27 8.19 Favored 'Cis proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.377 -1.51 . . . . 0.0 114.397 1.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.0 pt -136.45 161.01 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 68.9 m -96.97 131.87 43.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.014 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.682 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 11.9 pttp -132.72 135.88 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.095 0.474 . . . . 0.0 111.667 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.552 HH21 ' HB ' ' A' ' 16' ' ' THR . 12.6 ptp180 -103.79 134.81 46.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--N 1.323 -0.551 0 O-C-N 123.678 0.611 . . . . 0.0 110.778 -179.579 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.169 -0.239 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -123.18 121.32 27.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.215 0.507 . . . . 0.0 110.344 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.7 Cg_endo -73.1 48.43 1.45 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.98 2.454 . . . . 0.0 112.913 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.29 38.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.374 0.607 . . . . 0.0 111.715 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 22.2 m -95.3 -32.76 12.83 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.328 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.04 44.01 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.814 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 16.3 mt-10 -88.86 140.15 29.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.445 0.641 . . . . 0.0 111.658 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -97.69 148.04 23.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.197 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -144.58 128.09 17.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.687 0.756 . . . . 0.0 111.236 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.796 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -120.99 -32.63 3.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.137 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.45 -43.12 19.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.072 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.589 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 126.89 47.3 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.156 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -128.34 139.43 52.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.834 -0.183 . . . . 0.0 111.479 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -147.52 125.95 12.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 6.7 m-85 -95.93 -20.5 18.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.264 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -67.94 155.53 39.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.42 0.629 . . . . 0.0 111.762 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -80.9 132.17 35.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.453 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 64.93 17.69 63.46 Favored Glycine 0 C--N 1.329 0.165 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.484 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 82.2 m -97.48 135.34 39.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.094 0.473 . . . . 0.0 111.129 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 p -116.64 138.0 51.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.064 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 48.9 t -65.22 122.39 16.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.275 0.56 . . . . 0.0 110.884 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m -136.09 81.12 1.86 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.796 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 6.3 t90 -29.18 120.21 0.28 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.618 1.199 . . . . 0.0 112.814 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 92.9 Cg_endo -104.88 37.09 4.6 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.912 -1.287 . . . . 0.0 114.624 1.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -150.61 150.18 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.2 m -80.75 136.48 36.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.587 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 23.4 pttm -125.05 130.63 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 0.0 111.223 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.73 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 13.8 ptm180 -104.31 128.08 52.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 109.876 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 113.817 0.287 . . . . 0.0 113.817 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -120.62 126.05 26.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.405 0.603 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.76 49.95 1.3 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.276 2.651 . . . . 0.0 113.344 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -104.67 39.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.0 111.835 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -96.66 -34.7 11.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 26.68 56.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -131.88 155.38 47.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.026 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.0 p -108.21 141.71 39.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.122 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 6.1 t -115.27 38.91 3.07 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.371 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.691 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.0 t -72.55 -33.61 66.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.92 -16.19 48.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.322 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.498 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 86.43 38.26 8.41 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.693 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -143.66 135.37 26.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.103 0.161 . . . . 0.0 111.32 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -154.63 130.59 10.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.5 10.28 31.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.818 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.525 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -79.72 155.4 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.696 0.76 . . . . 0.0 112.091 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.22 130.7 40.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.555 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.13 27.48 46.12 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.7 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 81.3 m -99.36 134.76 41.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.935 0.397 . . . . 0.0 110.643 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.4 p -111.52 139.66 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 24.8 t -60.3 117.92 5.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 0.0 110.602 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m -137.39 75.31 1.52 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.691 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 27.7 t90 -35.78 128.68 0.61 Allowed Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 124.156 0.91 . . . . 0.0 112.321 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.8 Cg_endo -97.4 27.99 16.96 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.291 -1.546 . . . . 0.0 114.244 1.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.3 pt -133.11 -159.57 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.211 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 13.6 m -142.48 140.52 31.91 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -121.84 132.9 54.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.449 0.642 . . . . 0.0 112.131 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 22.6 ttm180 -102.56 125.31 49.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.445 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.767 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.8 mt -133.82 120.61 15.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -76.49 48.98 2.52 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.496 2.798 . . . . 0.0 112.284 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG23 HH11 ' A' ' 28' ' ' ARG . 8.1 m -103.59 31.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.321 0.581 . . . . 0.0 111.983 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.537 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 32.3 m -89.54 -34.82 16.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.78 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.14 30.5 50.61 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.573 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' OE2' HG23 ' A' ' 16' ' ' THR . 79.9 mt-10 -136.27 148.83 48.2 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.7 p -96.64 143.8 27.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -123.93 33.23 5.36 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.5 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.636 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.6 t -63.27 -26.42 68.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 110.095 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.5 pt? -80.88 -6.47 58.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.656 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.74 43.47 10.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.151 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -154.54 156.06 35.95 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.0 m -145.23 129.93 18.08 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.08 -24.26 17.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.984 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -70.38 154.41 41.92 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.736 0.779 . . . . 0.0 112.491 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -76.32 131.84 39.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.265 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 17.28 59.21 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.419 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 87.7 m -93.08 136.11 33.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.933 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -112.38 142.6 44.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.054 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.03 121.99 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 111.122 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.1 m -135.4 74.96 1.54 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.636 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.7 t90 -28.92 124.4 0.26 Allowed Pre-proline 0 C--O 1.232 0.148 0 O-C-N 124.858 1.349 . . . . 0.0 113.142 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.2 Cg_endo -103.22 32.22 8.1 Favored 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.393 -1.503 . . . . 0.0 114.221 0.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.0 pt -133.8 160.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 72.9 m -91.14 134.82 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.036 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 15.9 ttpt -131.65 123.1 27.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.781 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 9.6 ptp85 -107.68 135.77 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.583 0.23 . . . . 0.0 110.574 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.133 179.705 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' C ' HD22 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.438 0 CA-C-O 120.29 -0.172 . . . . 0.0 113.061 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 1' ' ' GLY . 2.7 mm? -133.48 132.48 21.93 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.979 0.389 . . . . 0.0 110.118 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.5 Cg_endo -73.54 49.34 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.782 2.321 . . . . 0.0 112.196 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.61 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.203 0.525 . . . . 0.0 112.328 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 37.0 m -89.31 -29.39 19.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.74 30.93 57.18 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.143 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -138.18 153.06 49.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 p -98.35 143.27 29.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.2 p -116.83 32.48 6.13 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.154 -1.019 . . . . 0.0 112.14 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -65.04 -29.49 70.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -3.97 55.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.942 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.43 46.27 15.8 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.29 154.26 28.77 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.636 -0.332 . . . . 0.0 110.631 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -151.33 126.01 9.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -80.1 -32.98 39.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.609 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 2.2 p -58.76 153.69 16.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.707 0.765 . . . . 0.0 112.872 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -79.62 131.17 35.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.43 24.51 75.05 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.931 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.015 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 7.7 t -93.33 147.07 23.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.4 p -128.95 141.98 51.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.05 126.21 28.95 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.639 0.733 . . . . 0.0 111.4 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 m -135.54 66.82 1.5 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.554 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.9 t90 -26.97 124.36 0.22 Allowed Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.483 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.2 Cg_endo -101.17 27.3 14.18 Favored 'Cis proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.2 -1.583 . . . . 0.0 113.898 0.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.04 154.05 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.015 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 67.0 m -88.45 137.25 32.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.687 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 18.5 ttpt -133.45 115.4 14.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.561 0.22 . . . . 0.0 111.57 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -108.28 140.68 41.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.562 ' HA2' ' HE2' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.57 0 CA-C-O 120.237 -0.202 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.4 mm? -119.16 125.29 27.7 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.144 0.472 . . . . 0.0 110.559 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.1 Cg_endo -75.99 49.91 2.66 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.264 2.643 . . . . 0.0 112.69 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.488 HG23 HH11 ' A' ' 28' ' ' ARG . 6.6 m -103.45 31.35 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.538 0.685 . . . . 0.0 111.48 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 16.5 m -98.18 -33.94 10.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.517 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.01 56.58 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.802 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-10 -134.0 146.49 50.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.58 145.19 26.51 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 10.3 p -127.22 37.96 4.16 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.052 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.668 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.2 t -63.03 -30.33 71.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.038 0.447 . . . . 0.0 110.029 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.06 -1.24 47.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.937 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.7 48.63 10.02 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.484 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -151.21 151.8 32.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.685 -0.303 . . . . 0.0 110.463 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.0 m -148.79 132.34 16.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 8.5 m-85 -102.25 -20.75 14.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.272 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.588 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.1 p -72.71 152.19 41.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.642 0.734 . . . . 0.0 112.328 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -75.56 134.47 40.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.663 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.27 4.34 29.33 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.32 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 87.8 m -85.05 135.88 33.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.228 0.537 . . . . 0.0 111.483 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 p -113.05 144.18 43.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.2 t -75.29 121.24 21.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.465 0.65 . . . . 0.0 111.423 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.1 m -135.67 83.16 2.0 Allowed 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.668 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 18.0 t90 -31.71 124.46 0.35 Allowed Pre-proline 0 C--N 1.332 -0.167 0 O-C-N 124.644 1.215 . . . . 0.0 112.81 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -104.73 32.28 6.91 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.528 -1.446 . . . . 0.0 114.304 0.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.2 pt -135.19 158.67 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -95.0 130.34 41.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HE2' ' HA2' ' A' ' 1' ' ' GLY . 18.5 ptmt -135.89 133.44 37.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.488 HH11 HG23 ' A' ' 4' ' ' VAL . 10.6 ptp85 -103.04 133.66 47.78 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.268 -178.72 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.28 -0.178 . . . . 0.0 113.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.0 138.73 28.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.787 0.327 . . . . 0.0 110.499 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 64.4 Cg_endo -74.34 52.67 2.84 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.846 2.364 . . . . 0.0 111.94 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.54 49.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.606 0.717 . . . . 0.0 112.211 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.604 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.0 m -119.43 -33.9 3.96 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.165 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.48 30.33 56.74 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.787 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.06 151.27 49.66 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 25.1 p -98.2 143.82 28.3 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -121.95 34.83 5.05 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.813 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.619 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.9 t -62.66 -30.42 71.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 110.135 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.72 -2.75 51.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.972 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 46.78 11.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -152.91 154.42 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.752 -0.263 . . . . 0.0 110.436 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -151.38 125.39 9.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.86 -22.86 27.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.557 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.629 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -70.93 156.84 39.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.674 0.749 . . . . 0.0 112.252 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.646 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 15.6 mp0 -89.97 131.62 35.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.599 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.56 16.43 80.1 Favored Glycine 0 N--CA 1.454 -0.148 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.25 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.4 m -100.61 135.35 42.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.8 p -115.74 142.32 46.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.419 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.75 121.52 16.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.609 0.718 . . . . 0.0 111.195 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -134.44 74.68 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.619 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.2 t90 -29.44 124.18 0.27 Allowed Pre-proline 0 C--O 1.231 0.118 0 O-C-N 124.829 1.331 . . . . 0.0 113.01 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.2 Cg_endo -103.42 31.57 8.31 Favored 'Cis proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.408 -1.496 . . . . 0.0 114.214 0.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 11.4 pt -132.89 158.47 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 74.7 m -86.53 132.21 33.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 14.7 ttmt -121.58 118.08 28.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 0.0 111.984 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.778 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 27.0 ttp180 -104.68 133.6 49.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.585 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 124.051 0.94 . . . . 0.0 112.644 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 113.334 0.093 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.5 mt -125.01 124.47 25.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.955 0.377 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 49.24 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.044 2.496 . . . . 0.0 113.101 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG23 ' HD3' ' A' ' 28' ' ' ARG . 4.0 m -103.36 54.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.976 0.893 . . . . 0.0 111.659 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 28' ' ' ARG . 58.0 m -128.64 -32.16 2.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.438 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.77 32.88 39.43 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.597 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 10.8 pt-20 -139.2 143.85 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.528 0.68 . . . . 0.0 112.367 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.3 p -92.13 146.37 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.191 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 12.6 p -125.7 37.19 4.41 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.304 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.7 t -62.62 -27.6 69.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.097 0.475 . . . . 0.0 110.047 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.46 -9.07 59.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.893 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 47.91 6.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.519 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -155.51 154.52 31.92 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.695 -0.297 . . . . 0.0 110.36 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -145.99 130.28 17.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -88.04 -30.38 19.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.692 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' CYS . 73.5 p -72.86 150.97 42.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.439 0.638 . . . . 0.0 111.816 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -82.59 133.94 35.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.92 50.34 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.127 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HB2' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -74.46 146.68 42.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.096 0.474 . . . . 0.0 110.954 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -127.0 142.02 51.65 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.87 121.28 14.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.709 . . . . 0.0 111.473 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -135.73 69.89 1.43 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.571 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 10.4 t90 -24.69 128.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 125.055 1.472 . . . . 0.0 113.323 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 72.2 Cg_endo -98.19 23.35 22.81 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.997 -1.668 . . . . 0.0 114.237 0.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.5 pt -134.97 158.75 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 121.81 -0.556 . . . . 0.0 112.306 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 73.2 m -85.24 138.12 32.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.583 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -133.48 130.15 38.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.65 ' HD3' HG23 ' A' ' 4' ' ' VAL . 14.0 ptm180 -102.79 121.15 41.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.077 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.454 0 CA-C-O 120.439 -0.089 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.9 mt -131.83 127.71 21.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.292 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.7 Cg_exo -74.66 49.35 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.311 2.674 . . . . 0.0 112.526 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 m -103.88 43.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.344 0.592 . . . . 0.0 112.286 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.0 m -99.43 -35.32 9.94 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.764 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.07 28.67 40.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.92 151.4 49.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 110.853 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -97.61 143.16 28.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 9.0 p -120.26 34.87 5.05 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.823 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -65.12 -24.86 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.067 0.461 . . . . 0.0 109.962 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.58 -15.28 57.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.03 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.53 43.63 6.09 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.981 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -154.78 156.94 37.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -149.56 126.63 11.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.83 -22.19 25.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.696 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.662 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.67 159.11 35.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.673 0.749 . . . . 0.0 112.55 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -80.73 131.77 35.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.179 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 65.05 18.79 65.14 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.115 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 72.3 m -92.91 134.02 35.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.067 0.46 . . . . 0.0 110.651 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 p -114.57 144.14 43.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.8 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -70.75 122.95 20.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.677 0.751 . . . . 0.0 111.254 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -135.17 71.0 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.59 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 17.3 t90 -27.39 123.57 0.24 Allowed Pre-proline 0 N--CA 1.462 0.172 0 O-C-N 125.002 1.439 . . . . 0.0 113.287 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 96.9 Cg_endo -103.16 31.23 8.71 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.348 -1.521 . . . . 0.0 114.016 0.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.4 pt -129.81 158.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.4 m -89.96 135.42 33.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.287 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 12.8 ttmt -124.79 117.72 24.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.664 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.761 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.9 ptm180 -108.22 133.3 52.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.432 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 CA-C-O 120.355 -0.136 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.1 mt -131.31 125.21 20.75 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.854 0.359 . . . . 0.0 110.157 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.86 47.92 2.08 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.192 2.594 . . . . 0.0 112.382 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 28' ' ' ARG . 5.3 m -104.85 45.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 35.5 m -97.96 -33.43 11.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.798 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.01 30.8 45.53 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.026 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.71 153.66 50.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.043 0.449 . . . . 0.0 110.529 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 40.9 p -101.37 143.0 31.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 t -122.19 41.88 3.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.734 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.7 t -73.04 -26.02 61.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.38 -18.8 44.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.401 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.9 34.93 7.42 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.437 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.0 p -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.573 0.349 . . . . 0.0 110.608 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.2 m -131.19 123.95 29.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.99 -25.63 27.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.767 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.622 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -68.21 153.93 42.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.589 0.709 . . . . 0.0 111.994 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -86.38 138.35 31.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.526 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 66.87 16.04 65.56 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.622 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 86.4 m -100.59 134.98 42.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -109.77 144.29 38.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.75 118.4 8.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.546 0.689 . . . . 0.0 110.414 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -136.21 73.17 1.45 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.734 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 26.9 t90 -34.44 127.3 0.49 Allowed Pre-proline 0 N--CA 1.465 0.29 0 O-C-N 124.367 1.042 . . . . 0.0 112.236 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -98.92 30.48 12.63 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 -1.471 . . . . 0.0 114.169 0.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -133.71 -164.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.965 0.412 . . . . 0.0 111.801 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.6 m -125.62 138.23 53.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 ttmp? -119.07 120.06 36.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.9 ptp180 -105.91 129.01 54.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 . . . . . 0 N--CA 1.472 0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.821 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.472 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.64 123.41 32.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.067 0.434 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.3 Cg_endo -76.76 52.57 3.76 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.213 2.608 . . . . 0.0 112.724 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.41 22.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 111.555 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 4.0 m -89.63 -33.82 16.53 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.5 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.16 25.97 56.29 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.206 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -125.76 144.08 50.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.129 0.49 . . . . 0.0 111.108 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.4 p -101.62 144.52 30.24 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.0 p -148.07 128.66 14.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.831 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.0 t -116.06 -34.03 4.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.961 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.4 -53.14 6.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.251 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.562 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 140.75 47.88 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 p -122.73 133.15 54.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -147.74 124.3 11.07 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -86.0 -25.22 26.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.664 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -69.65 154.45 41.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.439 0.637 . . . . 0.0 112.568 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -85.18 133.68 34.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.504 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.39 -12.45 26.49 Favored Glycine 0 C--O 1.23 -0.108 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.261 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 69.4 m -75.84 139.14 41.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.964 0.412 . . . . 0.0 111.142 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.9 p -122.42 142.43 50.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.812 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 42.6 t -71.72 121.79 19.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.362 0.601 . . . . 0.0 110.613 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 49.8 m -135.44 83.49 2.02 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.831 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 7.5 t90 -27.65 121.33 0.25 Allowed Pre-proline 0 C--N 1.331 -0.217 0 O-C-N 125.077 1.485 . . . . 0.0 113.091 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 86.5 Cg_endo -106.05 33.94 5.27 Favored 'Cis proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.863 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.7 pt -139.23 153.59 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -89.09 132.0 34.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 18.5 ptpt -136.12 133.58 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -103.85 131.68 50.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.891 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 113.814 0.285 . . . . 0.0 113.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -127.5 123.79 23.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.32 0.56 . . . . 0.0 110.399 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.2 Cg_endo -76.41 47.47 2.09 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.871 2.38 . . . . 0.0 112.668 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.421 HG23 ' HD2' ' A' ' 28' ' ' ARG . 7.7 m -104.8 48.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 47.9 m -101.12 -33.16 10.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.71 150.51 22.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 111.355 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.1 p -97.41 143.07 28.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.288 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.19 41.05 1.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.721 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.771 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.8 t -76.87 -34.93 57.77 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -82.0 -15.48 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.623 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 37.54 9.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.382 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -137.53 145.39 42.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.223 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.75 133.88 9.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -110.78 -10.79 14.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.609 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.591 ' HB ' HH21 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -71.84 154.95 40.93 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.687 0.756 . . . . 0.0 112.289 -178.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -68.3 129.85 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.246 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.45 28.25 50.29 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.591 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 85.3 m -96.77 135.57 38.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -113.49 140.03 48.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.18 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.14 115.29 10.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.466 0.65 . . . . 0.0 111.41 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -135.88 84.25 2.07 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.771 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.9 t90 -33.82 125.22 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.689 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 85.3 Cg_endo -104.45 33.04 6.73 Favored 'Cis proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.592 -1.42 . . . . 0.0 114.16 0.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.445 ' CG1' ' N ' ' A' ' 26' ' ' CYS . 11.9 tt -144.11 159.74 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 84.3 m -79.03 136.15 37.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.131 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 13.0 ttpp -127.56 116.11 19.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.054 0.454 . . . . 0.0 111.221 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.591 HH21 ' HB ' ' A' ' 16' ' ' THR . 8.5 ptp180 -104.7 128.36 52.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.26 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.148 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 4.1 mm? -114.63 122.19 34.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.434 0.617 . . . . 0.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.3 Cg_exo -77.62 50.01 3.09 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.693 2.929 . . . . 0.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 m -103.72 28.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.344 0.592 . . . . 0.0 111.608 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.492 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 10.9 m -89.49 -33.59 16.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.3 30.25 57.17 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.032 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.27 155.13 48.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.938 0.399 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 23.2 p -107.46 144.26 34.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.882 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 8.9 t -119.83 38.66 3.86 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.033 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.684 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.9 t -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.89 -18.71 42.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.54 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 44.63 4.35 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.17 152.65 26.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -142.42 130.29 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.85 -22.18 18.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.352 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.585 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -70.53 156.12 39.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.606 0.717 . . . . 0.0 112.096 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -85.39 133.25 34.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.48 -7.04 27.33 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.561 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 89.1 m -78.66 133.54 37.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -108.85 148.04 31.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.512 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.24 116.97 11.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.317 0.58 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -137.1 80.94 1.84 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.684 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 24.0 t90 -37.22 129.54 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 O-C-N 124.251 0.969 . . . . 0.0 112.079 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.7 Cg_endo -98.96 29.0 14.57 Favored 'Cis proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.389 -1.505 . . . . 0.0 114.225 1.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.4 pt -133.93 -167.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 112.301 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.7 m -128.86 138.79 52.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -135.17 133.44 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.194 0.521 . . . . 0.0 111.66 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.648 ' HD3' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -102.56 130.42 49.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.648 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 4.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.282 -0.177 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.595 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.2 mm? -121.83 113.97 31.37 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 117.252 0.526 . . . . 0.0 110.371 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 5.8 Cg_exo -79.85 43.31 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.49 2.793 . . . . 0.0 112.158 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 2' ' ' LEU . 6.5 m -104.75 42.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.235 0.54 . . . . 0.0 112.413 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' HH12 ' A' ' 28' ' ' ARG . 16.8 m -89.61 -32.79 16.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.67 24.87 52.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.732 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.77 150.84 52.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -98.35 141.78 30.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.755 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 m -114.58 40.79 2.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.743 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.692 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.7 t -74.32 -34.84 63.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.92 -37.15 27.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.033 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 45.4 1.01 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.602 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -139.74 143.42 36.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.821 -0.19 . . . . 0.0 111.097 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -154.2 122.83 6.21 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.35 -20.03 24.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.142 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -67.84 156.83 36.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.969 -179.123 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -84.28 134.89 34.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.16 -6.45 14.36 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.808 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.903 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 58.2 m -73.27 139.2 45.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 111.36 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 p -125.0 139.81 53.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.07 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.27 121.88 13.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.541 0.686 . . . . 0.0 111.509 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 m -135.03 73.67 1.49 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.692 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -33.69 127.02 0.44 Allowed Pre-proline 0 N--CA 1.463 0.213 0 O-C-N 124.414 1.071 . . . . 0.0 112.708 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -97.48 19.72 28.7 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.223 -1.574 . . . . 0.0 113.886 0.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 5.9 pt -116.99 -163.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 111.958 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.903 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 8.5 t -132.34 139.99 48.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.2 ttpm? -135.69 127.81 29.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.73 HH12 ' HA ' ' A' ' 5' ' ' CYS . 23.4 ptt-85 -115.31 130.26 56.85 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.655 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 113.461 0.145 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 97.4 mt -137.06 121.24 12.24 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 110.456 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 3.2 Cg_exo -76.93 54.32 4.51 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.46 2.774 . . . . 0.0 112.08 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.89 52.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.733 0.777 . . . . 0.0 112.269 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB3' HG21 ' A' ' 16' ' ' THR . 70.0 m -125.82 -30.3 3.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.426 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.03 -11.22 49.6 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.766 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' OE2' HG23 ' A' ' 16' ' ' THR . 48.4 mt-10 -88.33 145.89 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.462 0.649 . . . . 0.0 111.765 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.9 p -95.83 145.65 25.18 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -124.09 36.2 4.67 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.943 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.675 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.0 t -62.26 -28.68 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.056 0.455 . . . . 0.0 110.037 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -81.35 -2.31 48.73 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.437 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.48 45.43 14.02 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.092 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -157.24 155.96 31.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.6 m -143.74 127.7 17.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -84.76 -33.63 23.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.294 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.475 HG23 ' OE2' ' A' ' 7' ' ' GLU . 1.3 p -64.58 151.12 45.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.635 0.731 . . . . 0.0 111.953 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -82.68 137.13 34.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.382 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.94 -14.59 13.2 Favored Glycine 0 N--CA 1.454 -0.137 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.384 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -74.88 141.23 44.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -118.04 141.61 48.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.278 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.4 t -66.22 121.5 15.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.604 0.716 . . . . 0.0 111.19 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 m -136.43 73.94 1.48 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.675 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -29.28 125.68 0.26 Allowed Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 124.811 1.319 . . . . 0.0 113.074 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.7 Cg_endo -101.41 26.0 15.09 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.212 -1.578 . . . . 0.0 114.358 1.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.5 pt -131.83 160.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.459 0.647 . . . . 0.0 112.587 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -88.63 133.89 34.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.172 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 14.4 ttpp -132.06 123.84 28.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.949 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -104.48 132.0 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.857 179.479 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 CA-C-O 120.397 -0.113 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.5 mt -135.55 126.11 16.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.518 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.85 53.35 3.67 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.347 2.698 . . . . 0.0 111.992 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.36 43.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 112.463 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.663 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 59.0 m -112.2 -30.16 7.31 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.149 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.64 49.79 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.189 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -131.72 148.88 52.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 111.382 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 39.2 p -96.63 143.3 27.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.6 p -123.17 37.15 4.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.169 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.644 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.2 t -63.71 -28.45 69.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.17 0.51 . . . . 0.0 109.997 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.06 -18.16 47.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.205 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.44 46.91 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.316 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.58 154.3 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.806 -0.232 . . . . 0.0 110.442 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -150.15 126.74 10.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -78.46 -35.79 46.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 4.3 p -61.5 149.99 37.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.781 0.8 . . . . 0.0 112.193 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.58 134.67 34.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.12 -5.33 77.1 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.14 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -80.47 145.06 32.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.0 p -124.76 143.78 50.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.47 125.3 26.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.727 0.775 . . . . 0.0 111.833 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.2 m -135.58 70.73 1.43 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -28.43 125.14 0.24 Allowed Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 124.881 1.363 . . . . 0.0 113.105 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -101.55 28.57 12.4 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.285 -1.548 . . . . 0.0 114.072 0.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 5.2 pt -129.59 156.83 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.735 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 96.9 m -84.98 137.92 32.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 16.1 ttmt -135.09 121.18 19.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.441 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -108.8 133.55 52.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 123.543 0.527 . . . . 0.0 111.278 179.486 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.862 -0.095 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -128.44 123.51 22.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.323 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HB3' HD12 ' A' ' 25' ' ' ILE . 6.8 Cg_exo -74.16 50.13 2.15 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.459 2.773 . . . . 0.0 112.468 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.1 m -103.87 26.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.192 0.52 . . . . 0.0 111.924 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.9 m -91.69 -34.06 14.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.77 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.2 -8.1 61.91 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.796 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -87.82 145.3 26.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 111.426 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.4 p -98.49 147.39 24.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -132.81 38.69 3.38 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.664 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.6 t -64.95 -26.96 68.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.454 HD22 HG23 ' A' ' 10' ' ' THR . 2.5 mm? -80.75 -13.87 58.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.78 34.4 8.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.608 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -139.58 146.5 39.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.727 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.3 m -130.31 121.17 25.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.479 0.657 . . . . 0.0 109.853 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.49 -30.83 57.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.686 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.634 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -78.69 157.75 28.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.222 0.534 . . . . 0.0 112.046 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 18.2 mp0 -90.71 137.24 32.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.092 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.62 1.37 65.96 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.028 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 94.5 m -89.3 134.06 34.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.468 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.8 p -109.21 140.49 42.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.98 122.67 17.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.693 0.759 . . . . 0.0 111.027 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 71.09 1.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.664 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.2 t90 -26.56 121.45 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 124.777 1.298 . . . . 0.0 113.105 -176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -103.59 30.99 8.5 Favored 'Cis proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.455 -1.477 . . . . 0.0 114.284 0.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.8 pt -131.94 161.51 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.466 0.575 . . . . 0.0 112.49 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 86.1 m -101.2 134.36 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.843 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -123.48 129.9 51.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.195 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.706 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 57.5 ttp180 -104.27 132.54 50.41 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.321 -0.663 0 O-C-N 123.863 0.727 . . . . 0.0 110.57 -179.253 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.074 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.21 122.72 16.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 110.423 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.8 Cg_endo -76.83 52.37 3.71 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.048 2.498 . . . . 0.0 111.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -103.36 24.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.238 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 61.0 m -89.63 -30.55 18.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 33.83 64.65 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.615 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -131.92 147.97 52.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.01 0.434 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -93.16 142.79 26.91 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.1 p -124.84 33.5 5.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.94 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.592 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.4 t -64.34 -25.22 67.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.082 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 HG23 ' A' ' 10' ' ' THR . 2.8 mm? -80.66 -11.51 59.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.29 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.27 42.71 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.879 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.43 153.82 32.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.545 0.212 . . . . 0.0 111.12 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -144.44 129.57 18.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.49 -34.16 28.09 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -58.78 153.36 17.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.873 0.844 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -80.08 127.04 31.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.927 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.77 74.7 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.863 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 1.7 t -96.26 148.41 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.6 p -123.45 142.35 51.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.3 t -69.92 125.37 26.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.688 0.756 . . . . 0.0 111.732 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.8 m -135.49 69.07 1.44 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.592 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -26.6 124.46 0.22 Allowed Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 125.034 1.459 . . . . 0.0 113.414 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.5 Cg_endo -101.21 26.75 14.67 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.344 -1.523 . . . . 0.0 114.016 0.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -126.04 157.14 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 112.901 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.863 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 85.3 m -87.21 140.08 29.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.162 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 15.1 ttmt -135.43 117.52 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.928 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -106.58 133.59 51.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.7 0.286 . . . . 0.0 110.853 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.543 -179.729 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -121.51 120.97 28.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 117.007 0.404 . . . . 0.0 110.616 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.4 47.29 1.8 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.311 2.674 . . . . 0.0 113.293 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG23 HH11 ' A' ' 28' ' ' ARG . 6.0 m -105.83 34.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 112.093 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 31.3 m -89.41 -34.95 16.3 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.447 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.26 29.32 41.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.557 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -136.9 157.52 46.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.884 0.373 . . . . 0.0 110.061 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.6 p -109.05 140.62 42.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.572 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.4 t -107.56 33.45 4.04 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.061 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.606 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 13.1 t -71.55 -27.97 63.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.08 -16.28 50.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.331 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.09 41.83 6.13 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.23 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -170.02 160.07 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 111.01 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 m -161.2 134.98 6.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.806 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -97.44 10.18 40.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.711 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -82.9 158.46 22.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.541 0.686 . . . . 0.0 111.834 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.67 130.8 36.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.329 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 59.2 19.16 44.97 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.644 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.711 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 81.8 m -89.65 134.35 34.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.09 0.471 . . . . 0.0 111.104 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.3 p -108.25 141.61 39.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.5 t -62.71 118.86 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 110.463 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -136.66 68.7 1.42 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 10' ' ' THR . 31.8 t90 -34.6 128.94 0.48 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 124.319 1.012 . . . . 0.0 112.207 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 61.6 Cg_endo -95.03 25.23 23.01 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.063 -1.64 . . . . 0.0 114.216 1.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.2 pt -128.67 -159.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 121.929 -0.482 . . . . 0.0 111.477 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 27.1 m -144.98 140.83 28.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.323 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -127.37 133.63 50.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.1 ptp85 -103.61 128.74 50.85 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 -177.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.6 mt -135.47 121.69 14.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 117.174 0.487 . . . . 0.0 110.465 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 86.1 Cg_endo -78.33 47.54 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.949 2.433 . . . . 0.0 112.376 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.97 37.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.157 0.503 . . . . 0.0 112.336 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -89.58 -33.28 16.76 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.03 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.17 29.31 50.96 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.215 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 53.0 mt-10 -135.32 154.59 51.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.275 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.1 p -103.12 143.46 32.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.428 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.44 40.69 3.15 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.251 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -73.27 -27.37 61.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.87 -19.82 40.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.611 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.96 44.44 4.46 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.159 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -156.89 152.91 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -145.98 127.51 15.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -91.08 -19.4 23.18 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.003 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.576 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.45 155.62 40.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.509 0.671 . . . . 0.0 112.15 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -81.89 133.8 35.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.359 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 67.58 9.72 56.16 Favored Glycine 0 C--N 1.329 0.177 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.776 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 84.2 m -88.4 134.32 33.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.2 p -111.08 142.53 43.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.34 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.44 117.5 5.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.072 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 m -136.2 72.27 1.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.65 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.3 t90 -35.7 129.1 0.59 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 124.32 1.013 . . . . 0.0 112.256 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.1 Cg_endo -97.47 28.97 15.61 Favored 'Cis proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.26 -1.558 . . . . 0.0 114.163 1.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -132.87 -166.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 112.184 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.1 m -124.35 136.63 54.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.0 ttpp -126.16 123.25 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 111.446 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 12.2 ptm180 -104.59 133.73 48.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 112.73 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.682 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -130.68 126.13 21.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.675 ' HB3' HD12 ' A' ' 25' ' ' ILE . 7.8 Cg_exo -73.54 48.4 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.582 2.854 . . . . 0.0 112.805 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.02 38.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.498 0.666 . . . . 0.0 111.857 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 26.9 m -105.13 -33.47 8.26 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.368 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.17 55.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.986 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-10 -134.4 145.88 49.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.954 0.407 . . . . 0.0 110.922 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.8 p -97.89 145.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -127.46 38.84 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.214 -0.994 . . . . 0.0 112.085 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.602 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.5 t -64.88 -24.28 67.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.063 0.459 . . . . 0.0 109.837 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.47 -16.03 55.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.171 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.03 46.33 4.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.84 154.56 32.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -146.63 130.51 17.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.52 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 4.8 m-85 -96.66 -24.67 15.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.364 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' HH21 ' A' ' 28' ' ' ARG . 1.2 p -70.97 152.76 43.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.607 0.718 . . . . 0.0 112.376 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.19 136.53 38.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.574 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.39 10.41 42.27 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 93.2 m -91.56 132.28 36.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.235 0.54 . . . . 0.0 110.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -108.42 140.84 41.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -73.25 119.4 17.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.553 0.692 . . . . 0.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -137.14 84.02 2.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.602 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 11.8 t90 -31.56 124.12 0.35 Allowed Pre-proline 0 C--O 1.231 0.127 0 O-C-N 124.736 1.272 . . . . 0.0 112.759 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 90.6 Cg_endo -104.44 30.27 8.19 Favored 'Cis proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.377 -1.51 . . . . 0.0 114.397 1.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.0 pt -136.45 161.01 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 68.9 m -96.97 131.87 43.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.014 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.682 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 11.9 pttp -132.72 135.88 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.095 0.474 . . . . 0.0 111.667 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.552 HH21 ' HB ' ' A' ' 16' ' ' THR . 12.6 ptp180 -103.79 134.81 46.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--N 1.323 -0.551 0 O-C-N 123.678 0.611 . . . . 0.0 110.778 -179.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.169 -0.239 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -123.18 121.32 27.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.215 0.507 . . . . 0.0 110.344 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.7 Cg_endo -73.1 48.43 1.45 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.98 2.454 . . . . 0.0 112.913 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.29 38.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.374 0.607 . . . . 0.0 111.715 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 22.2 m -95.3 -32.76 12.83 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.328 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.04 44.01 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.814 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 16.3 mt-10 -88.86 140.15 29.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.445 0.641 . . . . 0.0 111.658 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -97.69 148.04 23.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.197 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -144.58 128.09 17.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.687 0.756 . . . . 0.0 111.236 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.796 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -120.99 -32.63 3.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.137 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.45 -43.12 19.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.072 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.589 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 126.89 47.3 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.156 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -128.34 139.43 52.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.834 -0.183 . . . . 0.0 111.479 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -147.52 125.95 12.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 6.7 m-85 -95.93 -20.5 18.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.264 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -67.94 155.53 39.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.42 0.629 . . . . 0.0 111.762 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.9 132.17 35.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.453 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 64.93 17.69 63.46 Favored Glycine 0 C--N 1.329 0.165 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.484 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 82.2 m -97.48 135.34 39.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.094 0.473 . . . . 0.0 111.129 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 p -116.64 138.0 51.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.064 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 48.9 t -65.22 122.39 16.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.275 0.56 . . . . 0.0 110.884 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m -136.09 81.12 1.86 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.796 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 6.3 t90 -29.18 120.21 0.28 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.618 1.199 . . . . 0.0 112.814 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 92.9 Cg_endo -104.88 37.09 4.6 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.912 -1.287 . . . . 0.0 114.624 1.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -150.61 150.18 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.2 m -80.75 136.48 36.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.587 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 23.4 pttm -125.05 130.63 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 0.0 111.223 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.73 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 13.8 ptm180 -104.31 128.08 52.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 109.876 -178.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 113.817 0.287 . . . . 0.0 113.817 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -120.62 126.05 26.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.405 0.603 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.76 49.95 1.3 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.276 2.651 . . . . 0.0 113.344 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -104.67 39.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.0 111.835 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.455 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -96.66 -34.7 11.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 26.68 56.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -131.88 155.38 47.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.026 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.0 p -108.21 141.71 39.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.122 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 6.1 t -115.27 38.91 3.07 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.371 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.691 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.0 t -72.55 -33.61 66.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.92 -16.19 48.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.322 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.498 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 86.43 38.26 8.41 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.693 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -143.66 135.37 26.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.103 0.161 . . . . 0.0 111.32 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -154.63 130.59 10.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.5 10.28 31.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.818 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.525 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -79.72 155.4 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.696 0.76 . . . . 0.0 112.091 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.22 130.7 40.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.555 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.13 27.48 46.12 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.7 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 81.3 m -99.36 134.76 41.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.935 0.397 . . . . 0.0 110.643 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.4 p -111.52 139.66 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 24.8 t -60.3 117.92 5.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 0.0 110.602 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m -137.39 75.31 1.52 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.691 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 27.7 t90 -35.78 128.68 0.61 Allowed Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 124.156 0.91 . . . . 0.0 112.321 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.8 Cg_endo -97.4 27.99 16.96 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.291 -1.546 . . . . 0.0 114.244 1.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.3 pt -133.11 -159.57 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.211 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 13.6 m -142.48 140.52 31.91 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -121.84 132.9 54.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.449 0.642 . . . . 0.0 112.131 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 22.6 ttm180 -102.56 125.31 49.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.445 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.767 -178.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.8 mt -133.82 120.61 15.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -76.49 48.98 2.52 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.496 2.798 . . . . 0.0 112.284 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG23 HH11 ' A' ' 28' ' ' ARG . 8.1 m -103.59 31.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.321 0.581 . . . . 0.0 111.983 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.537 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 32.3 m -89.54 -34.82 16.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.78 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.14 30.5 50.61 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.573 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' OE2' HG23 ' A' ' 16' ' ' THR . 79.9 mt-10 -136.27 148.83 48.2 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.7 p -96.64 143.8 27.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -123.93 33.23 5.36 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.5 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.636 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.6 t -63.27 -26.42 68.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 110.095 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.5 pt? -80.88 -6.47 58.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.656 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.74 43.47 10.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.151 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -154.54 156.06 35.95 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.0 m -145.23 129.93 18.08 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.08 -24.26 17.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.984 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -70.38 154.41 41.92 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.736 0.779 . . . . 0.0 112.491 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -76.32 131.84 39.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.265 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 17.28 59.21 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.419 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 87.7 m -93.08 136.11 33.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.933 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -112.38 142.6 44.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.054 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.03 121.99 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 111.122 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.1 m -135.4 74.96 1.54 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.636 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.7 t90 -28.92 124.4 0.26 Allowed Pre-proline 0 C--O 1.232 0.148 0 O-C-N 124.858 1.349 . . . . 0.0 113.142 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.2 Cg_endo -103.22 32.22 8.1 Favored 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.393 -1.503 . . . . 0.0 114.221 0.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.0 pt -133.8 160.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 72.9 m -91.14 134.82 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.036 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 15.9 ttpt -131.65 123.1 27.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.781 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 9.6 ptp85 -107.68 135.77 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.583 0.23 . . . . 0.0 110.574 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.133 179.705 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.411 ' C ' HD22 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.438 0 CA-C-O 120.29 -0.172 . . . . 0.0 113.061 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 1' ' ' GLY . 2.7 mm? -133.48 132.48 21.93 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.979 0.389 . . . . 0.0 110.118 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.5 Cg_endo -73.54 49.34 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.782 2.321 . . . . 0.0 112.196 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.61 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.203 0.525 . . . . 0.0 112.328 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 37.0 m -89.31 -29.39 19.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.74 30.93 57.18 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.143 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -138.18 153.06 49.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 p -98.35 143.27 29.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.2 p -116.83 32.48 6.13 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.154 -1.019 . . . . 0.0 112.14 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -65.04 -29.49 70.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -3.97 55.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.942 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.43 46.27 15.8 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.29 154.26 28.77 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.636 -0.332 . . . . 0.0 110.631 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -151.33 126.01 9.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -80.1 -32.98 39.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.609 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 2.2 p -58.76 153.69 16.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.707 0.765 . . . . 0.0 112.872 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -79.62 131.17 35.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.43 24.51 75.05 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.931 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.015 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 7.7 t -93.33 147.07 23.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.4 p -128.95 141.98 51.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.05 126.21 28.95 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.639 0.733 . . . . 0.0 111.4 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 m -135.54 66.82 1.5 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.554 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.9 t90 -26.97 124.36 0.22 Allowed Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.483 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.2 Cg_endo -101.17 27.3 14.18 Favored 'Cis proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.2 -1.583 . . . . 0.0 113.898 0.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.04 154.05 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.015 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 67.0 m -88.45 137.25 32.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.687 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 18.5 ttpt -133.45 115.4 14.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.561 0.22 . . . . 0.0 111.57 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -108.28 140.68 41.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.562 ' HA2' ' HE2' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.57 0 CA-C-O 120.237 -0.202 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.4 mm? -119.16 125.29 27.7 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.144 0.472 . . . . 0.0 110.559 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.1 Cg_endo -75.99 49.91 2.66 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.264 2.643 . . . . 0.0 112.69 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.488 HG23 HH11 ' A' ' 28' ' ' ARG . 6.6 m -103.45 31.35 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.538 0.685 . . . . 0.0 111.48 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 16.5 m -98.18 -33.94 10.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.517 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.01 56.58 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.802 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-10 -134.0 146.49 50.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.58 145.19 26.51 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 10.3 p -127.22 37.96 4.16 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.052 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.668 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.2 t -63.03 -30.33 71.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.038 0.447 . . . . 0.0 110.029 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.06 -1.24 47.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.937 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.7 48.63 10.02 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.484 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -151.21 151.8 32.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.685 -0.303 . . . . 0.0 110.463 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.0 m -148.79 132.34 16.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 8.5 m-85 -102.25 -20.75 14.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.272 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.588 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.1 p -72.71 152.19 41.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.642 0.734 . . . . 0.0 112.328 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -75.56 134.47 40.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.663 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.27 4.34 29.33 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.32 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 87.8 m -85.05 135.88 33.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.228 0.537 . . . . 0.0 111.483 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 p -113.05 144.18 43.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.2 t -75.29 121.24 21.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.465 0.65 . . . . 0.0 111.423 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.1 m -135.67 83.16 2.0 Allowed 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.668 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 18.0 t90 -31.71 124.46 0.35 Allowed Pre-proline 0 C--N 1.332 -0.167 0 O-C-N 124.644 1.215 . . . . 0.0 112.81 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -104.73 32.28 6.91 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.528 -1.446 . . . . 0.0 114.304 0.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.2 pt -135.19 158.67 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -95.0 130.34 41.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HE2' ' HA2' ' A' ' 1' ' ' GLY . 18.5 ptmt -135.89 133.44 37.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.488 HH11 HG23 ' A' ' 4' ' ' VAL . 10.6 ptp85 -103.04 133.66 47.78 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.268 -178.72 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.28 -0.178 . . . . 0.0 113.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.0 138.73 28.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.787 0.327 . . . . 0.0 110.499 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 64.4 Cg_endo -74.34 52.67 2.84 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.846 2.364 . . . . 0.0 111.94 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.54 49.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.606 0.717 . . . . 0.0 112.211 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.604 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.0 m -119.43 -33.9 3.96 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.165 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.48 30.33 56.74 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.787 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.06 151.27 49.66 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 25.1 p -98.2 143.82 28.3 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -121.95 34.83 5.05 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.813 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.619 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.9 t -62.66 -30.42 71.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 110.135 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.72 -2.75 51.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.972 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 46.78 11.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -152.91 154.42 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.752 -0.263 . . . . 0.0 110.436 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -151.38 125.39 9.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.86 -22.86 27.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.557 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.629 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -70.93 156.84 39.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.674 0.749 . . . . 0.0 112.252 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.646 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 15.6 mp0 -89.97 131.62 35.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.599 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.56 16.43 80.1 Favored Glycine 0 N--CA 1.454 -0.148 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.25 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.4 m -100.61 135.35 42.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.8 p -115.74 142.32 46.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.419 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.75 121.52 16.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.609 0.718 . . . . 0.0 111.195 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -134.44 74.68 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.619 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.2 t90 -29.44 124.18 0.27 Allowed Pre-proline 0 C--O 1.231 0.118 0 O-C-N 124.829 1.331 . . . . 0.0 113.01 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.2 Cg_endo -103.42 31.57 8.31 Favored 'Cis proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.408 -1.496 . . . . 0.0 114.214 0.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 11.4 pt -132.89 158.47 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 74.7 m -86.53 132.21 33.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 14.7 ttmt -121.58 118.08 28.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 0.0 111.984 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.778 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 27.0 ttp180 -104.68 133.6 49.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.585 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 124.051 0.94 . . . . 0.0 112.644 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 113.334 0.093 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.5 mt -125.01 124.47 25.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.955 0.377 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 49.24 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.044 2.496 . . . . 0.0 113.101 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG23 ' HD3' ' A' ' 28' ' ' ARG . 4.0 m -103.36 54.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.976 0.893 . . . . 0.0 111.659 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 28' ' ' ARG . 58.0 m -128.64 -32.16 2.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.438 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.77 32.88 39.43 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.597 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 10.8 pt-20 -139.2 143.85 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.528 0.68 . . . . 0.0 112.367 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.3 p -92.13 146.37 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.191 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 12.6 p -125.7 37.19 4.41 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.304 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.7 t -62.62 -27.6 69.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.097 0.475 . . . . 0.0 110.047 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.46 -9.07 59.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.893 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 47.91 6.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.519 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -155.51 154.52 31.92 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.695 -0.297 . . . . 0.0 110.36 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -145.99 130.28 17.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -88.04 -30.38 19.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.692 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' CYS . 73.5 p -72.86 150.97 42.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.439 0.638 . . . . 0.0 111.816 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -82.59 133.94 35.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.92 50.34 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.127 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HB2' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -74.46 146.68 42.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.096 0.474 . . . . 0.0 110.954 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -127.0 142.02 51.65 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.87 121.28 14.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.709 . . . . 0.0 111.473 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -135.73 69.89 1.43 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.571 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 10.4 t90 -24.69 128.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 125.055 1.472 . . . . 0.0 113.323 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 72.2 Cg_endo -98.19 23.35 22.81 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.997 -1.668 . . . . 0.0 114.237 0.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.5 pt -134.97 158.75 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 121.81 -0.556 . . . . 0.0 112.306 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 73.2 m -85.24 138.12 32.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.583 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -133.48 130.15 38.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.65 ' HD3' HG23 ' A' ' 4' ' ' VAL . 14.0 ptm180 -102.79 121.15 41.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.077 -177.582 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.454 0 CA-C-O 120.439 -0.089 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.9 mt -131.83 127.71 21.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.292 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.7 Cg_exo -74.66 49.35 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.311 2.674 . . . . 0.0 112.526 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 m -103.88 43.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.344 0.592 . . . . 0.0 112.286 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.0 m -99.43 -35.32 9.94 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.764 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.07 28.67 40.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.92 151.4 49.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 110.853 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -97.61 143.16 28.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 9.0 p -120.26 34.87 5.05 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.823 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -65.12 -24.86 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.067 0.461 . . . . 0.0 109.962 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.58 -15.28 57.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.03 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.53 43.63 6.09 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.981 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -154.78 156.94 37.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -149.56 126.63 11.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.83 -22.19 25.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.696 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.662 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.67 159.11 35.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.673 0.749 . . . . 0.0 112.55 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -80.73 131.77 35.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.179 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 65.05 18.79 65.14 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.115 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 72.3 m -92.91 134.02 35.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.067 0.46 . . . . 0.0 110.651 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 p -114.57 144.14 43.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.8 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -70.75 122.95 20.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.677 0.751 . . . . 0.0 111.254 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -135.17 71.0 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.59 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 17.3 t90 -27.39 123.57 0.24 Allowed Pre-proline 0 N--CA 1.462 0.172 0 O-C-N 125.002 1.439 . . . . 0.0 113.287 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 96.9 Cg_endo -103.16 31.23 8.71 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.348 -1.521 . . . . 0.0 114.016 0.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.4 pt -129.81 158.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.4 m -89.96 135.42 33.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.287 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 12.8 ttmt -124.79 117.72 24.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.664 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.761 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.9 ptm180 -108.22 133.3 52.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.432 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 CA-C-O 120.355 -0.136 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.1 mt -131.31 125.21 20.75 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.854 0.359 . . . . 0.0 110.157 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.86 47.92 2.08 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.192 2.594 . . . . 0.0 112.382 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 28' ' ' ARG . 5.3 m -104.85 45.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 35.5 m -97.96 -33.43 11.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.798 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.01 30.8 45.53 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.026 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.71 153.66 50.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.043 0.449 . . . . 0.0 110.529 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 40.9 p -101.37 143.0 31.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 t -122.19 41.88 3.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.734 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.7 t -73.04 -26.02 61.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.38 -18.8 44.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.401 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.9 34.93 7.42 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.437 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.0 p -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.573 0.349 . . . . 0.0 110.608 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.2 m -131.19 123.95 29.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.99 -25.63 27.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.767 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.622 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -68.21 153.93 42.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.589 0.709 . . . . 0.0 111.994 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -86.38 138.35 31.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.526 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 66.87 16.04 65.56 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.622 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 86.4 m -100.59 134.98 42.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -109.77 144.29 38.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.75 118.4 8.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.546 0.689 . . . . 0.0 110.414 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -136.21 73.17 1.45 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.734 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 26.9 t90 -34.44 127.3 0.49 Allowed Pre-proline 0 N--CA 1.465 0.29 0 O-C-N 124.367 1.042 . . . . 0.0 112.236 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -98.92 30.48 12.63 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 -1.471 . . . . 0.0 114.169 0.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -133.71 -164.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.965 0.412 . . . . 0.0 111.801 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.6 m -125.62 138.23 53.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 ttmp? -119.07 120.06 36.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.9 ptp180 -105.91 129.01 54.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.472 0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.821 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.472 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.64 123.41 32.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.067 0.434 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.3 Cg_endo -76.76 52.57 3.76 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.213 2.608 . . . . 0.0 112.724 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.41 22.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 111.555 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 4.0 m -89.63 -33.82 16.53 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.5 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.16 25.97 56.29 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.206 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -125.76 144.08 50.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.129 0.49 . . . . 0.0 111.108 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.4 p -101.62 144.52 30.24 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.0 p -148.07 128.66 14.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.831 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.0 t -116.06 -34.03 4.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.961 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.4 -53.14 6.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.251 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.562 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 140.75 47.88 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 p -122.73 133.15 54.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -147.74 124.3 11.07 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -86.0 -25.22 26.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.664 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -69.65 154.45 41.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.439 0.637 . . . . 0.0 112.568 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -85.18 133.68 34.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.504 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.39 -12.45 26.49 Favored Glycine 0 C--O 1.23 -0.108 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.261 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 69.4 m -75.84 139.14 41.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.964 0.412 . . . . 0.0 111.142 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.9 p -122.42 142.43 50.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.812 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 42.6 t -71.72 121.79 19.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.362 0.601 . . . . 0.0 110.613 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 49.8 m -135.44 83.49 2.02 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.831 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 7.5 t90 -27.65 121.33 0.25 Allowed Pre-proline 0 C--N 1.331 -0.217 0 O-C-N 125.077 1.485 . . . . 0.0 113.091 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 86.5 Cg_endo -106.05 33.94 5.27 Favored 'Cis proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.863 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.7 pt -139.23 153.59 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -89.09 132.0 34.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 18.5 ptpt -136.12 133.58 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -103.85 131.68 50.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 113.814 0.285 . . . . 0.0 113.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -127.5 123.79 23.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.32 0.56 . . . . 0.0 110.399 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.2 Cg_endo -76.41 47.47 2.09 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.871 2.38 . . . . 0.0 112.668 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.421 HG23 ' HD2' ' A' ' 28' ' ' ARG . 7.7 m -104.8 48.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 47.9 m -101.12 -33.16 10.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.71 150.51 22.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 111.355 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.1 p -97.41 143.07 28.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.288 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.19 41.05 1.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.721 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.771 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.8 t -76.87 -34.93 57.77 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -82.0 -15.48 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.623 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 37.54 9.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.382 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -137.53 145.39 42.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.223 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.75 133.88 9.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -110.78 -10.79 14.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.609 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.591 ' HB ' HH21 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -71.84 154.95 40.93 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.687 0.756 . . . . 0.0 112.289 -178.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -68.3 129.85 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.246 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.45 28.25 50.29 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.591 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 85.3 m -96.77 135.57 38.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -113.49 140.03 48.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.18 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.14 115.29 10.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.466 0.65 . . . . 0.0 111.41 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -135.88 84.25 2.07 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.771 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.9 t90 -33.82 125.22 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.689 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 85.3 Cg_endo -104.45 33.04 6.73 Favored 'Cis proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.592 -1.42 . . . . 0.0 114.16 0.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.445 ' CG1' ' N ' ' A' ' 26' ' ' CYS . 11.9 tt -144.11 159.74 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 84.3 m -79.03 136.15 37.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.131 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 13.0 ttpp -127.56 116.11 19.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.054 0.454 . . . . 0.0 111.221 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.591 HH21 ' HB ' ' A' ' 16' ' ' THR . 8.5 ptp180 -104.7 128.36 52.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.26 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.148 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 4.1 mm? -114.63 122.19 34.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.434 0.617 . . . . 0.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.3 Cg_exo -77.62 50.01 3.09 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.693 2.929 . . . . 0.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 m -103.72 28.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.344 0.592 . . . . 0.0 111.608 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.492 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 10.9 m -89.49 -33.59 16.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.3 30.25 57.17 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.032 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.27 155.13 48.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.938 0.399 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 23.2 p -107.46 144.26 34.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.882 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 8.9 t -119.83 38.66 3.86 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.033 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.684 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.9 t -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.89 -18.71 42.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.54 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 44.63 4.35 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.17 152.65 26.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -142.42 130.29 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.85 -22.18 18.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.352 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.585 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -70.53 156.12 39.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.606 0.717 . . . . 0.0 112.096 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -85.39 133.25 34.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.48 -7.04 27.33 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.561 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 89.1 m -78.66 133.54 37.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -108.85 148.04 31.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.512 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.24 116.97 11.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.317 0.58 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -137.1 80.94 1.84 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.684 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 24.0 t90 -37.22 129.54 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 O-C-N 124.251 0.969 . . . . 0.0 112.079 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.7 Cg_endo -98.96 29.0 14.57 Favored 'Cis proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.389 -1.505 . . . . 0.0 114.225 1.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.4 pt -133.93 -167.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 112.301 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.7 m -128.86 138.79 52.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -135.17 133.44 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.194 0.521 . . . . 0.0 111.66 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.648 ' HD3' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -102.56 130.42 49.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.648 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 4.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.282 -0.177 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.595 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.2 mm? -121.83 113.97 31.37 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 117.252 0.526 . . . . 0.0 110.371 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 5.8 Cg_exo -79.85 43.31 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.49 2.793 . . . . 0.0 112.158 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 2' ' ' LEU . 6.5 m -104.75 42.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.235 0.54 . . . . 0.0 112.413 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' HH12 ' A' ' 28' ' ' ARG . 16.8 m -89.61 -32.79 16.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.67 24.87 52.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.732 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.77 150.84 52.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -98.35 141.78 30.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.755 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 m -114.58 40.79 2.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.743 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.692 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.7 t -74.32 -34.84 63.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.92 -37.15 27.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.033 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 45.4 1.01 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.602 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -139.74 143.42 36.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.821 -0.19 . . . . 0.0 111.097 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -154.2 122.83 6.21 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.35 -20.03 24.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.142 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -67.84 156.83 36.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.969 -179.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -84.28 134.89 34.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.16 -6.45 14.36 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.808 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.903 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 58.2 m -73.27 139.2 45.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 111.36 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 p -125.0 139.81 53.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.07 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.27 121.88 13.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.541 0.686 . . . . 0.0 111.509 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 m -135.03 73.67 1.49 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.692 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -33.69 127.02 0.44 Allowed Pre-proline 0 N--CA 1.463 0.213 0 O-C-N 124.414 1.071 . . . . 0.0 112.708 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -97.48 19.72 28.7 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.223 -1.574 . . . . 0.0 113.886 0.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 5.9 pt -116.99 -163.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 111.958 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.903 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 8.5 t -132.34 139.99 48.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.2 ttpm? -135.69 127.81 29.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.73 HH12 ' HA ' ' A' ' 5' ' ' CYS . 23.4 ptt-85 -115.31 130.26 56.85 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.655 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 113.461 0.145 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 97.4 mt -137.06 121.24 12.24 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 110.456 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 3.2 Cg_exo -76.93 54.32 4.51 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.46 2.774 . . . . 0.0 112.08 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.89 52.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.733 0.777 . . . . 0.0 112.269 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB3' HG21 ' A' ' 16' ' ' THR . 70.0 m -125.82 -30.3 3.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.426 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.03 -11.22 49.6 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.766 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' OE2' HG23 ' A' ' 16' ' ' THR . 48.4 mt-10 -88.33 145.89 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.462 0.649 . . . . 0.0 111.765 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.9 p -95.83 145.65 25.18 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -124.09 36.2 4.67 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.943 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.675 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.0 t -62.26 -28.68 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.056 0.455 . . . . 0.0 110.037 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -81.35 -2.31 48.73 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.437 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.48 45.43 14.02 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.092 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -157.24 155.96 31.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.6 m -143.74 127.7 17.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -84.76 -33.63 23.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.294 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.475 HG23 ' OE2' ' A' ' 7' ' ' GLU . 1.3 p -64.58 151.12 45.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.635 0.731 . . . . 0.0 111.953 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -82.68 137.13 34.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.382 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.94 -14.59 13.2 Favored Glycine 0 N--CA 1.454 -0.137 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.384 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -74.88 141.23 44.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -118.04 141.61 48.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.278 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.4 t -66.22 121.5 15.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.604 0.716 . . . . 0.0 111.19 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 m -136.43 73.94 1.48 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.675 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -29.28 125.68 0.26 Allowed Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 124.811 1.319 . . . . 0.0 113.074 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.7 Cg_endo -101.41 26.0 15.09 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.212 -1.578 . . . . 0.0 114.358 1.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.5 pt -131.83 160.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.459 0.647 . . . . 0.0 112.587 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -88.63 133.89 34.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.172 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 14.4 ttpp -132.06 123.84 28.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.949 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -104.48 132.0 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.857 179.479 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 CA-C-O 120.397 -0.113 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.5 mt -135.55 126.11 16.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.518 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.85 53.35 3.67 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.347 2.698 . . . . 0.0 111.992 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.36 43.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 112.463 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.663 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 59.0 m -112.2 -30.16 7.31 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.149 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.64 49.79 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.189 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -131.72 148.88 52.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 111.382 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 39.2 p -96.63 143.3 27.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.6 p -123.17 37.15 4.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.169 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.644 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.2 t -63.71 -28.45 69.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.17 0.51 . . . . 0.0 109.997 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.06 -18.16 47.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.205 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.44 46.91 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.316 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.58 154.3 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.806 -0.232 . . . . 0.0 110.442 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -150.15 126.74 10.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -78.46 -35.79 46.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 4.3 p -61.5 149.99 37.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.781 0.8 . . . . 0.0 112.193 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -84.58 134.67 34.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.12 -5.33 77.1 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.14 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -80.47 145.06 32.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.0 p -124.76 143.78 50.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.47 125.3 26.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.727 0.775 . . . . 0.0 111.833 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.2 m -135.58 70.73 1.43 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -28.43 125.14 0.24 Allowed Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 124.881 1.363 . . . . 0.0 113.105 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -101.55 28.57 12.4 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.285 -1.548 . . . . 0.0 114.072 0.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 5.2 pt -129.59 156.83 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.735 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 96.9 m -84.98 137.92 32.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 16.1 ttmt -135.09 121.18 19.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.441 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -108.8 133.55 52.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 123.543 0.527 . . . . 0.0 111.278 179.486 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.862 -0.095 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -128.44 123.51 22.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.323 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HB3' HD12 ' A' ' 25' ' ' ILE . 6.8 Cg_exo -74.16 50.13 2.15 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.459 2.773 . . . . 0.0 112.468 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.1 m -103.87 26.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.192 0.52 . . . . 0.0 111.924 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.9 m -91.69 -34.06 14.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.77 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.2 -8.1 61.91 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.796 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -87.82 145.3 26.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 111.426 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.4 p -98.49 147.39 24.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -132.81 38.69 3.38 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.664 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.6 t -64.95 -26.96 68.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.454 HD22 HG23 ' A' ' 10' ' ' THR . 2.5 mm? -80.75 -13.87 58.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.78 34.4 8.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.608 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -139.58 146.5 39.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.727 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.3 m -130.31 121.17 25.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.479 0.657 . . . . 0.0 109.853 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.49 -30.83 57.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.686 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.634 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -78.69 157.75 28.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.222 0.534 . . . . 0.0 112.046 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 18.2 mp0 -90.71 137.24 32.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.092 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.62 1.37 65.96 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.028 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 94.5 m -89.3 134.06 34.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.468 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.8 p -109.21 140.49 42.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.98 122.67 17.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.693 0.759 . . . . 0.0 111.027 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 71.09 1.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.664 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.2 t90 -26.56 121.45 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 124.777 1.298 . . . . 0.0 113.105 -176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -103.59 30.99 8.5 Favored 'Cis proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.455 -1.477 . . . . 0.0 114.284 0.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.8 pt -131.94 161.51 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.466 0.575 . . . . 0.0 112.49 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 86.1 m -101.2 134.36 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.843 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -123.48 129.9 51.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.195 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.706 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 57.5 ttp180 -104.27 132.54 50.41 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.321 -0.663 0 O-C-N 123.863 0.727 . . . . 0.0 110.57 -179.253 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.074 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.21 122.72 16.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 110.423 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.8 Cg_endo -76.83 52.37 3.71 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.048 2.498 . . . . 0.0 111.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -103.36 24.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.238 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 61.0 m -89.63 -30.55 18.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 33.83 64.65 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.615 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -131.92 147.97 52.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.01 0.434 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -93.16 142.79 26.91 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.1 p -124.84 33.5 5.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.94 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.592 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.4 t -64.34 -25.22 67.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.082 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 HG23 ' A' ' 10' ' ' THR . 2.8 mm? -80.66 -11.51 59.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.29 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.27 42.71 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.879 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.43 153.82 32.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.545 0.212 . . . . 0.0 111.12 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -144.44 129.57 18.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.49 -34.16 28.09 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -58.78 153.36 17.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.873 0.844 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -80.08 127.04 31.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.927 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.77 74.7 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.863 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 1.7 t -96.26 148.41 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.6 p -123.45 142.35 51.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.3 t -69.92 125.37 26.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.688 0.756 . . . . 0.0 111.732 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.8 m -135.49 69.07 1.44 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.592 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -26.6 124.46 0.22 Allowed Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 125.034 1.459 . . . . 0.0 113.414 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.5 Cg_endo -101.21 26.75 14.67 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.344 -1.523 . . . . 0.0 114.016 0.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -126.04 157.14 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 112.901 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.863 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 85.3 m -87.21 140.08 29.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.162 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 15.1 ttmt -135.43 117.52 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.928 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -106.58 133.59 51.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.7 0.286 . . . . 0.0 110.853 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.543 -179.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -121.51 120.97 28.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 117.007 0.404 . . . . 0.0 110.616 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.4 47.29 1.8 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.311 2.674 . . . . 0.0 113.293 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.417 HG23 HH11 ' A' ' 28' ' ' ARG . 6.0 m -105.83 34.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 112.093 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 31.3 m -89.41 -34.95 16.3 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.447 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.26 29.32 41.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.557 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -136.9 157.52 46.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.884 0.373 . . . . 0.0 110.061 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.6 p -109.05 140.62 42.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.572 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.4 t -107.56 33.45 4.04 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.061 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.606 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 13.1 t -71.55 -27.97 63.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.08 -16.28 50.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.331 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.09 41.83 6.13 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.23 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -170.02 160.07 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 111.01 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 m -161.2 134.98 6.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.806 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -97.44 10.18 40.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.711 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -82.9 158.46 22.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.541 0.686 . . . . 0.0 111.834 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.67 130.8 36.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.329 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 59.2 19.16 44.97 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.644 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.711 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 81.8 m -89.65 134.35 34.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.09 0.471 . . . . 0.0 111.104 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.3 p -108.25 141.61 39.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.5 t -62.71 118.86 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 110.463 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -136.66 68.7 1.42 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 10' ' ' THR . 31.8 t90 -34.6 128.94 0.48 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 124.319 1.012 . . . . 0.0 112.207 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 61.6 Cg_endo -95.03 25.23 23.01 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.063 -1.64 . . . . 0.0 114.216 1.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.2 pt -128.67 -159.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 121.929 -0.482 . . . . 0.0 111.477 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 27.1 m -144.98 140.83 28.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.323 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -127.37 133.63 50.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.497 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.1 ptp85 -103.61 128.74 50.85 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 -177.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.6 mt -135.47 121.69 14.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 117.174 0.487 . . . . 0.0 110.465 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 86.1 Cg_endo -78.33 47.54 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.949 2.433 . . . . 0.0 112.376 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.97 37.79 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.157 0.503 . . . . 0.0 112.336 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -89.58 -33.28 16.76 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.03 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.17 29.31 50.96 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.215 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 53.0 mt-10 -135.32 154.59 51.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.275 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.1 p -103.12 143.46 32.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.428 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.44 40.69 3.15 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.251 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -73.27 -27.37 61.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.87 -19.82 40.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.611 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.96 44.44 4.46 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.159 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -156.89 152.91 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -145.98 127.51 15.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -91.08 -19.4 23.18 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.003 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.576 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.45 155.62 40.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.509 0.671 . . . . 0.0 112.15 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -81.89 133.8 35.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.359 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 67.58 9.72 56.16 Favored Glycine 0 C--N 1.329 0.177 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.776 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 84.2 m -88.4 134.32 33.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.2 p -111.08 142.53 43.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.34 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.44 117.5 5.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.265 0.555 . . . . 0.0 110.072 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 m -136.2 72.27 1.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.65 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.3 t90 -35.7 129.1 0.59 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 124.32 1.013 . . . . 0.0 112.256 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.1 Cg_endo -97.47 28.97 15.61 Favored 'Cis proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.26 -1.558 . . . . 0.0 114.163 1.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -132.87 -166.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 112.184 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.1 m -124.35 136.63 54.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.0 ttpp -126.16 123.25 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 111.446 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 12.2 ptm180 -104.59 133.73 48.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 112.73 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.682 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -130.68 126.13 21.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.675 ' HB3' HD12 ' A' ' 25' ' ' ILE . 7.8 Cg_exo -73.54 48.4 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.582 2.854 . . . . 0.0 112.805 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.02 38.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.498 0.666 . . . . 0.0 111.857 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 26.9 m -105.13 -33.47 8.26 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.368 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.17 55.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.986 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-10 -134.4 145.88 49.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.954 0.407 . . . . 0.0 110.922 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.8 p -97.89 145.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -127.46 38.84 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.214 -0.994 . . . . 0.0 112.085 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.602 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.5 t -64.88 -24.28 67.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.063 0.459 . . . . 0.0 109.837 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.47 -16.03 55.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.171 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.03 46.33 4.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.84 154.56 32.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -146.63 130.51 17.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 4.8 m-85 -96.66 -24.67 15.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.364 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' HH21 ' A' ' 28' ' ' ARG . 1.2 p -70.97 152.76 43.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.607 0.718 . . . . 0.0 112.376 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.19 136.53 38.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.574 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.39 10.41 42.27 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 93.2 m -91.56 132.28 36.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.235 0.54 . . . . 0.0 110.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -108.42 140.84 41.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -73.25 119.4 17.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.553 0.692 . . . . 0.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -137.14 84.02 2.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.602 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 11.8 t90 -31.56 124.12 0.35 Allowed Pre-proline 0 C--O 1.231 0.127 0 O-C-N 124.736 1.272 . . . . 0.0 112.759 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 90.6 Cg_endo -104.44 30.27 8.19 Favored 'Cis proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.377 -1.51 . . . . 0.0 114.397 1.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.0 pt -136.45 161.01 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 68.9 m -96.97 131.87 43.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.014 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.682 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 11.9 pttp -132.72 135.88 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.095 0.474 . . . . 0.0 111.667 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.552 HH21 ' HB ' ' A' ' 16' ' ' THR . 12.6 ptp180 -103.79 134.81 46.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--N 1.323 -0.551 0 O-C-N 123.678 0.611 . . . . 0.0 110.778 -179.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.169 -0.239 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -123.18 121.32 27.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.215 0.507 . . . . 0.0 110.344 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.7 Cg_endo -73.1 48.43 1.45 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.98 2.454 . . . . 0.0 112.913 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.29 38.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.374 0.607 . . . . 0.0 111.715 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 22.2 m -95.3 -32.76 12.83 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.328 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.97 -21.04 44.01 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.814 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 16.3 mt-10 -88.86 140.15 29.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.445 0.641 . . . . 0.0 111.658 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -97.69 148.04 23.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.197 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -144.58 128.09 17.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.687 0.756 . . . . 0.0 111.236 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.796 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -120.99 -32.63 3.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.137 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.45 -43.12 19.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.072 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.589 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 126.89 47.3 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.156 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -128.34 139.43 52.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.834 -0.183 . . . . 0.0 111.479 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -147.52 125.95 12.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 6.7 m-85 -95.93 -20.5 18.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.264 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -67.94 155.53 39.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.42 0.629 . . . . 0.0 111.762 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -80.9 132.17 35.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.453 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 64.93 17.69 63.46 Favored Glycine 0 C--N 1.329 0.165 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.484 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 82.2 m -97.48 135.34 39.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.094 0.473 . . . . 0.0 111.129 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 p -116.64 138.0 51.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.064 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 48.9 t -65.22 122.39 16.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.275 0.56 . . . . 0.0 110.884 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m -136.09 81.12 1.86 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.796 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 6.3 t90 -29.18 120.21 0.28 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.618 1.199 . . . . 0.0 112.814 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 92.9 Cg_endo -104.88 37.09 4.6 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.912 -1.287 . . . . 0.0 114.624 1.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -150.61 150.18 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.2 m -80.75 136.48 36.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.587 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 23.4 pttm -125.05 130.63 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 0.0 111.223 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.73 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 13.8 ptm180 -104.31 128.08 52.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 109.876 -178.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 113.817 0.287 . . . . 0.0 113.817 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -120.62 126.05 26.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.405 0.603 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.76 49.95 1.3 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.276 2.651 . . . . 0.0 113.344 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 m -104.67 39.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.469 0.652 . . . . 0.0 111.835 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 24.5 m -96.66 -34.7 11.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.58 26.68 56.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -131.88 155.38 47.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.026 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 24.0 p -108.21 141.71 39.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.122 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 6.1 t -115.27 38.91 3.07 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.371 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.691 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.0 t -72.55 -33.61 66.93 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.92 -16.19 48.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.322 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.498 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 86.43 38.26 8.41 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.693 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -143.66 135.37 26.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.103 0.161 . . . . 0.0 111.32 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -154.63 130.59 10.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.5 10.28 31.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.818 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.525 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -79.72 155.4 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.696 0.76 . . . . 0.0 112.091 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.22 130.7 40.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.555 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.13 27.48 46.12 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.7 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 81.3 m -99.36 134.76 41.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.935 0.397 . . . . 0.0 110.643 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.4 p -111.52 139.66 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 24.8 t -60.3 117.92 5.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 0.0 110.602 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m -137.39 75.31 1.52 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.691 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 27.7 t90 -35.78 128.68 0.61 Allowed Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 124.156 0.91 . . . . 0.0 112.321 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 64.8 Cg_endo -97.4 27.99 16.96 Favored 'Cis proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.291 -1.546 . . . . 0.0 114.244 1.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.3 pt -133.11 -159.57 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.211 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 13.6 m -142.48 140.52 31.91 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -121.84 132.9 54.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.449 0.642 . . . . 0.0 112.131 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.718 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 22.6 ttm180 -102.56 125.31 49.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.445 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.767 -178.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.487 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.8 mt -133.82 120.61 15.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -76.49 48.98 2.52 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.496 2.798 . . . . 0.0 112.284 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG23 HH11 ' A' ' 28' ' ' ARG . 8.1 m -103.59 31.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.321 0.581 . . . . 0.0 111.983 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.537 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 32.3 m -89.54 -34.82 16.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.78 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.14 30.5 50.61 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.573 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' OE2' HG23 ' A' ' 16' ' ' THR . 79.9 mt-10 -136.27 148.83 48.2 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.7 p -96.64 143.8 27.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -123.93 33.23 5.36 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.5 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.636 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.6 t -63.27 -26.42 68.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 110.095 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.5 pt? -80.88 -6.47 58.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.656 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.74 43.47 10.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.151 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -154.54 156.06 35.95 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.0 m -145.23 129.93 18.08 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.08 -24.26 17.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.984 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -70.38 154.41 41.92 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.736 0.779 . . . . 0.0 112.491 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -76.32 131.84 39.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.265 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 17.28 59.21 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.419 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 87.7 m -93.08 136.11 33.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.933 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -112.38 142.6 44.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.054 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.03 121.99 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 111.122 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.1 m -135.4 74.96 1.54 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.636 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.7 t90 -28.92 124.4 0.26 Allowed Pre-proline 0 C--O 1.232 0.148 0 O-C-N 124.858 1.349 . . . . 0.0 113.142 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.2 Cg_endo -103.22 32.22 8.1 Favored 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.393 -1.503 . . . . 0.0 114.221 0.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.0 pt -133.8 160.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 72.9 m -91.14 134.82 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.036 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 15.9 ttpt -131.65 123.1 27.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.781 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 9.6 ptp85 -107.68 135.77 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.583 0.23 . . . . 0.0 110.574 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.133 179.705 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' C ' HD22 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.438 0 CA-C-O 120.29 -0.172 . . . . 0.0 113.061 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 1' ' ' GLY . 2.7 mm? -133.48 132.48 21.93 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.979 0.389 . . . . 0.0 110.118 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 61.5 Cg_endo -73.54 49.34 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.782 2.321 . . . . 0.0 112.196 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.61 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.203 0.525 . . . . 0.0 112.328 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 37.0 m -89.31 -29.39 19.2 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.74 30.93 57.18 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.143 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -138.18 153.06 49.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 p -98.35 143.27 29.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.2 p -116.83 32.48 6.13 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.154 -1.019 . . . . 0.0 112.14 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.1 t -65.04 -29.49 70.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -3.97 55.76 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.942 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.43 46.27 15.8 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.29 154.26 28.77 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.636 -0.332 . . . . 0.0 110.631 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -151.33 126.01 9.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -80.1 -32.98 39.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.609 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 2.2 p -58.76 153.69 16.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.707 0.765 . . . . 0.0 112.872 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -79.62 131.17 35.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.43 24.51 75.05 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.931 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.015 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 7.7 t -93.33 147.07 23.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.4 p -128.95 141.98 51.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.05 126.21 28.95 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.639 0.733 . . . . 0.0 111.4 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 m -135.54 66.82 1.5 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.554 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.9 t90 -26.97 124.36 0.22 Allowed Pre-proline 0 N--CA 1.463 0.179 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.483 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.2 Cg_endo -101.17 27.3 14.18 Favored 'Cis proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.2 -1.583 . . . . 0.0 113.898 0.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.04 154.05 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.015 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 67.0 m -88.45 137.25 32.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.687 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 18.5 ttpt -133.45 115.4 14.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.561 0.22 . . . . 0.0 111.57 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -108.28 140.68 41.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.562 ' HA2' ' HE2' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.57 0 CA-C-O 120.237 -0.202 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.4 mm? -119.16 125.29 27.7 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.144 0.472 . . . . 0.0 110.559 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 25' ' ' ILE . 73.1 Cg_endo -75.99 49.91 2.66 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.264 2.643 . . . . 0.0 112.69 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.488 HG23 HH11 ' A' ' 28' ' ' ARG . 6.6 m -103.45 31.35 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.538 0.685 . . . . 0.0 111.48 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 16.5 m -98.18 -33.94 10.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.517 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.01 56.58 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.802 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-10 -134.0 146.49 50.47 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 21.1 p -97.58 145.19 26.51 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 10.3 p -127.22 37.96 4.16 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.052 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.668 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.2 t -63.03 -30.33 71.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.038 0.447 . . . . 0.0 110.029 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.06 -1.24 47.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.937 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.7 48.63 10.02 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.484 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -151.21 151.8 32.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.685 -0.303 . . . . 0.0 110.463 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.0 m -148.79 132.34 16.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 8.5 m-85 -102.25 -20.75 14.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.272 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.588 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.1 p -72.71 152.19 41.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.642 0.734 . . . . 0.0 112.328 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -75.56 134.47 40.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.663 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.27 4.34 29.33 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.32 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 87.8 m -85.05 135.88 33.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.228 0.537 . . . . 0.0 111.483 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 p -113.05 144.18 43.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.2 t -75.29 121.24 21.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.465 0.65 . . . . 0.0 111.423 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 54.1 m -135.67 83.16 2.0 Allowed 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.668 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 18.0 t90 -31.71 124.46 0.35 Allowed Pre-proline 0 C--N 1.332 -0.167 0 O-C-N 124.644 1.215 . . . . 0.0 112.81 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -104.73 32.28 6.91 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.528 -1.446 . . . . 0.0 114.304 0.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' A' ' 3' ' ' PRO . 9.2 pt -135.19 158.67 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -95.0 130.34 41.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HE2' ' HA2' ' A' ' 1' ' ' GLY . 18.5 ptmt -135.89 133.44 37.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.488 HH11 HG23 ' A' ' 4' ' ' VAL . 10.6 ptp85 -103.04 133.66 47.78 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.268 -178.72 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.28 -0.178 . . . . 0.0 113.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.0 138.73 28.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.787 0.327 . . . . 0.0 110.499 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 64.4 Cg_endo -74.34 52.67 2.84 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.846 2.364 . . . . 0.0 111.94 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.54 49.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.606 0.717 . . . . 0.0 112.211 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.604 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 10.0 m -119.43 -33.9 3.96 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.165 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.48 30.33 56.74 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.787 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.06 151.27 49.66 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 25.1 p -98.2 143.82 28.3 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -121.95 34.83 5.05 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.813 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.619 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.9 t -62.66 -30.42 71.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 110.135 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.72 -2.75 51.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.972 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 46.78 11.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -152.91 154.42 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.752 -0.263 . . . . 0.0 110.436 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.7 m -151.38 125.39 9.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.86 -22.86 27.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.557 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.629 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -70.93 156.84 39.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.674 0.749 . . . . 0.0 112.252 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.646 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 15.6 mp0 -89.97 131.62 35.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.599 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.56 16.43 80.1 Favored Glycine 0 N--CA 1.454 -0.148 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.25 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.4 m -100.61 135.35 42.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.8 p -115.74 142.32 46.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.419 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.75 121.52 16.67 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.609 0.718 . . . . 0.0 111.195 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -134.44 74.68 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.619 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 16.2 t90 -29.44 124.18 0.27 Allowed Pre-proline 0 C--O 1.231 0.118 0 O-C-N 124.829 1.331 . . . . 0.0 113.01 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.2 Cg_endo -103.42 31.57 8.31 Favored 'Cis proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.408 -1.496 . . . . 0.0 114.214 0.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 11.4 pt -132.89 158.47 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 74.7 m -86.53 132.21 33.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 14.7 ttmt -121.58 118.08 28.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 0.0 111.984 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.778 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 27.0 ttp180 -104.68 133.6 49.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.585 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 124.051 0.94 . . . . 0.0 112.644 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 113.334 0.093 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.5 mt -125.01 124.47 25.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.955 0.377 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 49.24 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.044 2.496 . . . . 0.0 113.101 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG23 ' HD3' ' A' ' 28' ' ' ARG . 4.0 m -103.36 54.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.976 0.893 . . . . 0.0 111.659 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 28' ' ' ARG . 58.0 m -128.64 -32.16 2.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.438 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.77 32.88 39.43 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.597 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 10.8 pt-20 -139.2 143.85 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.528 0.68 . . . . 0.0 112.367 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.3 p -92.13 146.37 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.191 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 12.6 p -125.7 37.19 4.41 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.304 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 13.7 t -62.62 -27.6 69.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.097 0.475 . . . . 0.0 110.047 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.46 -9.07 59.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.893 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 47.91 6.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.519 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -155.51 154.52 31.92 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.695 -0.297 . . . . 0.0 110.36 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -145.99 130.28 17.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -88.04 -30.38 19.99 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.692 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' CYS . 73.5 p -72.86 150.97 42.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.439 0.638 . . . . 0.0 111.816 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -82.59 133.94 35.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.92 50.34 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.127 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HB2' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -74.46 146.68 42.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.096 0.474 . . . . 0.0 110.954 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -127.0 142.02 51.65 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.87 121.28 14.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.709 . . . . 0.0 111.473 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -135.73 69.89 1.43 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.571 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 10.4 t90 -24.69 128.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 125.055 1.472 . . . . 0.0 113.323 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 72.2 Cg_endo -98.19 23.35 22.81 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.997 -1.668 . . . . 0.0 114.237 0.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.5 pt -134.97 158.75 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 121.81 -0.556 . . . . 0.0 112.306 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 73.2 m -85.24 138.12 32.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.583 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -133.48 130.15 38.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.65 ' HD3' HG23 ' A' ' 4' ' ' VAL . 14.0 ptm180 -102.79 121.15 41.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.077 -177.582 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.454 0 CA-C-O 120.439 -0.089 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.9 mt -131.83 127.71 21.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.292 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.7 Cg_exo -74.66 49.35 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.311 2.674 . . . . 0.0 112.526 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 m -103.88 43.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.344 0.592 . . . . 0.0 112.286 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.0 m -99.43 -35.32 9.94 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.764 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.07 28.67 40.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.92 151.4 49.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 110.853 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -97.61 143.16 28.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 9.0 p -120.26 34.87 5.05 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.823 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 15.2 t -65.12 -24.86 67.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.067 0.461 . . . . 0.0 109.962 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.58 -15.28 57.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.03 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.53 43.63 6.09 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.981 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -154.78 156.94 37.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -149.56 126.63 11.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.83 -22.19 25.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.696 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.662 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.67 159.11 35.03 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.673 0.749 . . . . 0.0 112.55 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -80.73 131.77 35.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.179 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 65.05 18.79 65.14 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.115 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 72.3 m -92.91 134.02 35.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.067 0.46 . . . . 0.0 110.651 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 p -114.57 144.14 43.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.8 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -70.75 122.95 20.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.677 0.751 . . . . 0.0 111.254 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -135.17 71.0 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.59 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 17.3 t90 -27.39 123.57 0.24 Allowed Pre-proline 0 N--CA 1.462 0.172 0 O-C-N 125.002 1.439 . . . . 0.0 113.287 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 96.9 Cg_endo -103.16 31.23 8.71 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.348 -1.521 . . . . 0.0 114.016 0.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.4 pt -129.81 158.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 73.4 m -89.96 135.42 33.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.287 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 12.8 ttmt -124.79 117.72 24.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.664 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.761 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.9 ptm180 -108.22 133.3 52.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.432 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 CA-C-O 120.355 -0.136 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.1 mt -131.31 125.21 20.75 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.854 0.359 . . . . 0.0 110.157 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.86 47.92 2.08 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.192 2.594 . . . . 0.0 112.382 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 28' ' ' ARG . 5.3 m -104.85 45.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 35.5 m -97.96 -33.43 11.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.798 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.01 30.8 45.53 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.026 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.71 153.66 50.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.043 0.449 . . . . 0.0 110.529 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 40.9 p -101.37 143.0 31.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 t -122.19 41.88 3.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.734 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.7 t -73.04 -26.02 61.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.38 -18.8 44.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.401 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.9 34.93 7.42 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.437 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.0 p -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 122.573 0.349 . . . . 0.0 110.608 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.2 m -131.19 123.95 29.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.99 -25.63 27.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.767 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.622 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -68.21 153.93 42.75 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.589 0.709 . . . . 0.0 111.994 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -86.38 138.35 31.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.526 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 66.87 16.04 65.56 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.622 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 86.4 m -100.59 134.98 42.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -109.77 144.29 38.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.75 118.4 8.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.546 0.689 . . . . 0.0 110.414 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -136.21 73.17 1.45 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.734 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 26.9 t90 -34.44 127.3 0.49 Allowed Pre-proline 0 N--CA 1.465 0.29 0 O-C-N 124.367 1.042 . . . . 0.0 112.236 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -98.92 30.48 12.63 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 -1.471 . . . . 0.0 114.169 0.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.6 pt -133.71 -164.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.965 0.412 . . . . 0.0 111.801 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.6 m -125.62 138.23 53.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 ttmp? -119.07 120.06 36.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 3.9 ptp180 -105.91 129.01 54.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.472 0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.821 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.472 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.64 123.41 32.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.067 0.434 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HB3' HD12 ' A' ' 25' ' ' ILE . 72.3 Cg_endo -76.76 52.57 3.76 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.213 2.608 . . . . 0.0 112.724 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.41 22.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.237 0.541 . . . . 0.0 111.555 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 4.0 m -89.63 -33.82 16.53 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.5 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.16 25.97 56.29 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.206 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -125.76 144.08 50.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.129 0.49 . . . . 0.0 111.108 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.4 p -101.62 144.52 30.24 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.0 p -148.07 128.66 14.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.831 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.0 t -116.06 -34.03 4.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.961 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.4 -53.14 6.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.251 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.562 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 140.75 47.88 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.364 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 p -122.73 133.15 54.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.3 m -147.74 124.3 11.07 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -86.0 -25.22 26.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.664 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -69.65 154.45 41.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.439 0.637 . . . . 0.0 112.568 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -85.18 133.68 34.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.504 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.39 -12.45 26.49 Favored Glycine 0 C--O 1.23 -0.108 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.261 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 28' ' ' ARG . 69.4 m -75.84 139.14 41.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.964 0.412 . . . . 0.0 111.142 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.9 p -122.42 142.43 50.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.812 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.562 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 42.6 t -71.72 121.79 19.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.362 0.601 . . . . 0.0 110.613 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 49.8 m -135.44 83.49 2.02 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.831 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 7.5 t90 -27.65 121.33 0.25 Allowed Pre-proline 0 C--N 1.331 -0.217 0 O-C-N 125.077 1.485 . . . . 0.0 113.091 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 86.5 Cg_endo -106.05 33.94 5.27 Favored 'Cis proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.701 -1.375 . . . . 0.0 113.863 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 3' ' ' PRO . 8.7 pt -139.23 153.59 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -89.09 132.0 34.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 18.5 ptpt -136.12 133.58 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -103.85 131.68 50.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 113.814 0.285 . . . . 0.0 113.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -127.5 123.79 23.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.32 0.56 . . . . 0.0 110.399 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.2 Cg_endo -76.41 47.47 2.09 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.871 2.38 . . . . 0.0 112.668 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.421 HG23 ' HD2' ' A' ' 28' ' ' ARG . 7.7 m -104.8 48.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 47.9 m -101.12 -33.16 10.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.71 150.51 22.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 111.355 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.1 p -97.41 143.07 28.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.288 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.19 41.05 1.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.721 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.771 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 9.8 t -76.87 -34.93 57.77 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -82.0 -15.48 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.623 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.25 37.54 9.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.382 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -137.53 145.39 42.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.223 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -157.75 133.88 9.45 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -110.78 -10.79 14.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.609 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.591 ' HB ' HH21 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -71.84 154.95 40.93 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.687 0.756 . . . . 0.0 112.289 -178.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -68.3 129.85 41.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.246 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 55.45 28.25 50.29 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.591 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 85.3 m -96.77 135.57 38.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -113.49 140.03 48.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.18 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.14 115.29 10.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.466 0.65 . . . . 0.0 111.41 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -135.88 84.25 2.07 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.771 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.9 t90 -33.82 125.22 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.689 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 85.3 Cg_endo -104.45 33.04 6.73 Favored 'Cis proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.592 -1.42 . . . . 0.0 114.16 0.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.445 ' CG1' ' N ' ' A' ' 26' ' ' CYS . 11.9 tt -144.11 159.74 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 84.3 m -79.03 136.15 37.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.131 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 13.0 ttpp -127.56 116.11 19.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.054 0.454 . . . . 0.0 111.221 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.591 HH21 ' HB ' ' A' ' 16' ' ' THR . 8.5 ptp180 -104.7 128.36 52.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.26 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.148 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 4.1 mm? -114.63 122.19 34.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.434 0.617 . . . . 0.0 111.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' ILE . 5.3 Cg_exo -77.62 50.01 3.09 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.693 2.929 . . . . 0.0 112.13 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 m -103.72 28.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.344 0.592 . . . . 0.0 111.608 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.492 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 10.9 m -89.49 -33.59 16.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.3 30.25 57.17 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.032 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -132.27 155.13 48.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.938 0.399 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 23.2 p -107.46 144.26 34.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.882 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 8.9 t -119.83 38.66 3.86 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.033 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.684 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.9 t -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.6 pt? -81.89 -18.71 42.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.54 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 44.63 4.35 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.145 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -157.17 152.65 26.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -142.42 130.29 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.85 -22.18 18.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.352 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.585 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -70.53 156.12 39.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.606 0.717 . . . . 0.0 112.096 -179.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -85.39 133.25 34.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.93 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.48 -7.04 27.33 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.561 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 89.1 m -78.66 133.54 37.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -108.85 148.04 31.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.512 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.7 t -70.24 116.97 11.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.317 0.58 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -137.1 80.94 1.84 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.684 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 24.0 t90 -37.22 129.54 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 O-C-N 124.251 0.969 . . . . 0.0 112.079 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.7 Cg_endo -98.96 29.0 14.57 Favored 'Cis proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.389 -1.505 . . . . 0.0 114.225 1.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.4 pt -133.93 -167.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 112.301 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.7 m -128.86 138.79 52.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -135.17 133.44 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.194 0.521 . . . . 0.0 111.66 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.648 ' HD3' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -102.56 130.42 49.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.648 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 4.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.282 -0.177 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.595 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.2 mm? -121.83 113.97 31.37 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 117.252 0.526 . . . . 0.0 110.371 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 5.8 Cg_exo -79.85 43.31 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.49 2.793 . . . . 0.0 112.158 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 2' ' ' LEU . 6.5 m -104.75 42.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.235 0.54 . . . . 0.0 112.413 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' HH12 ' A' ' 28' ' ' ARG . 16.8 m -89.61 -32.79 16.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.67 24.87 52.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.732 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.77 150.84 52.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -98.35 141.78 30.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.755 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 m -114.58 40.79 2.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.743 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.692 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.7 t -74.32 -34.84 63.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.92 -37.15 27.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.033 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 45.4 1.01 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.602 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -139.74 143.42 36.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.821 -0.19 . . . . 0.0 111.097 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -154.2 122.83 6.21 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.35 -20.03 24.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.142 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -67.84 156.83 36.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.969 -179.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -84.28 134.89 34.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.16 -6.45 14.36 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.808 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.903 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 58.2 m -73.27 139.2 45.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 111.36 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 p -125.0 139.81 53.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.07 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.27 121.88 13.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.541 0.686 . . . . 0.0 111.509 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 m -135.03 73.67 1.49 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.692 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -33.69 127.02 0.44 Allowed Pre-proline 0 N--CA 1.463 0.213 0 O-C-N 124.414 1.071 . . . . 0.0 112.708 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -97.48 19.72 28.7 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.223 -1.574 . . . . 0.0 113.886 0.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 5.9 pt -116.99 -163.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 111.958 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.903 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 8.5 t -132.34 139.99 48.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.2 ttpm? -135.69 127.81 29.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.73 HH12 ' HA ' ' A' ' 5' ' ' CYS . 23.4 ptt-85 -115.31 130.26 56.85 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.655 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 113.461 0.145 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 97.4 mt -137.06 121.24 12.24 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.923 0.392 . . . . 0.0 110.456 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 3.2 Cg_exo -76.93 54.32 4.51 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.46 2.774 . . . . 0.0 112.08 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.89 52.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.733 0.777 . . . . 0.0 112.269 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB3' HG21 ' A' ' 16' ' ' THR . 70.0 m -125.82 -30.3 3.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.426 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.03 -11.22 49.6 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.766 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' OE2' HG23 ' A' ' 16' ' ' THR . 48.4 mt-10 -88.33 145.89 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.462 0.649 . . . . 0.0 111.765 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 19.9 p -95.83 145.65 25.18 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -124.09 36.2 4.67 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.943 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.675 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.0 t -62.26 -28.68 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.056 0.455 . . . . 0.0 110.037 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -81.35 -2.31 48.73 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.437 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.48 45.43 14.02 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.092 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.3 m -157.24 155.96 31.7 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.6 m -143.74 127.7 17.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -84.76 -33.63 23.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.294 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.475 HG23 ' OE2' ' A' ' 7' ' ' GLU . 1.3 p -64.58 151.12 45.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.635 0.731 . . . . 0.0 111.953 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -82.68 137.13 34.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.382 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.94 -14.59 13.2 Favored Glycine 0 N--CA 1.454 -0.137 0 CA-C-N 115.828 -0.623 . . . . 0.0 113.384 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -74.88 141.23 44.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -118.04 141.61 48.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.278 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.4 t -66.22 121.5 15.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.604 0.716 . . . . 0.0 111.19 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 m -136.43 73.94 1.48 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.675 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -29.28 125.68 0.26 Allowed Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 124.811 1.319 . . . . 0.0 113.074 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.7 Cg_endo -101.41 26.0 15.09 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.212 -1.578 . . . . 0.0 114.358 1.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 6.5 pt -131.83 160.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.459 0.647 . . . . 0.0 112.587 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 82.7 m -88.63 133.89 34.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.172 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HD2' ' HA2' ' A' ' 1' ' ' GLY . 14.4 ttpp -132.06 123.84 28.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.949 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -104.48 132.0 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.857 179.479 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 CA-C-O 120.397 -0.113 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.5 mt -135.55 126.11 16.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.518 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.8 Cg_exo -75.85 53.35 3.67 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.347 2.698 . . . . 0.0 111.992 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.36 43.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 112.463 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.663 ' SG ' ' HG2' ' A' ' 28' ' ' ARG . 59.0 m -112.2 -30.16 7.31 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.149 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.64 49.79 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.189 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -131.72 148.88 52.61 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 111.382 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 39.2 p -96.63 143.3 27.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 13.6 p -123.17 37.15 4.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.169 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.644 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 12.2 t -63.71 -28.45 69.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.17 0.51 . . . . 0.0 109.997 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.06 -18.16 47.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.205 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.44 46.91 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.316 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 m -154.58 154.3 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.806 -0.232 . . . . 0.0 110.442 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -150.15 126.74 10.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -78.46 -35.79 46.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 4.3 p -61.5 149.99 37.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.781 0.8 . . . . 0.0 112.193 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -84.58 134.67 34.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.12 -5.33 77.1 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.14 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -80.47 145.06 32.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.0 p -124.76 143.78 50.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.47 125.3 26.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.727 0.775 . . . . 0.0 111.833 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.2 m -135.58 70.73 1.43 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 19.4 t90 -28.43 125.14 0.24 Allowed Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 124.881 1.363 . . . . 0.0 113.105 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.6 Cg_endo -101.55 28.57 12.4 Favored 'Cis proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.285 -1.548 . . . . 0.0 114.072 0.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 5.2 pt -129.59 156.83 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.735 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 96.9 m -84.98 137.92 32.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 16.1 ttmt -135.09 121.18 19.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.441 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -108.8 133.55 52.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 123.543 0.527 . . . . 0.0 111.278 179.486 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.862 -0.095 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 95.0 mt -128.44 123.51 22.37 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.323 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HB3' HD12 ' A' ' 25' ' ' ILE . 6.8 Cg_exo -74.16 50.13 2.15 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.459 2.773 . . . . 0.0 112.468 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.1 m -103.87 26.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.192 0.52 . . . . 0.0 111.924 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.538 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 20.9 m -91.69 -34.06 14.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.77 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.2 -8.1 61.91 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.796 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -87.82 145.3 26.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 111.426 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.4 p -98.49 147.39 24.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -132.81 38.69 3.38 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.664 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 10.6 t -64.95 -26.96 68.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.454 HD22 HG23 ' A' ' 10' ' ' THR . 2.5 mm? -80.75 -13.87 58.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.34 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.78 34.4 8.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.608 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -139.58 146.5 39.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.727 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.3 m -130.31 121.17 25.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.479 0.657 . . . . 0.0 109.853 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.49 -30.83 57.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.686 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.634 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -78.69 157.75 28.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.222 0.534 . . . . 0.0 112.046 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 18.2 mp0 -90.71 137.24 32.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.092 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.62 1.37 65.96 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.028 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 94.5 m -89.3 134.06 34.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.468 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.8 p -109.21 140.49 42.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.98 122.67 17.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.693 0.759 . . . . 0.0 111.027 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 71.09 1.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.664 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 23.2 t90 -26.56 121.45 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 124.777 1.298 . . . . 0.0 113.105 -176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 89.3 Cg_endo -103.59 30.99 8.5 Favored 'Cis proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.455 -1.477 . . . . 0.0 114.284 0.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 3' ' ' PRO . 7.8 pt -131.94 161.51 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.466 0.575 . . . . 0.0 112.49 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 86.1 m -101.2 134.36 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.843 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -123.48 129.9 51.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.195 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.706 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 57.5 ttp180 -104.27 132.54 50.41 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.321 -0.663 0 O-C-N 123.863 0.727 . . . . 0.0 110.57 -179.253 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.074 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.21 122.72 16.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 110.423 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 72.8 Cg_endo -76.83 52.37 3.71 Favored 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.048 2.498 . . . . 0.0 111.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -103.36 24.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.238 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 61.0 m -89.63 -30.55 18.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 33.83 64.65 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.615 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -131.92 147.97 52.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.01 0.434 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -93.16 142.79 26.91 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 11.1 p -124.84 33.5 5.19 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.94 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.592 ' HA ' ' HD1' ' A' ' 23' ' ' TRP . 14.4 t -64.34 -25.22 67.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.082 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 HG23 ' A' ' 10' ' ' THR . 2.8 mm? -80.66 -11.51 59.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.29 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.27 42.71 7.82 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.879 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.43 153.82 32.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.545 0.212 . . . . 0.0 111.12 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -144.44 129.57 18.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.49 -34.16 28.09 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 1.2 p -58.78 153.36 17.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.873 0.844 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -80.08 127.04 31.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.927 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.77 74.7 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.863 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 1.7 t -96.26 148.41 22.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.6 p -123.45 142.35 51.08 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.3 t -69.92 125.37 26.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.688 0.756 . . . . 0.0 111.732 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.8 m -135.49 69.07 1.44 Allowed 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.592 ' HD1' ' HA ' ' A' ' 10' ' ' THR . 15.2 t90 -26.6 124.46 0.22 Allowed Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 125.034 1.459 . . . . 0.0 113.414 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.5 Cg_endo -101.21 26.75 14.67 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.344 -1.523 . . . . 0.0 114.016 0.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -126.04 157.14 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 112.901 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.863 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 85.3 m -87.21 140.08 29.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.162 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 15.1 ttmt -135.43 117.52 15.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.928 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -106.58 133.59 51.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.7 0.286 . . . . 0.0 110.853 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 t30 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.543 -179.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -121.51 120.97 28.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 117.007 0.404 . . . . 0.0 110.616 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.4 47.29 1.8 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.311 2.674 . . . . 0.0 113.293 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG23 HH11 ' A' ' 28' ' ' ARG . 6.0 m -105.83 34.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 112.093 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 31.3 m -89.41 -34.95 16.3 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.447 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.26 29.32 41.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.557 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -136.9 157.52 46.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.884 0.373 . . . . 0.0 110.061 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . 34.6 p -109.05 140.62 42.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.572 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.4 t -107.56 33.45 4.04 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.061 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.606 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . 13.1 t -71.55 -27.97 63.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.08 -16.28 50.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.331 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.09 41.83 6.13 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.23 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -170.02 160.07 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 111.01 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 m -161.2 134.98 6.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.806 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -97.44 10.18 40.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.711 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -82.9 158.46 22.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.541 0.686 . . . . 0.0 111.834 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -78.67 130.8 36.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.329 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' ARG . . . 59.2 19.16 44.97 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.644 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.711 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 81.8 m -89.65 134.35 34.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.09 0.471 . . . . 0.0 111.104 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.3 p -108.25 141.61 39.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.5 t -62.71 118.86 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 110.463 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -136.66 68.7 1.42 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 10' ' ' THR . 31.8 t90 -34.6 128.94 0.48 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 124.319 1.012 . . . . 0.0 112.207 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 61.6 Cg_endo -95.03 25.23 23.01 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.063 -1.64 . . . . 0.0 114.216 1.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 7.2 pt -128.67 -159.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 121.929 -0.482 . . . . 0.0 111.477 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 27.1 m -144.98 140.83 28.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.323 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -127.37 133.63 50.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 10.1 ptp85 -103.61 128.74 50.85 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 -177.903 . . . . . . . . 0 0 . 1 stop_ save_